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Glossary of Abbreviations 
 
2C-B   4-Bromo-2, 5-dimethoxyphenethylamine  
2C-B-BZP  1-(4-Bromo-2, 5-dimethoxybenzyl) piperazine  
2C-D    2, 5-Dimethoxy-4-methylphenethylamine  
2C-I   2, 5-Dimethoxy-4-iodophenethylamine  
2C-T7   2, 5-Dimethoxy-4-n-propylthiophenethylamine  
2-FA   2-Fluoroamphetamine 
3FA   3-Fluoroamphetamine  
3-MeO-PCP   3-Methoxy Phencyclidine  
4-AcO-DALT  4-Acetoxy-N, N-diallyl tryptamine 
4-AcO-DET   4-Acetoxy-N, N-diethyltryptamine 
4-AcO-DMT   4-Acetoxy-N, N-dimethyl tryptamine 
4-FA    4-Fluoroamphetamine 
4-FPP /pFPP   1-(4-Fluorophenyl) piperazine or para-Fluorophenyl piperazine  
4-HO-DiPT   4-Hydroxy-di-isopropyl-tryptamine  
4-MeO-PCP  1-[1-(4-Methoxyphenyl) cyclohexyl]-piperidine (or) 4-methoxy  
   phencyclidine  
4-MTA  4-Methylthioamphetamine  
5-APB   5-(2-Aminopropyl) Benzofuran  
5-HIAA  5-Hydroxyindoleaceticacid 
5-HT   5-Hydroxytryptamine (or) serotonin  
5-MeO-DALT  N, N-diallyl-5-methoxytryptamine 
5-MeO-DiPT   5-Methoxy-diisopropyltryptamine 
5-MeO-MiPT   5-Methoxy-N-methyl-N-isopropyltryptamine 
6-APB   6-(2-Aminopropyl) benzofuran / Benzofury  
6-APDB   6-(2-Aminopropyl)-2, 3-dihydrobenzofuran / Benzofury  
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25B-NBOMe   4-Bromo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine  
25C-NBOMe   4-Chloro-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine  
25I-NBOMe   4-Iodo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine  
AIDS   Acquired immunodeficiency syndrome  
Benzofury   see 6-APB & 6-APDB   
BZP   N-benzylpiperazine or 1-benzylpiperazine  
CEVs   Closed Eye Visualizations 
CP-47,497  2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl)phenol  
CPK   Creatinine phosphokinase 
CPP    Chlorophenylpiperazine 
CRP   C-reactive protein 
Crystal meth   N-methyl-1-phenylpropan-2-amine (or) methamphetamine  
DBZP    1, 4-dibenzylpiperazine 
DEA   Drug Enforcement Administration  
DF   Drugs Forum 
DMAA  1, 3-dimethylamylamine  
DOB   2, 5-Dimethoxy-4-bromoamphetamine 
DOC   2, 5-Dimethoxy-4-chloroamphetamine 
DOI   2, 5-Dimethoxy-4-iodoamphetamine 
DXM   Dextromethorphan  
ECG   Electrocardiogram  
EMCDDA   European Monitoring Centre for Drugs and Drug Addiction  
EWS   Early warning system 
GC/MS  Gass Chromatography – Mass Spectrometry  
HU-210  1, 1-Dimethylheptyl-11-hydroxytetrahydrocannabinol   
JWH-018  1-Pentyl-3-(1-naphthoyl) indole  
JWH-073  Naphthalen-1-yl-(1-butylindol-3-yl) methanone       
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JWH-210  4-Ethylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone  
LC-MS  Liquid chromatography with tandem Mass Spectrometry 
LSD   Lysergic acid diethylamide  
LD50   Median lethal dose  
MAOIs  Mono-amine oxidase inhibitors 
MBDB  N-Methyl-1, 3-benzodioxolylbutanamine  
MBZP   1-Methyl-4-benzylpiperazine  
MDA   3, 4-Methylenedioxyamphetamine  
MDBZP   Methylenedioxy benzyl piperazine  
MDMA/ Ecstasy 3, 4-Methylenedioxy methamphetamine 
MDPV   Methylenedioxypyrovalerone  
MeOPP   1-(4-Methoxyphenyl) piperazine or para    
   Methoxyphenylpiperazine  
mCPP    meta-Chlorophenylpiperazine or 1-(meta-chlorophenyl)   
   piperazine) or 1-(3-chlorophenyl) piperazine)  
Mephedrone   4-Methyl methcathinone  
Naphyrone   Naphthyl pyrovalerone  
NMDA   N-methyl d-aspartate 
NPS   Novel Psychoactive Substances 
NRG-1  1-(2-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride  
NRG-2  (2α,3α)-Epithio-17α-methyl-17β-ol-N-Benzyloxycarbonyl-d- 
   proline  - a counterfeit NPS designed to evade the law 
PFA    para-Fluoroamphetamine 
PiHKAL   Phenethylamines I have known and loved 
ReDNet   The Recreational Drugs European Network project 
SERT    Serotonin transporter  
SSRIs   Selective serotonin reuptake inhibitors  
STA   Systematic toxicological analysis  
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TiHKAL  Tryptamines I have known and loved 
THC /Δ9-THC delta-9-Tetrahydrocannabinol  
TFMPP   m-Trifluromethylphenylpiperazine 
UPLC-TOF-MS Ultra liquid chromatography with time of flight mass   
   spectrometer  
UR-144   (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone  
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Abstract  
 
Objective: This research aimed at reviewing the information provided by the online drug 
misuse communities with reference to the available evidence-based literature on the novel 
psychoactive substances.  
 
Methodology: Among hundreds of novel psychoactive substances, four groups 
(phenethylamines, tryptamines, piperazines and miscellaneous) were selected for the study. 
Various website drug fora were identified by Google and Yahoo search engines using a set of 
specific key words. The methods consisted of extracting and analysing qualitative data from 
the identified website fora. This was also supplemented by critical reviewing the existing 
evidence-based literature search for each of the selected psychoactive compounds.  
 
Results: The combined search results identified 84 unique website fora from which 
qualitative data were extracted for thirty novel psychoactive substances and organised into 
technical folders. This data extracted from online communities has thrown some light on 
factors such as the mode of purchase, subjective experiences, reasons for use, combinations, 
legislation, mechanisms of action in the CNS, side effects, toxicity and its management. This 
would enable the clinicians to be obtain full history when assessing and would inform better 
treatment choices.    
 
Conclusions: A range of novel psychoactive substances have been made recently available 
across the globe. The sale is easily achieved through the Internet. New legislations are made 
to control some recreational substances whilst newer substances appear. Furthermore, the 
distributors sell the backlog of products even after controlling of the substance has occured 
and hence are liable to potentiating criminal investigations. It is here suggested as well that 
the 'genuinity' of each onlince susbtance is questionable. Evidence-based literature is scant 
for the vast majority of these substances. Accidental overdoses are common occurences and 
some of the potential life-threatening clinical situations include sympathomimetic toxidrome 
and serotonin syndrome. Benzodiazepines appear to help with agitation and neuropsychiatric 
manifestations. Better levels of international cooperation and rapid share of available 
information may be needed to tackle the emerging problem of the novel psychoactive 
substances. 
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Introduction 
 
The use and misuse of alcohol and drugs has been an inseparable part of human society for 
centuries across the globe. Records from Mesopotamia (5000 to 4000 BC) indicate the use of 
opium (Lindensmith, 1968) and an Egyptian papyrus (3500 BC) mentioned the production of 
alcohol in a brewery (Ford, 1969). The first recorded use of cannabis as an intoxicant 
occurred in 2737 BC by the Chinese emperor Shen Nung (National commission on 
Marihuana and Drug Abuse, 1972; Ray and Ksir, 1995). The practice of coca-leaf chewing 
was relatively common in prehistoric human populations from the southern coast of Peru 
(Indriati and Buikstra, 2001). Psychoactive substances have been available for very long time 
and there seems to be a remarkable change in the pattern and prevalence of drug misuse over 
the last century or so (Herxheimer and Sanz, 2008). Among several reasons, few are worth 
mentioning.  
 
First, improved cultivation of the plants yields higher concentration of the active ingredients 
and hence higher the potency of the drugs which are more pleasurable. For example, the THC 
content of marijuana has increased from 1.5% in 1980 to 2.5% in 1997 and to 15% in 2004 
(Licata et al, 2005). The National Drug Intelligence Centre in the USA published in a report 
that higher potency marijuana from cannabis was cultivated as a result of improved 
cultivation techniques (Domestic Cannabis Cultivation Assessment, 2007). Moreover the 
1980s marked the start of the use of recreational drugs which spread as an epidemic in the 
developed world along with the rapid spread of HIV disease. Researchers have found that the 
chronology and epidemiology of the recreational drug epidemics in American and European 
countries co-existed with AIDS epidemics, which led to the Drugs – AIDS hypothesis 
(Duesberg and Rasnick, 1997).  
 
The term ‘Novel Psychoactive Substances’ is more appropriately used throughout- than the 
term ‘Legal Highs’, as the latter term may cause confusion among users. These substances 
may not be ‘legal’ as the law changes rapidly in many countries and also the term ‘High’ can 
be misleadingly interpreted as producing euphoria without any toxic effects. Hence this term 
is to be avoided (Corazza et al, 2012).  
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A group of 'Novel Psychoactive Substances' (NPS) produced by clandestine laboratories have 
appeared in the market (Henderson, 1988). These chemicals are analogues to the controlled 
psychoactive substances but may or may not be legally banned in many countries. They 
generate biological responses not only similar to but are also enhanced as compared to the 
parental compounds (Cooper, 1988). In the mid-1980s’, one such drug, MDMA (Ecstasy), 
became popular and it was sold in massive amounts in certain parts of the western world 
(Collin and Godfrey, 1997). After a long and intense struggle in the courts, MDMA was 
permanently banned from the USA in 1988. However, there was a great demand for 
chemicals that were similar to ecstasy, but were not legally banned. When Alexander Shulgin 
published his books, PiHKAL
  
(Shulgin and Shulgin, 1991) describing 179 phenethylamines 
and TiHKAL (Shulgin and Shulgin, 1997) describing 64 tryptamines synthesised in his 
laboratory, these drugs gained popularity. Recently, he also published 'Shulgin Index' with a 
comprehensive account of 126 substances including their synthesis, biochemistry, 
pharmacology and legal status (Shulgin et al, 2011). Thus more than 360 psychoactive 
substances have been synthesised and a number of such substances have appeared in the drug 
market in the last few years (e.g., 2C-T7; DOC; 4-acetoxy-DMT etc). 
 
Another reason for the prevalence of novel psychoactive substances is that the Internet (‘e-
commerce market’) (Schifano et. al, 2003) has become the most popular instrument for the 
dissemination of knowledge and sale of these drugs, apart from the conventional ‘street 
market’ and the ‘free market’ i.e., selling drugs through mobile phone communication and 
among groups of friends (Littlejohn et. al, 2005). The ‘Operation Web Tryp’ investigated 
Internet websites distributing highly dangerous ‘designer’ drugs and made few arrests in 2004 
in the USA (DEA news release, 2004). Also among the innumerable clandestine laboratories 
in the USA, 132 “super labs” (capable of producing 10-20 or more pounds of substances per 
cooling cycle) were seized in 2003 and 5,471 clandestine “mom and pop” laboratories (small 
scale labs) were seized in 2004
 
(United States department of Health and Human Services, 
2005). 
 
Taking into account the above mentioned factors, it could be argued that as a result of the use 
of psychoactive substances either extracted or synthesised and easily marketed through the 
Internet, health related problems may be observed as a consequence. Therefore it is necessary 
that health care professionals have access to comprehensive data on the availability of the 
wide variety of novel psychoactive substances so that the information can be incorporated in 
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the treatment plan for the patients. But the evidence based literature on these drugs is scarcely 
available (Commission of the European Communities Directorate, 2002). 
 
The data available in the literature pertaining to novel psychoactive substances is obtained 
from a limited number of indicators, including both acute toxicity events (reported to: 
hospitals; other health professionals; poisons’ units etc), and the small number of seizures. 
However, reliable data are not typically extracted from the actual consumption by the drug 
misuse community. Furthermore, the number of seizures may be minimal compared to the 
enormous ongoing process of production in the clandestine laboratories, its sale through the 
Internet and its consumption by the drug misuse community. The European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) has implemented an Early Warning 
System (EWS), which mostly relies on data from the above described parameters 
 
(The 
European Monitoring Centre for Drugs and Drug Addiction, 2004).  
 
Another alarming factor is that the flood of drug related data available to vulnerable 
individuals due to both the ease and the rapidity of access to the Internet run constantly ahead 
of what is available to clinicians and regulatory authorities (Halpern and Pope, 2001). The 
Psychonaut Project 2002 made a valuable contribution in this area in identifying this lack of 
database for evolving drugs of misuse. This project contributed to the EWS by providing 
information about 100 new psychoactive compounds in 2002. Their findings may constitute a 
public health issue for vulnerable individuals, (i.e., children and adolescents) whose IT 
literacy can be surprisingly good but who are also at higher risk of experimenting with 
psychoactive substances
 
(Commission of the European Communities Directorate, 2002). 
 
Recently, the Recreational Drugs European Network [ReDNet] project (ReDNet project, 
2012). was formed. This project has identified several hundreds of psychoactive compounds. 
It is a multi-site research study which has a goal to disseminate the information to 
professionals and young people about such psychoactive compounds’ potential risks. The 
ReDNet project uses the existing Psychonaut [EWS] project database together with 
information from available literature and online searches to develop accurate information on 
new recreational drugs and to inform harm reduction strategies in research.   
The ‘psychedelic experience’, produced by these drugs is characterised by visual, auditory, 
tactile, olfactory hallucinations, reminiscent thoughts, déjà vu experiences, confusion and 
ineffable experiences (Leary et. al). The users look out for a particular experience which is 
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known as ‘closed eye hallucinations’ or ‘closed eye visualizations’ (CEVs) (Bluelight, 2012). 
This experience is graded into five levels depending on their intensity (Wikipedia, 2012).  
 
On the other hand, some of these drugs (e.g., MDMA, MDA) could cause serious 
complications such as hyperthermia, hypertension, seizures and cardiac arrest (Barone, 1997). 
Hence this study explored possible toxic effects experienced by the drug users as well.     
 
Since most of the novel psychoactive substances are synthesised from the parental 
compounds by altering the basic chemical structure, their effects could be totally different to 
those of their parental compounds. In fact, it may be misleading to determine the 
psychoactive and other medical effects of these compounds simply by examining their 
chemical structure. As a result, it is necessary for the researcher to obtain information about 
their effects from the drug users’ perspective. This Internet-based study explored the views 
and experiences of such users of psycho active substances which were bought online. This 
qualitative data was supplemented by the existing evidence based literature, if any, available 
for each compounds.   
 
Ethical approval: This research, supervised by Prof F Schifano and Dr P Deluca, forms a 
part of similar but larger projects known as the Psychonaut [web scanning] project and 
Recreational Drugs European Network [ReDNet] project, which are essentially an 
Information and Communications Technology [ICT] prevention service addressing the use of 
novel psychoactive substances in vulnerable individuals. Ethical approval for ReDNet was 
given by the University of Hertfordshire in 2010 and the protocol approval number is 
PHAEC: 10-42 (Appendix B). However, the Wandsworth Research Ethics Committee at St 
George's University of London advised that ethical approval was not required for the 
Psychonaut web scanning project under NHS research governance arrangements (Appendix 
C).   
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Aims 
 
1. To understand and identify the characteristics about novel psychoactive substances;  
2. To review the available evidence based literature on these novel psychoactive 
substances;   
3. To understand the subjective experience, the reasons for use, preference, 
combinations, any new insights about the drug misuse communities, sale websites etc;  
4. To explore a wide range of toxic effects experienced by the users, either short- or 
long-term and to identify any reports of deaths related to the intake of these 
compounds discussed in the selected fora;  
5. To obtain recommendations for the medical/psychiatric treatment for overdose or 
toxicity for NPS and;  
6. Ultimately, to contribute to the ‘Early Warning System’ (EWS) where the information 
collected related to these four groups of psychoactive compounds would be made 
available at the European Union-wide level (EMCDDA) through the ReDNet Project / 
Psychonaut Project. 
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Methodology 
 
Huge number of unidentified novel psychoactive substances are easily available through the 
Internet. Of those, three groups (phenethylamines, tryptamines and piperazines) were selected 
for the present study, because of their growing recognition among online drug misuse 
communities, easy availability through the Internet and the lack of evidence based literature.  
 
A) Groups selection:  
A wide variety of synthetic herbs/plants were also discussed by the online communities for 
their psychoactive effects. Hence these were also included as the fourth group (miscellaneous 
psychoactive substances). This research aims to explore the following four groups of 
compounds:  
 
1. Phenethylamine - based psychoactive compounds  
2. Tryptamine - based psychoactive compounds  
3. Piperazine - based psychoactive compounds  
4. Miscellaneous psychoactive compounds – (synthetic herbs/ plants)  
 
B) Selection of the total number of NPS: 
It was necessary to define the number of novel psychoactive substances to be researched and 
to identify them. Phenethylamines form the largest group of novel psychoactive substances 
and contains at least a few hundreds of such substances. A Shulgin described 179 of such 
substances in his book, PiHKAL. He also described 64 novel psychoactive substances from 
the tryptamine class in his book, TiHKAL. Recently, a further 126 substances have been 
added to this list (Shulgin et al, 2011). Thus more than 360 psychoactive substances have 
been available. Numerous piperazine preparations have been produced and marketed as novel 
psychoactive substances. Apart from these three groups, there are several other novel 
psychoactive substances available (miscellaneous group) as well. Thus the overall numbers of 
novel psychoactive substances may exceed several hundreds of psychoactive substances.  
 
As the total number of available novel psychoactive substances is enormous, it was decideded 
(phase 1 progression viva at the University of Hertfordshire) to margin the number to thirty 
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novel psychoactive substances. Hence about ten novel psychoactive substances were selected 
from the phenethylamine group, which formed the largest group. The remaining twenty were 
equally divded among the other three groups. Thus the number of compounds for each of the 
four groups is given below:   
 
1) Phenethylamines   = 10 psychoactive compounds 
2) Tryptamines    = 07 psychoactive compounds 
3) Piperazines   = 06 psychoactive compounds 
4) Miscellaneous    = 07 psychoactive compounds  
Total    = 30 psychoactive compounds  
 
Once the thirty novel psychoactive substances were identified as above, the following 
methodology adopted from the literature
 
(Deluca and Schifano, 2007) was used to carry out 
the required web searches. It was aimed at identifying various website fora through searching 
Google and Yahoo using specific key words and extracting qualitative data from the 
identified web fora. This was also supplemented by extensive evidence based literature 
search for each of the selected psychoactive compounds.  
C) Web fora / keyword(s) search:  
The key words were coined to capture webfora from all the four categories of compounds. 
The following key words were used to identify the unique web fora:   
 
1. “Phenethylamines misuse forum” 
2. “Piperazines misuse forum” 
3. “Tryptamines misuse forum”  
4. “Synthetic herbs/ plants forum” 
 
Searches were carried out using the websites by means of specific key words using the 
popular search engines: Google
TM
 and Yahoo
TM
. These two search engines were identified 
because of their popularity. For each set of the key words, the first 100 websites identified by 
Google
TM
 and Yahoo
TM
 were fully assessed, together with a further random samples selected 
by a specific web randomizer (Research Randomizer, 2012) of 5% of the remaining websites 
which were chosen among those actually available.  
D) Unique website identification:  
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Out of the identified websites, only those websites discussing the chosen groups of the 
psychoactive compounds in the user fora were included in this study. All other websites that 
were unrelated (such as information, sales, music, movies) excluded from the study. All the 
remaining unique web sites were listed (Appendix A).    
 
Most of the web fora can be viewed without becoming a member. However, to access certain 
contents such as picture files, attachements etc, a free registration is required. Most of the 
fora require free registration to post replies. The researcher obtained free registration for only 
one website (DF) and all the other websites were accessed without registration. No posts 
were made by the researcher. There were very few web fora which were completely closed 
and no information was obtained from such fora (Entheo-worldeyes, 2013).  
  
E) ‘Threads’ and ‘Posts’ identification: 
Once the unique website fora were identified, ways to access the website were analysed. 
Most of the website fora did not require registration to get access to the main fora. Very few 
websites required registration. In such cases, the researcher opened an account with a 
username, password and an e-mail account for few of such websites.  
 
In each website forum, there were a number of ‘threads’ (the topics for discussion) and a 
number of ‘replies’ or ‘posts’ (the responses and discussion by forum members). Only the 
‘threads’ discussing the thirty novel psychoactive compounds were included.   
 
F) Selection of novel psychoactive substances:  
 
A particular novel psychoactive substance was selected by various factors such as the 
popularity among the online drug misuse communities, novelty of the substances, levels of 
discussions on a particular substance ('hot topics'), any recent deaths reported in the 
newspapers (eg, Benzofury) etc. Thus the identified chemical and common names of these 
thirty novel psychoactive compounds are given below:  
Phenethylamines 
1) 4-Fluoroamphetamine (4-FA) or Para-Fluoroamphetamine (PFA)  
2) 2, 5-Dimethoxy-4-chloroamphetamine (DOC) 
3) 4-Methyl methcathinone (Mephedrone) 
4) Naphthyl pyrovalerone (Naphyrone)  
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5) 2, 5-Dimethoxy-4-n-propylthiophenethylamine (2C-T7) 
6) 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine(25B-NBOMe) 
7) 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine(25C-NBOMe) 
8) 4-Iodo-2, 5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) 
9) 5-(2-Aminopropyl) Benzofuran (5-APB) 
10) 6-(2-Aminopropyl) Benzofuran (6-APB)  
Tryptamines 
1) 4-Hydroxy-di-isopropyl-tryptamine (4-HO-DiPT) 
2) 4-Acetoxy-N, N-dimethyl tryptamine (4-AcO-DMT)  
3) 4-Acetoxy-N, N-diethyltryptamine (4-AcO-DET) 
4) 4-Acetoxy-N, N-diallyl tryptamine (4-AcO-DALT) 
5) N, N-diallyl-5-methoxytryptamine (5-MeO-DALT) 
6) 5-methoxy-diisopropyltryptamine (5-MeO-DiPT) 
7) 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT) 
Piperazines 
1) 1-methyl-4-benzylpiperazine (MBZP) 
2)  methylenedioxy benzyl piperazine (MDBZP) 
3) 1-(4-bromo-2, 5-dimethoxybenzyl) piperazine (2C-B-BZP)  
4) meta-Chlorophenylpiperazine (mCPP)  
5) 1-(4-Fluorophenyl) piperazine (4-FPP) or para-Fluorophenyl piperazine (pFPP) 
6) para-Methoxyphenylpiperazine (MeOPP)   
Miscellaneous compounds 
1) 1-pentyl-3-(1-naphthoyl) indole (JWH-018) 
2) naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) 
3) 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-210)  
4) 1, 1-dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210) 
5) 2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl) phenol (CP-47,497)  
6) (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone (UR-144)  
7) 3-Methoxy Phencyclidine (3-MeO-PCP) 
G) Evidence based literature search: 
 
Although there existed hardly any evidence based literature on these compounds, it was 
important to search the literature for any published information on these psychoactive 
compounds. Hence searches were carried out on all of the following data-bases: the Cochrane 
library, Athens library, Medline, Medscape and Google Scholar.   
 
H) Data analysis: Qualitative methods were applied to identify the key themes that emerge 
from the identified forum discussions. The systematic collection of information under the 
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headings for each of the psychoactive compound is known as the ‘technical folders’. Thus the 
data was organised under the following headings for each of the psychoactive compounds:  
1) Overview  
2) Key points  
3) Chemical characteristics of active constituents  
4) Appearance  
5) Available information on purchase price  
6) Modalities of intake  
7) Legal status  
8) Current use/medicinal use  
9) Information on recreational use/misuse in the E.U. (or elsewhere)  
10) Use in combination with other compounds  
11) Pharmacological characteristics  
12) Toxicological effects  
13) Desired psychoactive effects  
14) Physical/medical untoward effects  
15) Psychopathological disturbances associated with its use  
16) Clinical advice  
17) Related fatalities  
18) You tube videos  
19) Google insights  
20) Bibliography  
21) Sitography 
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Results 
 
The following procedure was carried out to identify the unique website fora. Comprehensive 
searches were done using Google and Yahoo search engines.  
 
1) Google search results: 
 
Searches were carried out using the 4 key word(s) using the Google search engine. For each 
key word(s), the first 100 websites and 5% of the remaining websites were analysed. A total 
of 2,016 websites for all the 4 key word(s) search were identified: 
 
1. “Phenethylamines misuse forum”        =   507 
2. “Piperazines misuse forum”   =   476 
3. “Tryptamines misuse forum”    =   585 
4. “Synthetic herbs/ plants forum”   =   448 
 Total number of relevant website fora = 2,016 
 
Of these 2,016 websites identified by Google, there were however only 90 website fora as 
given below:  
 
1. “Phenethylamines misuse forum”        =   21 
2. “Piperazines misuse forum”   =   31 
3. “Tryptamines misuse forum”    =   20 
4. “Synthetic herbs/ plants forum”   =   18 
 Total number of relevant website fora =   90 
 
2) Yahoo search results: 
 
Similarly, searches were carried out using Yahoo Search engine using the same 4 key 
word(s). For each key word(s), the first 100 websites and 5% of the remaining websites were 
analysed. A total of 2,943 websites for all the 4 key word(s) search were identified: 
 
1.  “Phenethylamines misuse forum”         =   724 
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2.  “Piperazines misuse forum”   = 1000  
3.  “Tryptamines misuse forum”    =   699 
4.  “Synthetic herbs/ plants forum”    =   520 
      Total number of websites    = 2943 
 
Of these 2,943 websites identified by Yahoo, there were however only 61websites.  
 
1.  “Phenethylamines misuse forum”         =   19 
2.  “Piperazines misuse forum”   =   12 
3.  “Tryptamines misuse forum”    =   23 
4.  “Synthetic herbs/ plants forum”    =   07 
      Total number of relevant website fora  =   61 
 
Combining Google and Yahoo relevant websites, the relevant website fora obtained by 
Google (90) and Yahoo (61) were analysed. All the duplicate website fora were identified 
and the duplicates removed. Few other websites were shut down. Thus final figures of 84 
Unique Website fora were identified (Appendix A).   
 
The relevant information was derived from these 84 unique website fora and qualitative data 
extraction and analysis were done simultaneousley.  
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The molecular structures of all these 30 compounds included in this study are given below:  
Basic molecular structures:       
     
Phenethylamine     Amphetamine    
     (α-methyl phenethylamine)  
A) Ring substituted amphetamines 
1. 4-FA      2.DOC 
 
   
 
B) Beta ketonated amphetamines (substituted cathinones)  
 
3. Mephedrone     4. Naphyrone 
 
    
  
C) Ring substituted phenethylamines 
 
5. 2C-T7 (2C-series)     6. 25B-NBOMe 
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7. 25C-NBOMe     8. 25I-NBOMe 
    
 
D) Ring substituted methylenedioxy amphetamines   
9. 5-APB 
 
 
 
10. 6-APB and 6-APDB 
 
  
Tryptamines  
A) Simple tryptamines: Ring 4- substituted  
11. 4-HO-DiPT     12. 4-AcO-DALT 
 
   
 
13. 4-AcO-DET     14. 4-AcO-DMT 
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B) Simple tryptamines: Ring 5-substituted 
 
15. 5-MeO-DALT    16. 5-MeO-DiPT 
   
         17. 5-MeO-MiPT 
  
Piperazines 
A) Benzylpiperazines 
  18. MBZP     19. MDBZP 
     
        20. 2C-B-BZP 
 
 
B) Phenylpiperazines 
21. mCPP  22. 4-FPP or pFPP   23. MeoPP 
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Miscellaneous compounds – A) Synthetic cannabinoids 
 
   24. JWH-018      25. JWH-073
    
26. JWH-210      27. HU-210 
   
 28. CP-47497     29. UR-144
    
Miscellaneous compounds – B) Dissociative compound 
 30. 3-MeO-PCP 
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Chapter I: PHENETHYLAMINES 
 
Introduction  
The aryl alkyl amine molecular structure forms the basis for majority of ‘Classic 
Hallucinogens’ from which two major groups of compounds are formed: the indole alkyl 
amine group (e.g., tryptamines) and the phenalkylamine group. Substitutions of the latter 
group further form phenethylamine or phenisopropylamine. A number of analogues could be 
formed by simple alteration of the parent molecule. This could potentially result in the 
formation of immeasurable compounds with altered characteristics.  
Phenethylamine (PEA), a derivative of the amino acid Phenylalanine, is a typical example 
where substitutions/ alterations of the basic parent molecule lead to hundreds of new 
compounds. N-α-methyl substitution in the terminal amine group of Phenethylamine results 
in the formation of α-methylphenethylamine which is commonly known as ‘Amphetamine’. 
The stimulant property of amphetamine requires the presence of unmodified aromatic ring, α-
carbon with methyl group (-CH3) and the terminal amino group (-NH2)
 
and the structure of 
PEA and Amphetamine confers stimulant properties through release of catecholamines, 
mainly dopamine (Nichols, 1994).       
Phenylalanine   Phenethylamine    Amphetamine 
Thus, the ‘novel’ substitution could occur in a number of possible ways either in 
phenethylamine molecule or amphetamine molecule leading to altered or enhanced 
psychoactive properties
 
(Nichols, 1994; Hill and Thomas, 2011) For example, substitution of 
the aromatic ring of PEA leads to 2C- series of compounds (2C-B, 2C-I etc) where as 
substitution of the aromatic ring of amphetamine leads to the formation of D- series of 
compounds (DOB, DOC, DOI etc). This D-series compounds, also known as ‘hallucinogenic 
amphetamines’, act via 5HT2a agonism (Nichols, 1994; Acuna-Castillo et. al, 2002) and 
possess several folds of hallucinogenic properties compared to the ‘parent’ amphetamine 
molecule.   
In another example of substitution, addition of ketone group to the β-carbon of amphetamine 
molecule (β-ketone) produces cathinones which are similar to the naturally occurring 
chemicals found in Khat. Further substitution of cathinone would result in a number of 
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compounds such as mephedrone, flephedrone etc. The presence of β-ketone group increases 
the polarity of the molecule and there by reduces entry into CNS (Hill and Thomas, 2011; 
Gibbons and Zloh, 2010). Hence re-dosing / use of high doses are common to gain entry into 
CNS for ‘psychedelic effects’, but with toxic peripheral effects and higher mortality (Hill and 
Thomas, 2011).  
Thus a countless novel psychoactive compounds have been emerging through the online 
market and their synthesis is marked by simple modification of its structure giving rise to an 
altered molecule with altered function. Here the characteristics of ten psychoactive 
compounds that belong to phenethylamine group are described:   
I.I  4-Fluoroamphetamine (4-FA) or Para-Fluoroamphetamine (PFA)  
I.II   2, 5-Dimethoxy-4-chloroamphetamine (DOC) 
I.III   4-Methyl methcathinone (Mephedrone) 
I.IV   Naphthyl pyrovalerone (Naphyrone)  
I.V   2, 5-Dimethoxy-4-n-propylthiophenethylamine (2C-T7) 
I.VI  4-Bromo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (25B- 
  NBOMe) 
I.VII  4-Chloro-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (25C- 
  NBOMe) 
I.VIII  4-Iodo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (25I- 
  NBOMe) 
I.IX  5-(2-Aminopropyl) Benzofuran (5-APB) 
I.X  6-(2-Aminopropyl) Benzofuran (6-APB) 
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I.I 4-Fluoroamphetamine (4-FA)  
 
4-FA Report 
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 OVERVIEW     
 Chemical name: 4-Fluoroamphetamine 
Synonyms: 4-FA; Para-fluoroamphetamine; PFA; PAL-303; Flux; Flits; R2D2;        
p-Fluoro-alpha-methylphenethylamine; 4-Fluoro-alpha-methylphenethylamine. 
Active constituents: 4-Fluoroamphetamine 
Type: Research chemical – Phenethylamine  
Origin: It is not known who first synthesised 4-FA but there are references to 
this compound in the literature since 1960s. However, the first seizure of 4-FA 
prepared in a clandestine laboratory for recreational purposes was reported in 
January 2003 in Germany.  
Status: Novel 
Chronology: Though the compound is known for many decades, its potential as 
a recreational compound was only known since 2003.   
[a] [1] [2] [3] [4] 
 KEY POINTS 
    
Amphetamine  4-Fluoroamphetamine Phenethylamine 
 
4-Fluoroamphetamine (4-FA) is a ring substituted amphetamine belonging to 
alpha methylated phenethylamine group. It closely resembles the structure of 
phenethylamine and amphetamine. There are three positional ring isomers: 2-
Fluoroamphetamine (2-FA), 3-Fluoroamphetamine (3-FA) and 4-
Fluoroamphetamine (4-FA) as well as two fluoro methoxy amphetamines. 
Unknown compounds seized in Germany were analysed by the gold standard 
Gas Chromatography and Mass Spectrometry (GC/MS). But the analysis 
confirmed the presence of isomeric fluoro amphetamines but could not 
differentiate among them. Hence a higher instrumentation (Gas 
chromatography–infrared spectroscopy and 1H- and 13C-nuclear magnetic 
resonance) was required to differentiate between fluoroamphetamines and 
fluoromethoxy amphetamines.  
[a]          
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 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 1-(4-fluorophenyl) propan-2-amine  
Molecular weight: 153.196683 [g/mol] 
Molecular formula: C9H12FN 
CAS Number: 459-02-9 
[1] [2] [3] [4]  
 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
Isomerism 
4-Fluoroamphetamine is a psychoactive drug and research chemical of the 
phenethylamine and amphetamine chemical classes. It produces stimulant and 
possibly entactogenic effects. [5] 
Sense Aromatic 
4FA aka para-fluoroamphetamine (PFA) is one of the latest additions to our 
stock. Its the highest quality powder form that we are going to supply for our 
loyal customers. [6] 
4FA IS STRICTLY NOT FOR HUMAN CONSUMPTION  
Soilek Chemicals 
4-FA (100g)  4-Fluoroamphetamine 
CAS: 459-02-9 
$400.00    [7]  
  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Different websites quote different price depending upon the country of sale and 
 the geographical location of the supplier. The following are examples from three 
 different websites:  
 10g for $90, 25g for $187, 50g for $300, 100g for $480, 250g for $1200, 
500g for $2100 and 1Kg for $3200 
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 1g for £13, 2g for £22, 10g for £72, 25g for £174, 50g for £272 and 100g for 
£390 
 50g for $300, 100g for $400, 250g for $600 and 1Kg for $1800 
[5] [6] [7]  
 MODALITIES OF INTAKE  
 Oral ingestion is the common mode of consumption.  Nasal insufflation is not as 
 common as it could be very painful in some cases. Intravenous route was tried 
 very rarely by few users who advice to reduce the dose (about half the oral dose) 
 but the duration of action was reported to be much shorter.  
[8] [9] [10] [11]  
 LEGAL STATUS 
4-FA is not controlled in the USA, but it can be considered as an analogue of 
phenethylamine and hence covered under the Federal Analogue Act. 
It is controlled in Poland, Israel (2007), Slovak Republic (2011) and Hungary 
(2012).  
4-FA is reported by the forum users to be a class A drug in the UK according to 
the Misuse of the Drugs Act 1971 (modification) Order 1977. 
[12] [13] [14] [15] [16] [17]  
 CURRENT USE / MEDICINAL USE  
 4-FA is not used for medicinal purposes. It is not intended for human 
 consumption.  
 In 1970s, 4-CA, a related compound, was tried as an antidepressant at 
 75mgs/day. But it was not well tolerated due to raphe nuclear degeneration and 
 neurotoxicity in animal studies. Also 4-CA was found to reduce the 
 concentration of serotonin in brain which was much against the widely accepted 
 hypothesis (in the 70s - increased concentrations of serotonin worked as an 
 antidepressant). Hence it was discontinued as an antidepressant.    
 [b] [c] [18] 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Several studies have shown that the substitution of hydrogen atom in the 
 amphetamine by fluorine atom makes it more lipophilic so that it can easily pass 
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 through the blood brain barrier. Hence Fluoroamphetamines enters the brain 
 more readily to produce potent effects. Thus 4-FA has become a recreational 
 drug. 
 The usual starting oral dose is about 50mgs to 80mgs for first time users. 
 Regular users reported ingesting doses above 100mgs and also re-dosing in one 
 session was a common occurrence to prolong the effects. The overall effects last 
 more than 15 hours.  
 In Denmark, a study was carried out recently to detect the presence of 
 Fluoroamphetamines in forensic cases. Most of these cases were motorists 
 driving under the influence of drugs. The compounds were identified from the 
 blood samples of subjects by ultra performance liquid chromatography with time 
 of flight mass spectrometer (UPLC-TOF-MS) as well as by UPLC tandem mass 
 spectrometer. Thirteen cases were confirmed with 4-FA intoxication and three 
 cases with 2-FA intoxication.  Another study reported two cases who had taken 
 4-FA in Germany. The serum concentrations of 4- FAwere found by GS/MS 
 method to be 350ng/mL and 475ng/mL at which level the compound was active. 
 It produced sympathomimetic effects as well as Psychostimulant effects. 
 [d] [e] [j] [k] [19]   
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With 2C-B 
 With 2C-D (severe side effects – nausea, severe vomiting, sweating) 
 With piracetam and methylone 
 With amphetamine and sertraline (palpitation, intense anxiety, prolonged 
nausea, increased body temperature and intense sweating) – It looked like a 
‘possible’ serotonin syndrome at its milder forms.  
 With methylone (tachycardia, hypertension -169/95mmHg followed by pulse 
rate falling down to 44beates /minute) 
 250mgs of 4-FA with 10mgs of paroxetine and 100mgs of codeine (this 
combination produced no euphoria but insomnia and loss of appetite) 
[20] [21] [22] [23] 
 PHARMACOLOGICAL CHARACTERISTICS 
The pharmacology of halogenated amphetamines (eg, Fluoro amphetamine, 
Chloro amphetamine) has been studied extensively over the last few decades. 
Older studies showed 4-FA to be a serotonin depletor, but more recent studies 
have established that it is a stronger dopaminergic and weaker serotonergic 
compound with actions similar to amphetamine.  
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Studies on structural activity relationship studies established that the activity of 
para-substituted phenylalkylamines differed from their respective parent 
compound.  
It was observed in several studies in the 1960s that halogenated amphetamines 
lowered the serotonin level in the brain. The serotonin depletion failed to last 
longer for 4-FA when compared with 4-CA.  
In the 70s, a study was carried out to find out the ability of 4-haloamphetamines 
to deplete the serotonin in the animal brain. It highlighted that 4-FA produced a 
transient and reversible depletion of serotonin in comparison with other 
halogenated amphetamines. The depletion of serotonin by 4-FA lasted only few 
hours when compared with 4-CA or 4-BA which lasted longer. Thus 4-
chloroamphetamine produced both a short term reversible and a long term 
irreversible depletion of serotonin and 5 Hydroxyindoleacetic acid (5HIAA). 
Hence it concluded that 4-FA possesses pharmacological properties that are 
different from its related compounds (4-BA and 4-CA) and also 4-FA was 
metabolised in a different manner to that of other 4-haloamphetamines.  
Fenfluramine, a serotonergic agent, is a compound which is structurally similar 
to 4-FA. Animal experiment has confirmed that the effects of fenfluramine were 
similar to 4-FA in releasing serotonin.  
Pharmacological properties of 4-FA was compared with amphetamine and other 
halogenated amphetamines (4-CA, 4BA). When compared with 4-CA or 4-BA, 
4-FA showed stronger inhibition of dopamine than 5HT uptake in rat brain 
synaptosomes. These studies indicated that the pharmacological characteristic of 
4-FA was distinct from other halogenated amphetamines and that it resemble 
more closely to amphetamines (stimulant effects) than halogenated 
amphetamines.  
[a] [f] [g] [h] [i] [j] [k] [l] [m]  
 TOXICOLOGICAL EFFECTS 
The first accounts of neurotoxicity of halogenated amphetamines were derived 
from animal studies carried out in late 1970s. It was shown that a single 
injection of 4-CA (4-chloroamphetamine) produced irreversible depletion of 
serotonin and 5-Hydroxyindoleacetic acid (5-HIAA) for more than 4 months. 4-
BA (4-bromoamphetamine) also reproduced the same results. However 4-FA 
produced depletion that lasted less than 24hours. The long term toxicity of 4-FA 
is not yet established. Online users’ seriously cautioned against regular use of 
any fluorinated compounds to avoid ‘bone mutations’ and possible 
neurotoxicity.  
[n] [24] [25]  
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 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria 
 Music appreciation 
 Socialising  
 Energetic  
 Fun 
 Sexual enhancement   
[26] [27] [28]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Loss of appetite 
 Insomnia  
 Sympathomimetic effects (eg, Tachycardia)   
[29] [30]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 One user reported that his friend became psychotic and jumped out of the 
window and fractured his bones after ingesting 4-FA. 
 Psychosis  
 Hallucinations 
 Violent behaviour  
[m] [31]  
 CLINICAL ADVICE 
 4-FA is a weak serotonergic agonistic action and hence it could cause ‘Serotonin 
 syndrome’ especially if combined with other serotonin releasing compounds.  
[20] [21] [22] [23]  
 RELATED FATALITIES  
 None.  
 YOU TUBE VIDEOS 
 There was only one video for sale of 4-FA found on You Tube. [32]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
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 includes a graph with the search volume, indicating interest over time (GMT) for 
 4-fluoroamphetamine, plotted on a scale from 0 to 100; the totals are indicated 
 next to bars by the search term, a break down of how the categories are 
 classified, lists of the top searches and top rising searches, a world heat map 
 graphically displaying the search volume index with defined regions, cities and 
 towns.   
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I.II  2, 5-Dimethoxy-4-chloroamphetamine (DOC) 
 
 
 
DOC Report 
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 OVERVIEW 
 Chemical name: 2, 5-Dimethoxy-4-chloroamphetamine 
Synonyms: DOC 
Active constituents: 2, 5-Dimethoxy-4-chloroamphetamine 
Type: Research chemical – Phenethylamine  
Origin: It was first synthesised by Coutts and Malicky whilst synthesising 
analogues of l-(2, 5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in 
1972. It was also synthesised and tried by A Shulgin which was later published 
in his book, PiHKAL in 1991.  
Status: Novel 
Chronology: Online users report the availability of DOC on the market since 
2005. 
[a] [b] [1] [2]  
 KEY POINTS 
2, 5-Dimethoxy-4-chloroamphetamine (DOC) is a ring substituted alpha 
methylated phenethylamine. The characteristic features of this compound are its 
activity at small doses and its longer duration of action. It produces strong 
CEVs, increased appreciation of music and movements. However it could 
potentially cause serious toxicity since it is active at a very low dose compared 
with other compounds from the same class.   
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name:  1-(4-chloro-2,5-dimethoxy-phenyl)propan-2-amine 
Molecular weight: 229.70 g/mol 
Molecular formula: C11H16ClNO2 
CAS Number: 123431-31-2 
[2] [3] [4]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
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All legal herbal 
2,5-Dimethoxy-4-chloroamphetamine is a chemical that belongs to amphetamine class. 2,5-
Dimethoxy-4-chloroamphetamine is also known as DOC and is considered a psychedelic drug 
that influences activity of the 5-HT2A receptor. CAS number:123431-31-2 [5] 
Tradett (from China) 
2,5-Dimethoxy-4-chloroamphetamine [6] 
“CONTACT NOW Click here to send enquiry”              
Hi-Supplier (from China) 
Wuhan Entai Technology Development Co., Ltd 
2 5-Dimethoxy-4-chloroamphetamine [7] 
“CONTACT NOW Click here to send enquiry”               
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
There are several whole sale suppliers of this compound originating from 
different parts of the world, but largely from China. The websites advertise to 
contact their company to get more information on price, mode of payment, 
delivery etc. However one website quoted $240 for 10g of DOC. [5] [6] [7]  
 MODALITIES OF INTAKE  
Nasal insufflation is the common mode of intake. Equally, oral ingestion of the 
powder is also common. [8] [9]  
 LEGAL STATUS 
In late 2005 and late 2007, DOC was sold on blotting paper which was hard to 
detect by the human eye. A seizure in the USA confirmed the presence of 2,5-
dimethoxy-4-chloroamphetamine (DOC) by GC/MS in 2007.  
In the USA 2,5-dimethoxy-4-chloroamphetamine (DOC) is not explicitly listed 
as a controlled drug. But 2,5-dimethoxy-4-bromoamphetamine (DOB) is a 
Schedule 1 drug and so DOC could be covered under The Federal Analog Act 
and hence possibly prosecuted for possession (for human consumption) of this 
compound. 
In the UK, DOC is controlled under the Misuse of Drugs Act (1971). However 
in the rest of the EU, it is still legal to possess DOC. [c] [d]  
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 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical and not intended for human consumption. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
It is a very popular psychedelic compound among online users who believe that 
DOC has got the shortest duration of action among other D-series compounds. It 
is active at a very small dose of 1.5mgs. The duration is usually longer and lasts 
between 12 and 24 hours. A typical user experience on DOC is as follows: 
[T+00:00] oral ingestion of 4 mgs of DOC.  
[T+00:43] euphoria started  
[T+01:45] music appreciation 
[T+02:56] visual effects similar to low dose LSD; Euphoria sill strong. 
[T+03:26] strong ++ and intensifying sounds  
[T+03:55] nasal insufflation of 0.5-1 mg to accelerate the come-up.  
[T+04:08] nasal insufflation of additional 0.5-1 mg 
[T+05:14] strong visuals 
[T+06:45] nasal insufflation of another 1-2 mg  
[T+07:39] mental confusion  
[T+08:01] cascade of visuals appear  
[T+08:32] body discomfort  
[T+08:41] CEV (Very strong +++) 
[T+09:03] low pulse rate (70-75). 
[10] [11] [12] [13] [14] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With MDMA 
 With mushrooms, opium and 2C-C 
 With LSD 
 With LSD and 2C-B 
 With DOM and cannabis 
 With 2C-I and alprazolam 
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 With Kratom 
 With cocaine (extreme anxiety) 
[d] [15]  
 
 PHARMACOLOGICAL CHARACTERISTICS 
 It is well known that hallucinogens exert their effects by binding to 5HT2 
 receptors. However it is not clear which of the sub-receptors are involved. An 
 interesting study evaluated about 17 phenylisopropylamines at 5-HT2A, 5-
 HT2B, and 5-HT2C receptors in human population. The Ki value for DOC at the 
 5HT2a, 5HT2b and 5HT2c receptors were 1.4, 31.8 and 2.0 respectively 
 implying a greater affinity for 5HT2a and 5HT2c than for 5HT2b. The study 
 concluded that the hallucinogenic effects were exerted predominantly through 
 5HT2a receptors than 5HT2b or 5HT2c. [e]  
 TOXICOLOGICAL EFFECTS 
DOC is considered to possess severe toxicological effects in high doses. 
Compared with LSD, DOC does not have a confirmed safety profile. A case 
report confirmed sympathomimetic toxicity in a 20 year old man who consumed 
DOC. He had no significant past medical history. He suffered from a tonic 
clonic seizure with reduced level of consciousness (Glasgow Coma Scale of 
3/15). He had tachycardia (152/min), blood pressure of 144/57 mmHg and non 
reactive, dilated (6mm) pupils. Biochemical and haematological analysis 
revealed random blood glucose of 9.6mmol/L, albumin (30g/L) and creatinine 
kinase 1314 IU/L (initially) which peaked to 4924 IU/L. He also had metabolic 
acidosis which was corrected. He was extubated after 22hours and was then 
discharged. Other toxic effects include extreme fatigue lasting for days and 
persistent tachycardia. [d] [10] [16]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Strong euphoria lasting longer 
 Good music and colour appreciation  
[17]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Sympathomimetic effects (palpitation) 
 Tiredness [d]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE     
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 Paranoid delusions 
 Visual hallucinations  
 Drug induced psychosis  
 Intense anxiety and produced mental ‘trauma’  
 Poor concentration  
[18] [19] [20]  
 CLINICAL ADVICE 
 DOC is active at small doses as little as 1.5mgs. Hence accurate measurement is 
 necessary. Accidental overdoses are common if there was error in measurement. 
 Online users post warning messages to measure doses accurately and start at
 very small dose. The short term toxicity is essentially of sympathetic 
 overactivity and hence it can be treated symptomatically at the Emergency 
 Departments. [d] 
 RELATED FATALITIES  
 There were no death reports directly linked to DOC. However, there were 
 several overdoses reported. [21]  
 YOU TUBE VIDEOS 
There was only one video available under the title “Buy DOC research 
chemical”. [22]  
 GOOGLE INSIGHTS 
 Google Insight for Search was unable to show search volume patterns for 
 specific key words such as 2, 5-Dimethoxy-4-chloroamphetamine or DOC.  
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 Mephedrone  
 OVERVIEW 
 Chemical name: 4-Methyl methcathinone 
Synonyms:  4-MMC; 4MMC; MMCat; Meph; Drone; Rush; Bubbleluv pill; 
Meow Meow/ Miaow Miaow (UK esp. Brighton and Hove); Plant feeder; 
lobster smelling compound; MD3; Roxy; Mefedron (Norway); Krabba 
(Sweden); Bubbles; White magic; Rush; Challenge (= Mephedrone + Ketamine) 
Active constituents: 4-Methyl methcathinone 
Type: Research Chemical (RC) – Phenethylamine 
Origin: Mephedrone was first synthesised in 1929. It is a phenethylamine with a 
relatively short history of human consumption. Forum users report about their 
availability since 2007. 
Status: Novel 
 
[a] [1] [2] 
 
 KEY POINTS 
4-Methyl methcathinone (mephedrone) is a derivative of cathinone, a compound 
found in Khat. Mephedrone belongs to the family of phenethylamine. It is a 
stimulant / empathogen and has been compared to other stimulant drugs such as 
amphetamine, MDMA, MBDB and methylone. It was placed under Class B 
category according to the Misuse of Drugs Act 1971 on 16
th
 April 2010.  
   
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 2-methylamino-1-p-tolylpropan-1-one  
Molecular weight: 177.242 g/mol   
Molecular formula: C11H15NO  
CAS Number: 923013-67-6  
[1] [3] [4] 
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 APPEARANCE  
 In addition to its physical characteristics (white crystalline powder with a light 
 yellow hue), mephedrone is characterised by a distinctive, unpleasant odour 
 (vanilla and bleach, stale urine, electric circuit boards) that can make the eyes 
 water (lacrimator). [4][5][6][7][8][9] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
PLANTFEEDSHOP 
We are one of international premium providers of 4-MMC/Mephedrone, bk-
MDMA/Methylone,MDAI, 4-MEC/Modified mephedrone and MDPV.  
We are proud of offer high quality product, one of most reliable company on the market and 
get satisfied feedback from our customers. 
Our price includes registered air mail delivery. Delivery time 4- 10 days. [10] 
We are one of Asia’s premium providers of 4-MMC/Mephedrone. 
 
Watch how 99.9% pure 4-MMC/Mephedrone (4-Methylmethcathinone) will magically 
transform your garden right before your very own eyes. Thus leaving you with the most 
desired garden in your street, for every envious eye to see. 
 
THE CHEMICALS SOLD BY SLYPLANTS ARE STRICTLY NOT FOR HUMAN 
INTAKE. [11]  
4MMC 
We purchase all 4MMC POWDER/CRYSTAL directly from our International Manufacturer 
who have developed this great product over the past 6 months of tireless research and 
development. Purchasing via this route of supply means we can not only guarantee the best 
prices in the UK 07413873XXX  [12]  
 
Popular websites bearing the names of mephedrone (meow right now; 
mephedrone2u; buymephedrone) do not sell mephedrone any more. One website 
announced that mephedrone was not available for sale after 15
th
 April 2010 (one 
day before its ban). Instead, the same websites sold other new compounds such 
as DXM (dextromethorphan), 4-MeO-PCP, 5-MeO-DALT, Benzofury, 
Ethylphenidate etc.  
Another website (Neorganics.net) sold mephedrone under brand names such as 
‘Spirit’; ‘Neo Doves’; ‘S.C.’ before its ban (2010). The same website currently 
sells products named ‘Neo 7’; ‘Neo Dove 2’; ‘S.C.D.’ through (redirect to) a 
different website. There were no information available apart from a general 
description such as the one given below: “The ultimate MDMA analogue by 
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Neorganics. Still available”. It remains unclear if these products still contain 
mephedrone or an entirely different compound.  
Packaging and/or product descriptions of these commercial products describing 
Mephedrone as ‘plant feeder’, ‘bath salts’, ‘multivitamins’ or ‘not for human 
consumption’ often include detailed instructions suggesting the legitimate use of 
the products as ‘plant feeder’ or ‘bath salts’. However, instructions may also 
implicitly suggest how to use the product as a drug. This type of marketing is 
employed to circumvent laws and regulations controlling medicines and other 
legal substances not intended for human consumption.  
[10] [11] [12] [13] [14] [15] [16] [17] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 One website sold 10 grams of mephedrone for $169.99 as on 1
st
 Aug 2012. 
 Another website displayed the price (for varying quantity) as follows: 5g for 
 $96.00; 10g for $160.00; 20g for $240.00; 250g for $1500.00; 500g for 
 $2100.00 and  1Kg for $3100.00.  
 [16] [17] [18] 
 MODALITIES OF INTAKE  
 The most common modalities of intake are: 
 - Oral ingestion by either swallowing capsules or ‘bombing’ (wrapping 
 mephedrone powder in cigarette papers and swallowing)  
 - Insufflation 
 Of these two, oral ingestion is probably the preferred method of administration 
 (but not necessarily most common) by recreational users due to the unpleasant 
 side effects of insufflation (see Physical/medical untoward effects). 
 Less common methods of administration include: 
 - Rectal administration by either plugging or by administering an enema of 
 mephedrone dissolved in water 
 - Smokeable formulation 
 - IV administration (a more recent/less tested method): It is recommended 
 that dosage for IV administration to be ½ to 2/3 of a ‘normal’ oral dose. 
 It is recommended that mephedrone must be taken on an empty stomach. 
 Re-dosing in a single session is common, and is recommended prior to the 
 ‘come-down’ effect, and to be of equal or higher weight than the previous  dose. 
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 20-50mg reportedly elicits some effect.  However, doses usually vary between 
 100mg – 1g over an entire session (including re-doses). 
 [4][5][6][7][8][9] 
 LEGAL STATUS 
 Mephedrone was placed under Class B category according to the Misuse of 
 Drugs 1971 on 16
th
 April 2010. It is also controlled in many countries like 
 Austria, Belgium, Croatia, Denmark, Estonia, France, Finland, Germany, 
 Hungary, Italy, Israel, Lithuania, Norway, Netherlands, Poland, Romania, 
 Russia, Spain and Sweden. 
 In the USA, mephedrone along with methylone and MDPV was placed under 
 temporary scheduling on 21
st
 Oct 2011.  
 [b] [19] [20] [21] 
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical and not intended for human consumption. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Mephedrone is a legal stimulant/ empathogen and research chemical, and has 
 been compared variously to speed (amphetamine), ecstasy, amphetamine-
 cocaine, amphetamine-MDMA, bk-MBDB, and methylone. Mephedrone is a 
 semi-synthetic compound related to cathinone which is identified in the khat 
 plant. It is not detected in standard drug tests according to  online users. 
 Recreationally, Mephedrone is desirable as it elicits euphoria, sociability, 
 stimulation, and music appreciation, with a smoother ‘come-up’ and ‘come-
 down’ than MDMA (similar to methylone) and with the absence of a hangover 
 the following day. However, it is considered less potent than MDMA gram for 
 gram (approximately ½), and the elicited effects are much shorter in duration. 
 The duration of mephedrone effects are on average:- 
 Come up: 10-20mins   Peak: 45-60mins Come down: 60-120mins 
 According to users there is a highly addictive quality to the substance i.e., a 
 strong compulsion to re-dose (this may be related to the duration of effects). 
 This addictive quality means that binges in which large amounts of the 
 substance are consumed in single sessions are common. Users also report the 
 development of tolerance to the substance after prolonged use. In response to an 
 increase in reports of individuals experiencing ‘Mephedrone addiction’ specific 
 threads discussion on issue related to this have been established.  
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 Lack of information about long-term side effects and toxicity, as well as reports 
 of impurities identified by differences in colour, odour, side effects etc. in 
 commercially available mephedrone has led some online users to label it a  ‘dirty 
 drug’. However, other forum members still favour mephedrone due to its 
 effects and accessibility. Indeed, some forum members are concerned about 
 recent media attention and YouTube videos about the substance and how this 
 might affect its legal status. One forum in particular has restricted its 
 membership policy and access to certain forum threads.  
 Mephedrone appears to be particularly popular in the UK from a European 
 perspective. The 2009 UK MixMag Drug Survey revealed 41.7% of respondents 
 had tried the drug and 33.6% had tried the drug in the last month. Moreover, 
 reports from drug and alcohol teams, GPs and health services to the 
 Psychonaught Web Mapping project indicate that a number of people reporting 
 having used mephedrone, as well as the number of people reporting adverse 
 effects, is increasing. The popularity of Mephedrone and other similar research 
 chemicals (i.e., keto-amphetamines) appears to be related to its psychoactive 
 effects, accessibility, and legal status. In addition, the decreaing purity of 
 cocaine and MDMA may also play a vital role in popularising mephedrone. 
  
 In terms of the rest of the world, it does not seem to have become popular in the 
 USA but is increasing in popularity in Australia.  
 Mephedrone is sold through online shops. As at August 2012, a search of ‘buy 
 mephedrone’ in Google Search retrieved many results. However, a number of 
 dedicated websites selling Mephedrone have been shut down (e.g., 
 www.topdogplantfood.co.uk, www.shopmephedrone.co.uk, 
 www.plantfeeders.co.uk, www.buymephedrone.co.uk, www.4-mmcshop.co.uk, 
 www.4-mmc.com).  Some websites which sold mephedrone before its ban, sell 
 other legal compounds instead of Mephedrone (e.g., 
 www.plantfoodpalace.co.uk, www.mephedrone2u.com). Few websites 
 automatically got redirected to a different website selling different compounds 
 (e.g., www.mrmeph.com redirected to www.mrlegals.com). In addition, 
 advertising for Mephedrone and dedicated pages/ groups/ members associated 
 with Mephedrone (and the sale of Mephedrone) have also been found on social 
 networking sites, Facebook, Twitter. In the UK, forum users have also suggested 
 that street level dealers have started to supply Mephedrone (sometime sold as 
 ‘Rush’) as an alternative to cocaine.  
 [c][n][4][5][6][7][8][9][23][24]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 Mephedrone is taken in combination with a variety of other compounds 
 including: 
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 Alcohol 
 Other research chemicals (e.g., Methylone, MDPV, Butylone) 
 Cocaine 
 MDMA 
 Ketamine (combination also known as Challenge) 
 GBL 
 Heroin (similar to ‘speedball’) 
 Cannabis 
 Kratom (often taken during ‘come-down’ period) 
 Pharmaceutical depressants (e.g., Benzodiazepines, Hydrocodone (often 
taken during ‘come-down’ period) 
 Pharmaceutical stimulants e.g., Modafinil, Adderall 
 Viagra 
 BZP, TFMPP or DMAA (1,3-Dimethylamylamine; ClearShot) 
 Nitrous Oxide 
 Isobutyl nitrite (Poppers) 
 Metamfepramone, Phthalimidopropiophenone, Caffeine – in commercial 
products. 
 
 [4] [5] [6] [7] [8] [9] 
 PHARMACOLOGICAL CHARACTERISTICS 
 It is reported that the synthesis of mephedrone is similar to that of amphetamine 
 or MDMA. There are few published papers on the neuropharmacological effects 
 of mephedrone. A recent article reported that mephedrone inhibits serotonin (5-
 HT) and noradrenaline uptake provided they are available endogenously. This 
 could possibly lead to the sympathetic effects exerted by mephedrone.  
 Another study concluded that the effects of mephedrone resembled that of 
 MDMA and amphetamine. Mephedrone caused rapid release and destruction of 
 dopamine and serotonin (5-HT) in nucleus accumbens. Since it works though 
 the dopamine reward pathways it could potentially cause dependence.  
 A survey based on websites reported that the users  compared the effects of 
 mephedrone to that of MDMA and believed that the effects were marginally 
 safer and more pleasurable.  
 Form users reported that the action of mephedrone was essentially 
 sympathomimetic similar to ecstasy and cocaine. The possible mechanisms of 
 action of mephedrone are discussed in detail in advanced drug discussion web 
 fora. The following speculations were made:- 
 A) It can be speculated that the para substituted compound 4-
 methylmethcathinone may have reduced stimulant activity, but, it is likely to 
 have additional affect on serotonin via both monoamine reuptake/ SERT 
 inhibition and direct agonist affects of the 5HT2b receptors. Concerns have been 
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 raised regarding the actions of 4-methylmethcathinone in relation to peripheral 
 5HT (serotonin) stimulation and how that, combined with other catecholamine 
 activity, may be dangerous to the heart.  
 The peripheral 5-HT2b activity coupled with catecholamine activation likely 
 accommodates for most of the peripheral side-effects (vasoconstriction) of 
 mephedrone. In addition, the persistent anxiety, confusion, and depression also 
 support the idea that norepinephrine/ dopaminergic activity exacerbated the 
 likely peripheral serotonergic activity of mephedrone. 
 B) The 'blue-limb' effect was attenuated by lying down flat, and also that the 
 first part of the body to turn blue were the knees followed by the feet (lower 
 body joints). This suggests that the vaso constrictive activity was dependent 
 upon postural orientation. 
 C) High doses of mephedrone probably trigger the complement at some level or 
 other immune system activation, creating a temporary vasculitis. A vasculitis 
 would be more consistent than vasoconstriction given the symptoms since it is 
 thin areas of skin rather than distal extremities which show changes. Colour 
 changes around lips, gums and around the eyes (black / green) - possible caused 
 by methemoglobinemia. 
 D) Ergotism: It may also explain posture-dependent bruising and occasional 
 convulsions. Mephedrone may thin the blood (thrombocytopenia), thereby 
 directly contributing to it's anti-immune and bruising activity; this might be why 
 so many individuals get sick and observe sores in the mouth. 
 E) The skin symptoms are similar to some of the symptoms of dermatomyositis, 
 which is an autoimmune disease of the skin and muscles. The actual mechanism 
 may possibly a focal vasculitis seen at the joints (knee, elbow, knuckles) which 
 is mediated by the compliment pathway of the immune system clogging up 
 capillaries. 
 A study investigating the pharmacokinetics of mephedrone, using Gas 
 Chromatography/ Mass Spectrometry (GC/MS) technique conducted on 
 samples of rat and human urine has identified the key metabolic steps as 
 follows:  
 N-demethylation to the primary amine (formation of the nor-mephedrone, 
nor-dihydro mephedrone and nor-hydroxytolyl mephedrone metabolites) 
 reduction of the keto moiety to the respective alcohol (formation of the nor-
dihydro mephedrone and 4-carboxy-dihydro mephedrone metabolites) 
 oxidation of the tolyl moiety to the corresponding alcohols and carboxylic 
acid (formation of the hydroxytolyl mephedrone and nor-hydroxytolyl 
mephedrone metabolites) 
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 The metabolites of mephedrone such as nor-mephedrone, nor-dihydro 
 mephedrone, hydroxytolyl mephedrone, and nor-hydroxytolyl mephedrone were 
 detected in the urine. The author concluded that using the systematic 
 toxicological analysis recreational drugs such as mephedrone, butylone and 
 methylone can be detected from the urine. However the paper could not 
 provide any information on the time limit for detection of the metabolites in 
 urine.    
 [d][e][f][g][h][4][5][6][7][8][9][24][25][26][27][28][29][30] 
 TOXICOLOGICAL EFFECTS 
 A case series presented the toxicity symptoms subsequent to the review of 15 
 patients who attended the Emergency Department following self-reported 
 ingestion of mephedrone. The significant clinical features included agitation in 
 53%, tachycardia in 40%, systolic hypertension in 20% and seizures in 20%. In 
 this study toxicological analysis was not done.  
 In another case series, toxicological analyses of serum samples were done using 
 a standardised method GC/MS. In addition, Liquid Chromatography with 
 tandem Mass Spectrometry (LC-MS) which is a powerful technique to identify 
 compounds in a complex mixture and to qualitatively analyse mephedrone use. 
 The result confirmed the presence of mephedrone in all the 7 samples and 
 showed acute mephedrone-related toxicity with symptoms of agitation, 
 palpitation, hypertension, chest pain, seizures (self- limiting) and headaches.  
 Anecdotal reports posted by users on fora indicate the following potential 
 toxicological effects: 
 Potential peripheral neuropathy and/ or pronounced vasoconstriction/ 
ischemia. Reported symptoms include foot drop/ intermittent pain in feet, 
cyanosis in fingernails/ toes, and numbing sensation/neuralgic-type pain on 
left side of head/ scalp. Other associated symptoms include, flash headaches, 
tinnitus and other audio distortions. As these are anecdotal reports from users 
and not the results of scientific studies it is not certain whether these 
symptoms are related to mephedrone use or something other, or if these are 
the effects of mephedrone or of rumoured impurities in commercial 
mephedrone/ mephedrone products. Immunological toxicity. Reported 
symptoms include vasculitis (as opposed to vasoconstriction), infections 
(e.g., influenza), and ulcerations (e.g., in the mouth) 
 Other symptoms that may be attributed to mephedrone toxicity including 
kidney pain (nephrotoxicity), cardiac problems (cardiotoxicity), and 
respiratory problems (respirotoxicity). 
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Users also report that these symptoms become more pronounced/more chronic 
with sustained use of mephedrone.  This may indicate mephedrone toxicity with 
prolonged use. 
 
A forum user reported symptoms such as anxiety, agoraphobia, depression and 
‘few heart problems – irregular heart beats / angina’ following continuous use 
for about 6 months on mephedrone. He also reported a prolonged withdrawal 
syndrome consisting of day time hallucinations, night terrors and sleep paralysis 
(also known as ‘old-hag syndrome’).    
 
[i][j][4][5][6][7][8][9][31] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Desired psychoactive include:- 
 - Euphoria 
 - Empathy 
 - Stimulation (shivers/rushes/‘speediness’) (mellow and relaxed in  
  moderate doses but intense/pushy in higher doses – similar to MDMA) 
 - Intensification of sensory experience stimulation (particularly auditory 
  e.g., music appreciation)  
 - Mild sexual stimulation 
 - Mood enhancement 
 - Decreased hostility/insecurity 
 - Increased insight and/or mental clarity 
 - Hallucinations  
 
 [4][5][6][7][8][9] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
A confirmed case of myocardial damage induced by mephedrone was reported. 
According to online users, negative side effects increase exponentially with 
heavy use. These include:- 
 Loss of appetite.  
 Insomnia 
 Increase in mean body temperature (sweating/‘mephedrone sweat’ and hot 
flushes) 
 Decrease in mean body temperature  
 Tense jaw, mild muscle clenching, stiff neck, bruxia (teeth grinding) 
 Elevated heart rate (tachycardia) and blood pressure, and chest pains 
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 Respiratory difficulties 
 Dehydration and dry mouth 
 Nausea/vomiting and stomach discomfort/abdomen pain 
 Influenza like symptoms 
 Dermatitis like symptoms (Itch and rash), ulcerations on skin  
 Numbness and lack of tactile sensitivity with very large amounts. 
 Painful joints 
 Discolouration of extremities/joints 
 Mydriasis (abnormal pupil dilation) 
 Nystagmus 
 Painful nasal drip following insufflation is associated with the presence of 
blood clots/mucous the day after consumption, and burns/ulcerations in the 
mouth 
 Light-headedness and dizziness 
 Cervicogenic / flash headaches 
 Tremors and convulsions 
 Cravings and compulsive binging 
 Nightmares 
 Fatigue 
 Loss of concentration and memory loss/amnesia 
 Anxiety 
 Paranoia 
 Dysphoria 
 Depression 
 Hallucinations 
 Cold extremities 
 Purple elbows / legs (‘permanent’)  
 [k][4][5][6][7][8][9][24][25][26][27][28][29][30][32] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 They include, possible mild dopamine induced psychosis (short-term) and 
 mania. In addition, symptoms of depression initially reported as side 
 effects reportedly last for longer periods of time with prolonged/increased use. 
 Forum users have speculated whether this represents a depletion of serotonin 
 and/or dopamine as a result of mephedrone use. As yet, none of these have been 
 supported by experimental/clinical data. [l]  
 CLINICAL ADVICE 
 It is a research chemical with a relatively short history of human consumption 
 for recreation, although there have been no confirmed safety data on humans.  
 RELATED FATALITIES  
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 There have been reports of several deaths attributed to mephedrone since 2010. 
 In a recent paper, at least 125 deaths  have been alleged to use of mephedrone in 
 the UK and the Channel Islands, although some of them were not related to 
 mephedrone use. This has been reported to the National Programme on 
 Substance Misuse Deaths (np-SAD). A summary of the findings is given below: 
 Mephedrone not found at post mortem  = 25 cases 
 Results still pending     = 13 cases 
 Confirmed at post-mortem   = 87 cases  
 Apart from these published materials, online users discuss the toxicity and 
 fatalities on web fora. One users who lived close to the Suffolk and Essex 
 border reported (Nov 2011) that many teenagers around this area had used 
 mephedrone and some of them died as a result of ‘heart attack’ due to 
 mephedrone use. He believed that these teenagers who consumed mephedrone 
 attended the Papworth and Basildon and Thurrock University Hospitals and their 
 deaths were recorded as myocardial infarction but not as a result of mephedrone 
 use in a way to avoid a formal Inquest to which the press and the public would 
 have full access. Therefore he concluded that there were far more deaths due to 
 the use of mephedrone than it were actually reported.  
 [m] [n] [o] [p] [q] [r] [u] [16][17][18][19][20][21][33] 
 YOU TUBE VIDEOS 
 There were more than 500 You Tube videos available using the search term 
 ‘Mephedrone’ as on 16th August 2012. The top four videos are described below:  
 Mephedrone to be made banned Class B drug: This short clip uploaded on 
 29
th
 March 2010 by ITN News shows a speech from the Home Secretary Alan 
 Johnson about plans to ban mephedrone and other related synthetic compounds. 
 Few weeks later, mephedrone was banned in the UK. This has got 2,775 views 
 as on 16
th
 Aug 2012. [34]  
 Mephedrone - Chemistry Behind the Headlines 1: This video was 
 ‘Uploaded by ‘Professor Dave at York’ on Mar 17, 2010. In this video Professor 
 Dave inferred the possible action/ toxicity of mephedrone by comparing its 
 molecular structure with that of MDMA, amphetamine and methamphetamine 
 (crystal meth). About 2 and ½ years after the upload of this video, a person 
 commented (July 2012) that Professor Dave’s logic was in error as the actions of 
 methamphetamine and mephedrone are dissimilar though they have close 
 molecular resemblance. Professor Dave replied that he was only trying to give 
 some information about this compound 2 and ½ years ago, when there was no 
 information available to the public who assumed that this compound was just a 
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 plant extract. It has got the most number of views (183,925 views) as on 16
th
 
 Aug 2012. [35] 
 Mephedrone’s Ramifications (HD): This well edited video clip shows 
 mephedrone use and its effects potrayed using graphics. This video was 
 uploaded by diegobaud on Oct 31, 2011 and has 4,769 views as on 16
th
 Aug 
 2012. [36] 
 Mephedrone Student Documentary - 'Not For Human Consumption': This 
 video shows Chris Pendlebury, the presenter, travelling to various places such as 
 the market place in Camden and St. George’s, London and interviewing people 
 like a dealer, a medical student and Dr John Ramsay, director of TICTAC 
 company to get more information on mephedrone. The highlights of this video 
 are the comments made by Dr J Ramsay (quote) “it (mephedrone) has never 
 been tested for safety or efficacy by anybody. So if we think we know about it 
 …is by observing young people who bought it and finding out what happens to 
 them…”. After this, he completed this clip with his personal opinion on 
 mephedrone. This video was uploaded by Mattpoz1 on Mar 17, 2010 and has 
 earned 42,977 views as on 16
th
 Aug 2012. [37] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 Mephedrone, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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I.IV  Naphthyl pyrovalerone (Naphyrone)  
 
NRG-1 or 
Naphyrone Report 
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 Naphyrone    
 OVERVIEW 
 Chemical name: naphthyl pyrovalerone 
Synonyms:  Energy-1, NRG-1, Naphyrone, O-2482 
Active constituents: naphthyl pyrovalerone 
Type: Research chemical – Phenethylamine 
Origin: Unknown 
Status: Novel 
Chronology: It has relatively a short history of human consumption. Meltzer and 
colleagues described the synthesis of Naphyrone. Google Insight suggests NRG-
1 became popular among online users by the end of 2009. [a]  
 KEY POINTS 
  
 Naphyrone Pyrovalerone   Mephedrone   MDPV  
  
NRG-1 or Naphyrone is a naphthyl analogue of the cathinones. It structurally 
resembles compounds such as pyrovalerone, mephedrone and methylenedioxy 
pyrovalerone (MDPV).   
 
The identity of products sold as NRG-1 remains dubious. Following the ban of 
mephedrone in April 2010, a replacement product (known as NRG-1) was sold 
online. However, few review papers reported that only few products contained 
NRG-1 and many others sold as NRG-1 contained other compounds such as 
cathinone mixtures including mephedrone, butylone, 4-methyl-N-
ethylcathinone, flephedrone and MDPV. Another report described that a batch 
of “NRG-1” contained a 1:1 mixture of MDPV and a ring-fluorinated 
methcathinone.  
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Furthermore, there have been two structural isomers (alpha and beta-naphthyl 
isomers) sold online. It is usually the beta-naphthyl isomer which is well known 
and published but descriptions on the alpha-naphthyl isomer is very limited.  
[b] [c] [j] [1] [2] [3]          
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one  
Molecular weight: 281.391 g/mol  
Molecular formula: C19H23NO 
CAS Number: 850352-53-3 and 850352-11-3 (hydrochloride) 
[4] [5] [6]   
 APPEARANCE OF COMMERCIAL PRODUCTS 
 NRG-1 has the appearance of a white crystalline powder. Forum users report 
 that it tasted sour like vinegar with a very sticky consistency (even stickier than 
 MDPV). [7]   
Product description  
Legal powder Ltd. 
Naphyrone (O-2482, Nrg-1)  
Very pure crystalline product from China, 99.5% purity. [8] 
Chemicals Trading Co.  
Naphyrone is a drug derived from pyrovalerone that acts as a triple reuptake inhibitor, 
producing stimulant effects and has been reported as a novel designer drug.[9] 
Cayman Chem. 
Pyrovalerone is a psychoactive compound with stimulatory effects. It is a controlled drug that 
has been found as a contaminant in products sold as bath salts. Naphyrone (hydrochloride) is 
an analogue of pyrovalerone that is characterized by the substitution of the methylphenyl 
group of pyrovalerone with a naphthyl group. [10] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price varied considerably among different websites. One website quoted the 
 following price: 100g for $500; 500g for $1,200; 1Kg for $2,100; 2Kg for 
 $3,200; 5Kg for $5,600; 10Kg for $7,500.  
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 Another website quoted the following price: 10g for $250; 500g for $2,450; 1Kg 
 for $3,950.  
 [8] [9] [10]  
 MODALITIES OF INTAKE  
Nasal insufflation was the common mode of intake. It can also be ingested 
orally. Users report that NRG-1 was inactive when smoked. Rarely it was taken 
Intra venously which produced the same effects as nasal insufflation.   
[7] [11] [12] [13]  
 LEGAL STATUS 
In the UK, several cathinones such as mephedrone and MDPV were placed as 
Class B under the Misuse of Drugs Act 1971 on 16
th
 April 2010. However, 
Naphyrone was not included under this ban. Hence a number of websites 
reported the sale of Naphyrone as a mephedrone replacement. On 12
th
 July 2010, 
Naphyrone was made a class B drug in the UK.  
 
The Drug Enforcement Administration (DEA) requested for information on 
naphyrone on April 2011. It is not a controlled substance in the USA or other 
EU countries.  
 
[d] [e] [14] 
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical and not intended for human consumption. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 NRG-1 was sold as glass or jewellery cleaner to circumvent the law in some 
 countries. It is potent at a very low dose. The usual dose is 25mgs which is at 
 least 10 times lower than the usual dose of mephedrone.   
 Come up: several minutes Peak: 3 to 4 hours Come down: 7 to 10 hours 
  
 A typical users experience is described below: 
  
 T+00 Nasal insufflation of 10mgs of NRG-1. 
 T+20 Mild effects of high; Re-dosed with 20mgs of NRG-1. 
 T+30 No empathy or euphoria.  
 T+60 Re-dosed another 25mg. 
 T+70 Walking easy.  
 T+90 A background buzz. 
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 T+360 Everything interesting.  
 T+12 hours Effects started subsiding.  
 
 [f] [7] [15]  
 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
IV NRG-1 and IV 5MeO-DALT (intense tripping effects started immediately, 
but very unpleasant).  
[16]   
 PHARMACOLOGICAL CHARACTERISTICS 
 There are no data on the pharmacokinetics or pharmacodynamics on human 
 subjects. A study reported the synthesis of naphyrone and  other pyrovalerone 
 analogues. This study also compared the ability of these compounds to affect the 
 reuptake of the monoamine neurotransmitters such as serotonin, dopamine and 
 norepinephrine by interacting with the serotonin transporter, dopamine 
 transporter, and norepinephrine transporter. It concluded that naphyrone was the 
 only compound which had the ability to inhibit the reuptake of all the three 
 neurotransmitters at very low concentrations. 
A recent study showed that naphyrone acts as a non-selective monoamine 
reuptake inhibitor similar to cocaine. It was also found that the permeability of 
the blood-brain was high in an in vitro model.  
[a] [g] [17]  
 TOXICOLOGICAL EFFECTS 
 There are no human toxicological data. However, there are several reports from
 patients experiencing toxic effects and attending emergency departments. This 
 could be due to the effects of NRG-1 at a very low dose compared with 
 mephedrone. Since it was advertised as a replacement for mephedrone, users 
 believed that the same dose could be taken as the recommended dose and hence 
 the toxic effects.    
 A case report documented a patient presented with acute sympathomimetic 
 toxicity following ingestion of 100mgs of NRG-1. He displayed restlessness, 
 insomnia, anxiety, and hallucinations lasting for 2 days. A blood sample 
 analysed by Gas Chromatography with Mass Spectrometry (GC/MS) showed a 
 concentration of 0.03mg/L and 0.02 mg/L, 40 h and 60 h after drug intake, 
 respectively. 
 A major concern among online users was the carcinogenicity of naphyrone. 
 Since naphyrone has not yet been studied on human or animal models, the 
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 closest match would be pronethalol which was investigated on animal model. 
 The epoxidized naphyrone, which is formed through the oxidation of 
 naphthalene ring, was reported to be a carcinogen. Since naphyrone possesses 
 a similar naphthalene ring, it is speculated that it could trigger carcinogenesis on 
 long term.  
    
 Pronethalol       
    
 Naphyrone     Epoxidized naphyrone 
 [h] [j] [k] [23] [24]   
  DESIRED PSYCHOACTIVE EFFECTS 
 Very mild euphoria  
 No emapathogenic quality  
 Socialising  
 Energetic   
 [18] [19]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Tachycardia (>145/ minute) (on doses above 200mgs) 
 Cold blue fingers 
 Tingling sensation over extremities  
 Insomnia 
 Loss of appetite 
 Vascular: colour changes: blue or green or purple - hands, arms and knees;  
 Burning hands and feet; pins and needles sensation 
 High blood pressure 
 Sweating 
 Increased body temperature 
 Jaw stiffness  
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[15] [18] [19] [20]   
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE 
 Paranoia 
 Visual hallucinations occurring for 48 hours  
 Disorganised thoughts 
 Intense anxiety 
 Depression 
 Obsessive symptoms  
 Poor concentration 
 Insomnia lasting for more than 5 days 
 Short term memory loss 
 Lack of motivation 
 Low self esteem 
 
One user reported having depression and anxiety lasting for about 6 months after 
regular use of NRG-1 for a year. He made several suicidal attempts. He was 
treated with anti depressant medication.  
 
[7] [15] [21] [22] 
 CLINICAL ADVICE 
 It is speculated that the vendors were selling off their old stocks of mephedrone 
 (after its ban) and re naming it as NRG-1. The potential problem that could be 
 anticipated is that when the genuine stocks of NRG-1 becomes available; the 
 users may take the same dose as before which could result in significant toxicity. 
 This is because the dose of NRG-1 is significantly lower than the dose of 
 mephedrone.  
 It is reported that NRG-1 could cause carcinogenicity, due to the presence of 
 naphthyl ring which could possibly be metabolised to an extremely reactive 
 napthylepoxide.  
 [h] [i]  
 RELATED FATALITIES  
 There are several reports of toxicity and few death reports are linked to the 
 consumption of NRG-1. However there has not been any coroner’s report to 
 confirm deaths linked to NRG-1.  
 [i] [k]  
 YOU TUBE VIDEOS 
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There are several videos on NRG-1 and few interesting video clips are given 
below: 
 Naphyrone - NRG-1 - Chemistry Behind The Headlines 2 (Professor Dave) 
 NRG-1 (whole sale) 
 NRG-1, aka Naphyrone, the new legal high, reported by Sky News  
 Naphyrone (NRG-1) THE NEW KILLER!  
 NRG 1 to be banned 2day or next week the government have said, (a user 
pleading not to ban NRG-1) 
 Buy naphyrone 
[25] [26] [27] [28] [29] [30]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 NRG-1, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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I.V  2, 5-Dimethoxy-4-n-propylthiophenethylamine (2C-T7) 
 
 
 
2C-T-7 Report 
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 2C-T-7    
 OVERVIEW 
 Chemical name: 2, 5-Dimethoxy-4-n-propylthiophenethylamine  
Synonyms: Blue Mystic, 7
th
 Heaven, Tweety-Bird Mescaline, Lucky 7, 
Beautiful, Belladonna, Red raspberry, T7, Tripstasy, 7-Up, PT-DM-PEA  
Active constituents: 2, 5 Dimethoxy-4-(propylthio) phenethylamine  
Type: Research chemical – Phenethylamine  
Origin: 2C-T-7 was first synthesised by Alexander Shulgin in Jan 1986. This 
was published in his book, PiHKAL in 1991. An informal review reported that 
2C-T-7 appeared on ‘smart shops’ in Netherlands in 1999, following the ban on 
2C-T-2.  
Status: Novel 
Chronology: Though it was reported to be synthesised in small kitchen-type 
laboratory in the USA in 1999, the first confirmed seizure occurred in 2001.  
[a] [b] [c] [d] [e] [1] 
 KEY POINTS 
 2C-T-7 is reported by the online users to be the most potent compound among 
 the 2C-x family of phenethylamines. A Shulgin in his book, PiHKAL, ranked 
 2C-T-7 on the top along with 2C-T-2, 2C-B, 2C-E and Mescaline.     
 
Structure of 2C-T-7 
The name 2C-T-7 is derived from 2-C which stands for the 2-Carbon amino 
ethane chain and T (thio) which stands for the substitution of the sulphur.  
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MDMA   Mescaline   2C-T-7 
 
2C-T-7 is a psychedelic compound belonging to phenethylamine class. 
Structurally, it closely resembles MDMA and Mescaline.  
[f] [1] [2] [3] [4] [5] [6]        
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 2-(2, 5-dimethoxy-4-propylsulfanylphenyl) ethanamine  
Molecular weight: 255.37634 g/mol    
Molecular formula: C13H21NO2S 
CAS Number: 207740-26-9 [7] [8] [9]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
Legal Powder Ltd. 
Packing: This product comes in a polyethylene package is fully sealed, with glued tag 
"powder for polishing, also be accompanied by a certificate.  
Order 2C-T-7 On-Line 
To buy 2C-T-7 or other legal powders, please fill out the form and we will contact you. [10] 
Cayman Chemical 
This product requires special processing and/or additional information before it can be 
shipped. A Customer Service representative will contact you within 24 hours of receipt of 
your order. Warning This product is not for human or veterinary use. See distributor in your 
area for pricing. 
Promos-Chem (pure chemicals) 
2,5-Dimethoxy-4-n-propylthiophenethylamine 
CAS: 207740-26-9 
This product is NOT for human consumption! [12] 
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 AVAILABLE INFORMATION ON PURCHASE PRICE  
 There were not many websites selling this compound. One company 
 (Promos) sold 50g for €950. The price of another company (Legal powder) is as 
 follows: 100g for 580 USD; 500g for 1320 USD; 1000g for 2190 USD; 2000g 
 for 3400 USD; 5000g for 5810 USD; 10000g for 8000 USD.   
 [10] [11] [12]  
 MODALITIES OF INTAKE  
 Oral ingestion of the powder seems to be the popular method of use. 
 Vapour inhalation of the substance was popularly known as ‘Chasing the 
dragon’. Users recommend a small dose of 3mgs to start with. The 
compound was placed in an aluminium foil and the vapours inhaled.  
 Intra venous (IV) and intra muscular (IM) injections, though rarely practised 
causes severe and prolonged nausea and vomiting.  
 Nasal insufflation was reported to be more potent than the oral route. A 12 
mgs dose of nasal insufflation equals 30mgs of the oral dose – as reported by 
the users.  
[13] [14] [15] [16] [17] 
 LEGAL STATUS 
2C-T-7 was temporarily banned in 2002 by the Drug Enforcement 
Administration (DEA) and was permanently placed under Schedule 1 in the 
USA in 2004. It was banned in Australia (2005), Denmark (2003), Estonia 
(2011), Greece (2003), Italy (2005), Portugal (2005), Slovakia (2009) and 
Sweden (2004).   
In the UK, it is categorised under Class A of the Misuse of Drugs Act 1971, as it 
is a derivative of phenethylamines. It is reported to be legal in Austria, Canada 
etc.  
[18] [19] [20] [21] 
 CURRENT USE / MEDICINAL USE  
None. It is a research chemical and not intended for human consumption. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
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Shulgin in his book, PiHKAL, reported that 2C-T-7 produces psychedelic and 
entheogenic effects lasting between 8 to 15 hours with an oral dose range of 10-
30mgs. However users have tried doses higher than his recommended dose and 
there have been many reports of toxicity and death.  
Come up: 1 to 2 hours  Peak: 6-8 hours Come down: 15 hours  
A typical user’s trip experience is summarised below:  
T+ 0 min: 24.5 mg of 2C-T-7 ingested   
T+36min: enhanced visual distortions, inability to speak. 
T+74min: ‘stories seem to emerge from inanimate objects like a toilet or guitar’.  
T+ 112min: Stomach cramps observed. 
T+ 142min: Very strong visual distortions.  
T+ 194min: Significant body 'load' and unpleasant mental cloudiness. 
T+ 225min: fluctuations of body temperature.  
T+ 269min: jaw tension and a minor headache. 
 
[f] [22]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
Some users advised not to use 2C-T-7 in combination with other compounds as 
it could increase the risk of cardio toxicity. However, few examples of the 
combinations used by the online users are given below:  
 With LSD (‘very intense and scary experience; would not recommend to 
anyone’) 
 With AMT, methamphetamine, cannabis (Violence towards police; later in 
coma for a week)  
 With DMT  
 With MDMA 
 With mushrooms 
 With ketamine 
 With 2C-I, MDMA, methylone  
 With Salvia Divinorum 
 [23] [24] [25] 
 PHARMACOLOGICAL CHARACTERISTICS 
      
 Dopamine    Norepinephrine  Serotonin  
 There are naturally occurring mono amine neurotransmitters such as the 
 Dopamine, Norepinephrine, Serotonin etc. The basic phenethylamine skeletal 
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 structure forms the base of these compounds. 2C-T-7 which closes resembles 
 these neurotransmitters also bind to the protein substrates to produce various 
 biochemical effects. These are not well studied in human population but there 
 are few animal studies available.   
 A study concluded using animal model that 2C-T-7  showed greater affinity for 
 5-HT2A and 5-HT2C receptors and lower affinity for 5-HT1A receptors.  
 Another study showed the potent and selective ability of 2C-T-7 to reversibly 
 inhibit MAO-A activity and no significant MAO-B activity.  
 There were no human studies on the metabolism of 2C-T-7. An animal study 
 identified the steps in metabolism of 2C-T-7 using GC/MS from rat urine. The 
 steps involved in the metabolism of 2C-T-7 follows two pathways: 
 The major pathway involved the hydroxylation of the propyl side chain 
followed by N-acetylation and sulfoxidation and also by deamination 
followed by oxidation to acid or by reduction to alcohol.  
 A minor pathway involved S-dealkylation followed by N-acetylation, S-
methylation and sulfoxidation.   
[g] [h] [i]  
 TOXICOLOGICAL EFFECTS 
 One user reported his friend consuming 2C-T-7 with AMT, methamphetamine 
 and cannabis. He became violent, confused and was in coma for a week. [26]  
 DESIRED PSYCHOACTIVE EFFECTS 
 ‘sense of inner peace’ 
 Increased music appreciation 
 Empathogenic effects  
 Mood lift/ euphoria  
[27] [28]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Severe and persistent vomiting reported by many users 
 Acute effects on nasal insufflation of 15mgs of 2C-T-7: Heart rate 
(180/minute), high blood pressure, dyspnoea, severe sweating and stomach 
cramps – needed admission to Emergency Department.   
 Very high blood pressure 
 Delirium  
 Seizure  
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 Clot in the lungs (D-Dimer test done at the emergency department showed 
positive result for a person who took 33mgs of 2C-T-7) (it was reported that 
usually death occurred due to pulmonary oedema).  
 Jaw clenching 
 Dilated pupil and blurring of vision  
 Cardiac arrhythmias  
 Sexual dysfunction 
 Muscular spasms 
 
[d] [29] [30] [31] [32] [33] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Delusions lasting for 24hours (on 70mgs of 2C-T-7) 
 Hallucinations - ‘couldn’t see the real world’ (on 60mgs)  
 Auditory and visual hallucinations on 15mgs 
 Violent behaviour  
 Anxiety 
 Panic attacks 
 Distortion of time sense  
 Insomnia 
 Memory loss 
[j] [34] [35] [36]  
 CLINICAL ADVICE 
Two doses of Ativan (lorazepam) were given to a patient who took 15mgs of 
2C-T-7 and was hallucinating uncontrollably. Lorazepam helped the patient to 
sleep and the symptoms disappeared in a short while. [37]  
 RELATED FATALITIES  
 There are a number of death reports (both confirmed and unconfirmed) 
 available. There were two deaths resulted from snorting 10mgs of 2C-T-7. Other 
 death reports include:  
 Jake Duroy, October 2000, Oklahoma, Insufflation – this was the first 
confirmed death report by coroner due to the presence of 2C-T-7 in the 
blood sample. 
 Joshua Robbins, April 1 2001, Memphis, Insufflation  
 Name Withheld, April 8 2001, Seattle, Oral – combined with 2C-T-7 and 
MDMA 
79 
 
 A 20 year old man died after ingesting 35mgs of 2C-T-7. The post-mortem 
 findings confirmed the presence of this compound using Gas Chromatography 
 with Nitrogen Phosphorus Detection (GC-NPD) and electron ionization Gas 
 Chromatography-Mass Spectrometry (GS/MS). It also showed that a large 
 quantity of 2C-T-7 was excreted unchanged in urine.  
 [k] [38] [39] [40]  
 YOU TUBE VIDEOS 
 There were no sale videos in the You Tube, but there were few clips where A 
 Shulgin spoke about phenethylamine group of compounds including 2C-T-7. 
 1, 2 and 3 of 3 Sasha Shulgin - Drugs of Perception: In these 3 video clips, 
A. Shulgin Shulgin speaks at the Psychedelic conference Santa Barbra in 
1983. 
 A Conversation with Terence Mckenna and Alexander (Sasha) Shulgin 
1993 
[41] [42] [43] [44]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 2C-T-7, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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I.VI 4-Bromo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine 
(25B-NBOMe) 
 
 
 
25B-NBOMe Report 
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 25B-NBOMe  
 OVERVIEW 
 Chemical name: 25B-NBOMe 
Synonyms:  CIMBI-36; NBOMe-2C-B; BOM 2-CB; 25B-NBMeO; NBOMe-
2CB; 4-Bromo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine; N-(2-
Methoxybenzyl)-4-bromo-2, 5-dimethoxyphenethylamine;  
Active constituents: 25B-NBOMe 
Type: Research chemical – Phenethylamine 
Origin: 25B-NBOMe was discovered by Ralf Heim at the Free University of 
Berlin in 2003. It was made popular by David Nicholas and team at Purdue 
University. 25B-NBOMe is derived from the phenethylamine 2C-Br by 
substitution on the amine with a 2-methoxybenzyl (BOMe) group.  
Status: Novel 
Chronology: The 25B-NBOMe is claimed to have first appeared online in 2010.  
[1] [2] 
 KEY POINTS 
25B-NBOMe is a N-o-methoxybenzyl analogue of the 2C-x family of phen 
ethylamines, and is agonist of 5-HT2a receptor which can cause hallucinations. 
It becomes active at extremely low doses similar to LSD.  
Since 25B-NBOMe acts as a highly potent and selective agonist for the human 
5-HT2a receptor, a radio-labelled form of 25I-NBOMe can be used as a tool for 
mapping the distribution of 5-HT2a receptors in the brain. However, this 
compound has become a drug of misuse because of its characteristic effect on 
serotonin receptor. [a] [b] [c] [d]     
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 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 2-(4-Bromo-2, 5-dimethoxyphenyl)-N-(2-methoxybenzyl) 
ethanamine 
Molecular weight: 380.275 g/mol  
Molecular formula: C18H22BrNO3 
CAS Number: 1026511-90-9 
[3] [4] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
EC21: Hoffman: Nbometrade Gmbh. 
25B-NBOMe (NBOMe) 
Free sample available!!!! only from us!!! 
Don’t hesitate to contact us for this unique chemical which is available for sale on very cheap 
price.  
Lab. location: Germany [5] 
Isomerism 
25B-NBOMe (NBOMe-2C-B, BOM 2-CB, Cimbi-36) 
Lab. location: Asia (CN) [6] 
Promos-Chem 
25B-NBOME 
This product is NOT for human consumption! 
Can be used for laboratory purposes only![7]  
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Prices varied considerably depending on the websites. One website sold the 
 powder as follows: 100mgs for $25 or €20; 200mgs for $40 or €35; 500mgs for 
 $80 or €70. Another website sold as follows: 100 milligrams for $70; 1 gram for 
 $250; 5 grams for $1,100. Yet another website sold 1 gram for €200.  
 [8] [9] [10] 
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 MODALITIES OF INTAKE  
 25B-NBOMe powder is extremely potent at very low doses (in micrograms). It 
 does not mix well with water. So it is generally mixed with some solvents such 
 as alcohol to make a mixture and calculate the dose to ingest the liquid orally. 
 The liquid can be instilled nasally, which is a popular method.  
 Also interestingly, few users have experimented with soaking the liquid on a 
 blotter and keeping it on the buccal mucosa for several minutes. Buccal 
 absorption can be enhanced by adding Cyclodextrins. Some users apply the 
 method of buccal absorption which was demonstrated by Josef in 1991 in his 
 research paper. They recommend addition of HPBCD (Hydroxy-Propyl-Beta-
 CycloDextrin) to improve the buccal absorption to about 95%.  
 [11] [12] [13] [14] [15] [e] [f] 
 LEGAL STATUS 
 25B-NBOMe is currently uncontrolled in the United Kingdom, as N-benzyl 
 derivatives of phenethylamine are not covered by the phenethylamine 
 derivatives clause of the Misuse of Drugs Act 1971. Hence this compound 
 remains as a ‘Novel psychoactive substance’.  
 [16] 
 CURRENT USE / MEDICINAL USE  
 None.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The usual dose is between 300 to 600 micrograms. 
 Come up: 10 to 30 minutes Peak:1-2 hours Come down: >4hours 
 [17]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With amphetamine (MDMA) [18] 
 PHARMACOLOGICAL CHARACTERISTICS 
 An experiment was conducted to show the affinity of 25B-NBOMe for the 5-
 HT2a receptors in pig’s brain. This study (Ettrup A et al, 2010) noted that when 
 compared with other NBOMe series of compounds, 25B-NBOMe (CIMBI-36) 
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 has the highest potency, highest affinity and highly selective agonism to 5-HT2a 
receptor. [b]  
TOXICOLOGICAL EFFECTS 
As this is fairly recently available online, no further information is available. 
DESIRED PSYCHOACTIVE EFFECTS 
 Strong sound distortions 
 Spasmodic body high 
 Complete loss of ego [19] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Nausea 
 Extreme anxiety [20] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Disorientation in time, place and person [19] 
 CLINICAL ADVICE 
 25B-NBOMe is very active in extremely small doses. The users may not have 
 sophisticated weighing scale; hence the chances of accidental overdoses are 
 quite high. 
 RELATED FATALITIES  
 None.  
 YOU TUBE VIDEOS 
 NBOMe research chemical [21] 
 GOOGLE INSIGHTS 
 There are not enough search volume to show some graph.  
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 25C-NBOMe   
 OVERVIEW 
 Chemical name: 25C-NBOMe 
Synonyms:  CIMBI-82; PANDORA; DIME; NBOMe-2C-C; 4-Chloro-2, 5-
dimethoxy-N-(2-methoxybenzyl) phenethylamine; N-(2-Methoxybenzyl)-4-
chloro-2, 5-dimethoxyphenethylamine;   
Active constituents: 25C-NBOMe 
Type: Research chemical – Phenethylamine 
Origin: The first compound in the NBOMe series, 25I-NBOMe, was discovered 
by Ralf Heim at the Free University of Berlin in 2003. It was made popular by 
David Nicholas and team at Purdue University. 25I-NBOMe is derived from the 
phenethylamine 2C-I by substitution on the amine with a 2-methoxybenzyl 
(BOMe) group.  
25C-NBOMe is also claimed to have been first synthesised by Dr Anders Ettrup, 
at the Neurobiology Research Unit, Denmark in 2009 and this work was 
published in 2011. Structurally, it is obtained by substituting Chloro for Iodo at 
R4 position in the 25I-NBOMe molecule.   
Status: Novel 
Chronology: The 25C-NBOMe is claimed to have first appeared online in 2010. 
[1] [2] [a] [b] [c] [d]    
 KEY POINTS 
25C-NBOMe is a N-o-methoxybenzyl analog of the 2C-x family of phenyl 
ethylamines, and is agonist of 5-HT2a receptor which can cause hallucinations. 
It becomes active at extremely low doses similar to LSD.  
Since 25C-NBOMe acts as a highly potent and selective agonist for the human 
5-HT2a receptor, a radio-labelled form of 25I-NBOMe can be used as a tool for 
mapping the distribution of 5-HT2A receptors in the brain. However, this 
compound has become a drug of misuse because of its characteristic effect on 
serotonin receptor. [1] [2] [a] [b] [c] [d]     
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 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 2-(4-Chloro-2, 5-dimethoxyphenyl)-N-(2-methoxybenzyl) 
ethanamine  
Molecular weight: 335.824 g/mol 
Molecular formula: C18H22ClNO3 
CAS Number: 1227608-02-7  [1] [2]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Isomerism 
2C-C-NBOMe (NBOMe-2C-C, 25C-NBOMe, Cimbi-82, Pandora, Dime) 
CAS# 1227608-02-7 Form: HCl Purity 99%+ Lab. location: Asia (CN) [3] 
9W Pharmaceutical Technology Co., Ltd 
25c-nbome 
Appearance: White or Similar crystalline powder 
Assay: >99.5% 
Packing: 1kg/Aluminium foil bag or Customized 
Usage: For Research 
Storage: Keep away from fire and heat source; hermetically deposit; keep in shady, cool and 
dry condition; protect against the tide.[4] 
EC21: Jahn Haffman: Nbometrade Gmbh 
25C-NBOMe (NBOMe) is a derivative of the cc, which acts as a potent partial agonist for the 
receptor, and has been studied in its  radiolabelled form as a potential ligand for mapping the 
distribution of 5ht receptors, using positron emission tomography (PET).  Anecdotal reports 
suggest 25C-NBOMe to be an active at  as little as 200-500mcg .[5] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Prices vary depending on the vendors distribution areas. In Europe, 10grams is 
 sold for €300; 50grams for €850; 100grams for €1,400; 500grams for €5,100. As 
 on 31
st
 May 2012, few websites announced that this product was sold out. 
 100gram powder is sold for £95 and 500grams for £280 in the UK (but currently 
 out of stock).  In the USA, 1gram is sold for $300; 5grams for $1,300; 10grams 
 for $2,100. [6] [7] [8]  
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 MODALITIES OF INTAKE  
 25C-NBOMe powder is extremely potent at very low doses (in micrograms). It 
 does not mix well with water. So it is generally mixed with some solvents such 
 as alcohol to make a mixture and calculate the dose to ingest the liquid orally.  
 Also interestingly, few users have experimented with soaking the liquid on a 
 blotter and keeping it on the buccal mucosa for several minutes. Buccal 
 absorption can be enhanced by adding Cyclodextrins. Some users apply the 
 method of buccal absorption which was demonstrated by Josef in 1991 in his 
 research paper. They recommend addition of HPBCD (Hydroxy-Propyl-Beta-
 CycloDextrin) to improve the buccal absorption to about 95%. Others methods 
 include: 
 Sublingual route – placing the liquid on a blotter paper 
 Another method is to prepare the mixture (powder with a solvent) and 
placing one drop on a foil and inhaling the vapour. 
 
 Nasal insufflation of the powder or the liquid preparation is also tried by 
users. 
 Snorting the powder  [9a] [9b] [e] [f]  
 LEGAL STATUS 
 25C-NBOMe is currently uncontrolled in the United Kingdom, as N-benzyl 
 derivatives of phenethylamine are not covered by the phenethylamine 
 derivatives clause of the Misuse of Drugs Act 19718. Hence this compound 
 remains as a ‘Novel psychoactive substance’. [10] 
 CURRENT USE / MEDICINAL USE  
 None. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The dose has to be carefully adjusted, as it is very potent in micrograms. The 
 forum users emphasise the precise weighing of the compound and caution 
 against accidental overdose. Users also suggested various ways to make the 
 preparation of the mixture and to accurately measure the dose. Once such 
 example is (quote): “for example, 2mgs of 25C was dissolved in 1ml of water to 
 make 2mgs/ml of water; then 1/4 ml (0.25 ml; 250 ul) with an oral 1ml syringe 
 to deliver 500 ug and insufflate the liquid”. 
 Usual dose: 250micrograms to 500 micrograms 
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 Come up: 30minutes  Peak: 1-2 hours Come down: 5-8 hours 
 A user tested for allergic reaction using 50micrograms per drop. As no effects 
 were noted, further test with 3 drops sublingual was tried few weeks later. After 
 a month, the user tried 600micro grams sublingual. A typical experience is given 
 below: 
 00:00 - Mood was starting to be lifted; dancing.  
 01:00 – Euphoria; music sounds better then normal; mild visuals noted. The 
 feeling is reminiscent of the come up of my MDMA experiences.  
 01:15 - Intense euphoria for at least 20 minutes.  
 01:35 – Peak is reached; still strong euphoria, very similar to MDMA along with 
 some visuals.  
 02:30 - Feelings still going strong,  
 03:30 - Still lots of euphoria, the music appreciation still present.  
 05:00 - At this point I feel the effects are starting to subside.  
 08:00 - Small residual effects.  
  
 [11] [12] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With 4-AcO-DMT 
 With Cannabis 
 With MDMA 
 With 4-Aco-DMT and DXM 
 [13] [14] [15] [16] 
 PHARMACOLOGICAL CHARACTERISTICS 
 An experiment was conducted to show the affinity of 25C-NBOMe for the 5-
 HT2a receptors in pig’s brain. This study (Ettrup A et al, 2010) noted that when 
 compared with other NBOMe series of compounds, 25C-NBOMe has the high 
 potency, high affinity and high selective agonism to 5-HT2a receptor.  
 This study (Ettrup A et al, 2010) compared the uptake of tracers by 
 different NBOMe series of compounds [b]. 
 TOXICOLOGICAL EFFECTS 
 In Auckland, Dr Paul Fitzmaurice, Crown Research Institute, commented that a 
 sample of DIME was tested in their drugs lab (GC/MS analysis) and the sample 
 was found to contain 25C-NBOMe (also known as Pandora or Cimbi-82). 
 
 Convulsions have been reported following its intake.  
 
 [17] [18] [19] [20] [21]  
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 DESIRED PSYCHOACTIVE EFFECTS 
 Users compare the effects of 25C with that of 2-C and report that it was light on 
 the body, less stimulating, less prone to anxiety and more euphoric.  
 Strong visuals  
 Enhanced sense of humour  [22] [23] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Light headache towards the end  
 vasoconstriction,  
 nausea  
 irregular heartbeat [24] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 A dissociative experience filled with intense anxiety, loss of touch with reality 
 with graphic visual and auditory hallucinations; underlying these experiences 
 was a short live paranoid delusional state which disappeared after the trip.  
 Visual hallucination (‘seeing angels’) 
 Paranoid delusions/ Schizophrenia like symptoms. 
 [17] [18] [19] [25]   
 CLINICAL ADVICE 
 25C-NBOMe is very active in extremely small doses. The users may not have 
 sophisticated weighing scale; hence the chances of accidental overdoses are 
 quite high. 
 RELATED FATALITIES  
 None. 
 YOU TUBE VIDEOS 
 There was a video clip on the You Tube for sale. “NBOMe research chemical” 
 [26] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) 
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 for 25C-NBOMe, plotted on a scale from 0 to 100; the totals are indicated next 
 to bars by the search term, a break down of how the categories are classified, 
 lists of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 25I-NBOMe   
 OVERVIEW 
 Chemical name: 25I-NBOMe 
Synonyms: Solaris; CIMBI-5-2; CIMBI-5; 25I-NBMeO; INBMeO; 2C-I-
NBOMe; 25I; NBOMe-2C-I 
Active constituents: 25I-NBOMe 
Type: Research chemical – Phenethylamine 
Origin: The NBOMe series of chemicals are mainly N-o-methoxybenzyl analogs 
of the 2C-x family of phenyl ethylamines, and are agonists of 5-HT2a receptor 
which can cause hallucinations. These hallucinogenic compounds become active 
at extremely low doses similar to LSD. 
Status: Novel 
Chronology: It is reported to have first appeared on line for recreational purpose 
under the brand name ‘Solaris’ in 2007. 
[1] [2] [3] 
 KEY POINTS 
The first compound in the NBOMe series, 25I-NBOMe, was discovered by Ralf 
Heim at the Free University of Berlin in 2003. It was made popular by David 
Nicholas and team at Purdue University. 25I-NBOMe is derived from the 
phenethylamine 2C-I by substitution on the amine with a 2-methoxybenzyl 
(BOMe) group. Since it acts as a highly potent and selective agonist for the 
human 5-HT2A receptor, a radio-labelled form of 25I-NBOMe can be used as a 
tool for mapping the distribution of 5-HT2A receptors in the brain. However, 
this compound has become a drug of misuse because of its characteristic effect 
on serotonin receptor.  
[a] [b] [c] [d] [4] 
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
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IUPAC name:  
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2methoxyphenyl) methyl] ethanamine 
or 
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C] methoxybenzyl) ethanamine 
Molecular weight: 426.277384 [g/mol] 
Molecular formula: C18H22INO3  
CAS Number: 919797-19-6; 1043868-97-8 (hydrochloride) 
[5] [6]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
EC Plaza Global 
Any amount is available from mg to kg from as little price as 25 usd or 20 euro buy 25I-
nbome which is for sale on very cheap price so you can sell this easily! We are the best online 
vendor for Nbome! Free sample available!!!! CAS number 919797-19-6 1043868-97-8 
(hydrochloride) [7] 
Joychem Co., Ltd 
Categories: Research Chemicals 
Grade Standard: Medicine Grade 
CAS No.: 1043868-97-8 
Other Names: 25I-NBOMe(hcl) 
Purity: 99.9%  
Appearance: white powder/crystal [8] 
Shining Stuff 
99.9% Pure 25i-nbome  
Contact tony montana: 99.9% pure 25i-NBOME, 25C-NBOME,Mephedrone, Methylone 
,Methedrone,Bulytone, MDAI, JWH,MDPV and other RSC for sale [9] 
  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Prices vary depending on the vendors distribution areas. In Europe, 5grams is 
 sold for €200; 50grams for €900; 100grams for €1,600; 500grams for €6,350. As 
 on 31
st
 May 2012, few websites announced that this product was sold out. 
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 100gram powder is sold for £95 and 500grams for £280 in the UK (but currently 
 out of stock). In the USA, 1gram is sold for $280; 5grams for $1,100; 10grams 
 for $1,900. [10] [11] [12] [13]  
 MODALITIES OF INTAKE  
 25I-NBOMe powder is extremely potent at very low doses (in micrograms). It 
 does not mix well with water. So it is generally mixed with some solvents such 
 as alcohol to make a mixture and calculate the dose to ingest the liquid orally. 
 
 Also interestingly, few users have experimented with soaking the liquid on a 
 blotter and keeping it on the buccal mucosa for several minutes. Buccal 
 absorption can be enhanced by adding Cyclodextrins. Some users apply the 
 method of buccal absorption which was demonstrated by Josef in 1991 in his 
 research paper. They recommend addition of HPBCD (Hydroxy-Propyl-Beta-
 CycloDextrin) to improve the buccal absorption to about 95%.  
 
 Another method is to prepare the mixture (powder with a solvent) and placing 
 one drop (about 250 micrograms) on a foil and inhaling the vapour. 
 
 Nasal insufflation of about 500micrograms of the powder is also tried by users. 
 Very rarely, it can be injected intra muscularly. [14] [15] [16] [17] 
 
 LEGAL STATUS 
 25I-NBOMe is currently uncontrolled in the United Kingdom, as N-benzyl 
 derivatives of phenethylamine are not covered by the phenethylamine 
 derivatives clause of the Misuse of Drugs Act 19718. Hence this compound 
 remains as a ‘Novel psychoactive substance’. [18] 
 CURRENT USE / MEDICINAL USE  
 None. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Users reported that it produces more of empathic feelings than MDMA. It also 
 causes smaller anxiety levels on come down when compared with 2C-I 
 compounds. 
 The dose has to be carefully adjusted, as it is very potent in micrograms. Users 
 report that it is at least 17 times more potent than 2C-I compound. So the forum 
 users emphasise the precise weighing of the compound and caution against 
 accidental overdose. Users also suggested various ways to make the preparation 
 of the mixture and to accurately measure the dose. Once such example is (quote) 
 “to add 100mg of 25i-nbome to 50ml of 95% etoh (instead of 100ml of 95% 
 etoh) for a final drug ratio of 200ug per each 0.100ml on the insulin syringe”.   
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 Following nasal insufflation of the powder, it has a rapid onset of action (usually 
 within 20minutes). Usual dose: 350micrograms to 500 micrograms.  
 Come up: 20 minutes  Peak: 2 hours  Come down: 6-8 hours 
 [e] [f] [19] [20]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With 5 MeO –MIPT to get stronger visuals.   
 With 6-APB 
 [21] 
 PHARMACOLOGICAL CHARACTERISTICS 
 Studies on classical hallucinogens suggest that various types of these 
 compounds (Phenyl alkyl amine hallucinogens) act at 5-HT receptors which 
 consist of 5-HT2a, 5-HT2b, 5-HT2c etc. Recent studies have compared only few 
 Phenyl alkyl amine hallucinogens and it seems that these compounds show little 
 selectivity for one subpopulation over the other. In the case of 25I-NBOMe, the 
 affinity for 5HT2a & 5-HT2c seems to be stronger than any other compounds 
 such as LSD. Lower Ki value corresponds to higher receptor binding ability. 
 The affinity (Ki value) for 5-HT2a is at 0.044 and for 5-HT2c is at 2.0.  For 
 comparison, in case of LSD the Ki value is only 3.55 at HT2a and 23.0 at 5-
 HT2c.  
 [g] [h] [22] [23] [24] 
 TOXICOLOGICAL EFFECTS 
 These are very early days, as the compound has recently entered the market. 
 There are reports of (at least five) individuals ingesting 25I and being 
 hospitalised in Virginia, Richmond, USA. Two of them were reported to have 
 cerebral bleeding.  
 Another user took 500micrograms of 25I-NBOMe (powder mixed with alcohol) 
 and became unresponsive to any stimuli. He was taken to the emergency 
 department and was found to have developed dangerously low 
 hypomagnesaemia and hypokalemia. He was treated in the hospital for 5 days.  
 Neuro toxicity: seizure like activity, confusion and disorientation. 
  [25] [26] [27a] [27b] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Strong visuals  
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 Extremely colourful visuals 
 Body high 
 No nervous feelings  
 [28]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Severe headache (on coming down) 
 Severe breathlessness, chocking sensation requiring endotracheal intubation. 
 ‘Near death experience’ resulted in coma – required hospitalisation. 
[29] [30] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Episodes of depression. 
 Violent outbursts. 
 Visual hallucinations, intense hallucinations 
 Extreme anxiety  
 Panic attacks 
 Intense synaesthesia and spatial distortion (on 2.5mg sublingual dose) 
 Auditory as well as visual hallucinations occurring together  
[31] [32a] [32b] 
 CLINICAL ADVICE 
 It is about 16 times more potent than 2C-1 and is active at a dose of 
 500microgram. Since the dosage is extremely small and the users may not have 
 sophisticated weighing scale, the chances of accidental overdoses are quite high. 
 RELATED FATALITIES  
 None. 
 YOU TUBE VIDEOS 
1. Tripping on 25i NBOMe 
2. NBOMe research chemical 
3. Tripping 25i NBOMe coming down  
[33] [34] [35]  
 GOOGLE INSIGHTS   
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 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 25I-NBOMe, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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I.IX 5-(2-Aminopropyl) Benzofuran (5-APB) 
 
5-APB Report 
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 5-APB   
 OVERVIEW 
Chemical name: 5-(2-Amino Propyl) Benzofuran (5-APB) 
Synonyms: APB, 5-(2-Aminopropyl) benzofuran; 1-(1-Benzofuran-5-yl) 
propan-2-amine.  
Active constituents: 5-(2-Aminopropyl) benzofuran 
Type: Research chemical – Phenethylamine and amphetamine class; it acts as an 
entactogen and Psychostimulant. 
Origin: 5-APB was synthesised by David E Nichols and his team in 1990s. 
Status: Novel 
Chronology: Since its synthesis, many compounds or derivatives are being 
synthesised. 5-APB has two isomers (4-APB and 6-APB) and about 20 
analogues such as MDA (3, 4-Methylenedioxyamphetamine), 5-IT (5-(2- 
Aminopropyl) Indole), 5-APDB, 6-APDB etc.  
[1] [2] [3] [4] 
 KEY POINTS 
MDA is one of its analogues where the 3, 4-methylenedioxyphenyl ring system 
has been replaced with benzofuran ring. The molecular diagram of both MDA 
and 5-APB is given below:  
 
 
 
MDA (3, 4-Methylene Dioxy Amphetamine) 
 
 
 
5-APB 5-(2-Aminopropyl) benzofuran [5]    
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 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 5-(2-aminopropyl) benzofuran 
Molecular weight: 175.23 g/mol 
Molecular formula: C11H13NO 
CAS Number: 286834-80-8 [6] [7] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Professor Nutty 
Description: 5-APB is capped for your convenience and supplied in discreet packaging.  
Now a well-established research chemical 5-APB is the ‘little-brother’ of 6-APB. 5-APB 
produces less psychedelic but more stimulating and empathogenic effects. [8] 
Benzo Fury 
We are pleased to announce that genuine 5-APB 1-(1-benzofuran-5-yl) propan-2-amine is in 
stock now. 
 5-APB is a derivative of 6-APB or Benzo Fury as it is known and the Official 5 are once 
again proud to be the only official suppliers of this chemical. [9] 
V X Chem 
5-APB is also a variant of 6-APB, but at least 30% stronger than 6-APB. 
 For scientific research purposes only, strictly not for human consumption. [10] 
 
 One particular vendor published a report on their sale product (5-APB) which 
 was allegedly tested by NMR and a GC/MS on 24/01/2012 and war alleged to 
 be a genuine product. Their report was also put on their sale page. [11]  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The prices vary considerably from website to website. Various vendors quote a 
 price range from £29 to £82 per 1 gram. Some vendors even attract customers by 
 putting up a 50% off on 5 APB using specific codes.  
 [12] [13] [14] [15] 
 MODALITIES OF INTAKE  
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 Oral ingestion: The pellet forms can be swallowed. The powder can be 
 insufflated or snorted. Nasal insufflation can be painful, but a lower dose range 
 (25-50mgs) is suggested.  
 Rectal route: Very rarely, users take this produce through enema.  
 [16] [17] 
 LEGAL STATUS 
 It is uncontrolled in the USA. It is still legal in the UK.   
 CURRENT USE / MEDICINAL USE  
 None. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The usual dose is between 75mgs to 100 mgs.  
 Come up: 40-60min.  Peak: 2 hours Come down: 6-8 hours 
 5-APB is discussed to be 30% stronger than 6-APB.  
 [18] [19] [20] [21]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 The usual combination is with 6-APB to intensify the effects. This 
combination is also used to prolong (for days) the euphoric effects. One 
user re-dosed on this combination and the effects lasted for 2 and ½ days. 
 Few users have suggested combining 5 & 6 APB with mushrooms.  
[22] [23] [24] 
 PHARMACOLOGICAL CHARACTERISTICS 
 5-APB belongs to the class of Phenethylamine and Amphatamine and it is also 
 an analogue of MDA. Based on the characteristics of these class of compounds 
 (Phenyl alkyl amine hallucinogens), they act as agonist on the 5-HT2a serotonin 
 receptors. Studies on classical hallucinogens suggest that various types of these 
 compounds (Phenyl alkyl amine hallucinogens) act at 5-HT receptors which 
 consist of 5-HT2a, 5-HT2b, 5-HT2c etc. Recent studies have compared only few 
 Phenyl alkyl amine hallucinogens and it seems that these compounds show little 
 selectivity for one subpopulation over the other. [a] 
 TOXICOLOGICAL EFFECTS 
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 Usually it occurs when the dose is above 250mgs or used in combination with 
 other compounds. The symptoms of toxicity are given below: 
 Nausea 
 Vomiting 
 Stomach cramps 
 Tachycardia [25a] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Mild euphoria 
 Mild visuals 
 Sexual stimulation 
 Enhanced music appreciation [25b] 
 
PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Nausea 
 Lethargy 
 Body load 
 Yawning  
 Headaches  
 Dizziness 
 Restless, agitation 
 Unable to stay still 
 Pupillary dilatation – sensitivity to light 
 Terrible hangover the following day 
[26a] [26b] 
  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Visual hallucinations (transient) 
 Short lived paranoid delusions similar to psychotic episode [27] 
 CLINICAL ADVICE  
 As 5-APB is thught to act on serotonergic receptor, it could potentially cause 
 ‘serotonin syndrome’; so people with overdose could be treated along those 
 treatment lines.  
 RELATED FATALITIES  
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 None. 
 YOU TUBE VIDEOS 
1. EZ Test Mecke for 5-APB 
2. 5-APB research chemical testing by Benzofury me 
 [28] [29] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 5-APB, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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 6-APB & 6-APDB  
 OVERVIEW    
The molecular structure of 6-APDB and 6-APB are very similar except that the 
6-APB contains a double bond between carbons 2 and 3 on the furan ring (see 
left side). The 6-APDB molecule does not have a double bond, but pairs of 
hydrogen atoms on carbons 2 and 3.   
This subtle difference between the two molecular structures can produce entirely 
different effects, side-effects and toxicity. The structure of 6-APDB and 6-APB 
closely resemble MDA.   
 Chemical names:     6-(2-aminopropyl) benzofuran = 6 APB  
6-(2-aminopropyl)-2, 3-dihydrobenzofuran = 6 APDB [1] 
4-Desoxy-MDA = 6 APDB  
 
Synonyms: Benzofury; often 6-apdb & 6-apb are regarded as the 
same; but they are different compounds.    
 
Type: Research Chemical – a derivative of Phenethylamine  
 
Origin: It is a Research Chemical with very short history of 
human consumption.  
 
Active constituents: 6-(2-aminopropyl) Benzofuran  (= 6 APB) and  
6-(2-Aminopropyl)-2, 3- dihydro benzofuran (= 6 APDB)  
 
Status:   Legal 
 
Chronology:   David Nichols with team synthesized 6-APB in 1993 
whilst investigating non-neurotoxic MDMA analogues. 6-
APDB is often confused with 6-APB which is a derivative 
of 6-APDB [a]  
 KEY POINTS  
 
It is an analogue of MDA where the heterocyclic 4-position oxygen from the 3, 
4-methylenedioxy ring has been replaced with a methylene group.  
 
[2]  
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The molecular diagrams of all three compounds look quite similar:  
 
 
 
MDA (3, 4-Methylene dioxy amphetamine) 
  
 
6-APB (Note the double bond on the furan ring) [3]  
 
  
 
6-APDB  (Note: No double bond on carbons 2 and 3 on the furan ring) [4] 
 
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
6-APB 
IUPAC Name: 6-(2-aminopropyl) benzofuran 
CAS Number: 286834-85-3 (racemic free base) 
286834-84-2 (racemic hydrochloride salt)  
Formula:  C11H13NO 
Molar Mass:  175.23 g/mol  
 
6-APDB 
IUPAC Name: 1-(2, 3-dihydro-1-benzofuran-6-yl) propan-2-amine  
   hydrochloride 
CAS Number: 152623-93-3 
Formula:  C11H15NO  
Molar Mass:  177. 22702 g/mol  
 
[5] [6] 
 
 APPEARANCE OF COMMERCIAL PRODUCTS 
It's a tan grainy type of powder which is supposed to be pure. The pellet form 
which contain varying doses of 6-APB mixed with caffeine and potentially 
another trivial stimulant (from analysis). Usually 6-APB is mixed with 
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magnesium stearate as a cutting agent. One user thinks it’s not magnesium 
stearate but glucose was used in his case [7] [8].   
     
Product Description 
This product is a research chemical. As with all of our products this is for chemical research 
purposes only. Strictly NOT for human consumption, please refer to our Conditions of Use for 
further information. 
Regular Price:£40.00  Special Price:£36.00 [12]  
6-APB is a synthetic raw chemical compound made popular around the world as the main 
active substance in Benzo Fury Pellets. We are proud to offer the highest purity 6-APB 
Powder sold anywhere online in an environment which has been saturated with low-grade 
and imitation 6-APB. Our 6APB comes as a low density flour-like brown/off-white powder 
which is soluble in water and responds well to marquis tests. As with all our research 
chemicals we advise that you are a qualified chemist with access to a lab capable of handling 
responsive raw materials. Please also be aware that 6-APB is under no circumstances 
permitted for in-vivo testing. [13] 
Our Price: £37.00 (Inc. 20% VAT) Earn 37 Loyalty Points  
The Official 6-APB Pellets are a tried and tested RC proving to be very popular. You can buy 
50 Pellets from this page; free standard delivery is included with this product. 
IF YOUR LAB IS NOT EQUIPPED WITH AN ANALYTICAL BALANCE CAPABLE OF 
kWEIGHING ACCURATELY DOWN AS LOW AS 10MG WITH AN ACCURACY OF +-
5 MG (THIS IS THE MINIMUM SPEC) THEN PLEASE DON’T ORDER THIS PRODUCT 
BECAUSE YOU ARE CLEARLY NOT PREPARED FOR ANY BONAFIDE SCIENTIFIC 
RESEARCH.[14] 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
2011 prices can be seen in the above picture. The prices have fallen almost to 
half in 2012, for e.g., the price for 1g is £32 and 25g costs £400.  
[15] [16] 
 
 MODALITIES OF INTAKE  
Usual mode of use is oral ingestion.  
Few users have tried nasal route – it was a very painful experience [11]. 
 LEGAL STATUS 
6-APB is currently legal in the UK. It is also uncontrolled in the USA.  
 CURRENT USE / MEDICINAL USE  
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None.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
The forum users for 6-APB report very strong effects at 100mgs and 200mgs 
produce even more powerful experience than MDA. The psychedelic 
experiences for 6-APB was more intense than MDA and MDMA (6-
APB>MDA>MDMA). Yet the ‘magical’ experience was hardly ever reached for 
6-APB (MDMA>MDA>6-APB). The euphoria was followed by a wave of 
nostalgia. A typical example of progression of effects:   
Come up: 30-60 min     Peak: 3-4 hours         Come down: 2 to 12 hours.  
T+15: green purple visuals and breathing walls 
T+30: strong sense of nausea and sickness on and off; also experiences body 
lightness similar to experience on MDMA; the eye wiggles started (vibrating 
visual field) – so unable to focus on any objects  
T+30-60: visuals getting stronger but remained clear headed. Colours and 
shadows intensified and the nausea subsided 
T+60:  remained on peak for about 3-4 hours  
T+ 4hours: still very visual with sparkles (the computer screen is animated and 
extra coloured).    
T+5hours: physical exhaustion   
T+7hours: euphoric and seeing visuals spark and colour shifts again. 
T+12hours: still getting visuals; insomnia for long time & tiredness.  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
Usual combinations are given below: 
- With 5-APB to get more euphoria and to prolong the effects 
- With 1,4 Butanediol to make the user more sociable  
- With methylone to add more euphoria and to get feel like MDM  
- With Mephedrone, Methylone and MDAI – severe toxic effect (heart – 
severe tachycardia; brain- insomnia, headaches) lasted for 3 days.  
[17] [18] [19] [35]  
 PHARMACOLOGICAL CHARACTERISTICS 
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6-APB is believed to release serotonin, norepinephrine and dopamine. Although 
it has not been assayed or validated, it is thought to be an agonist at the 5-HT2C 
serotonin receptor as well as at the 5-HT2A and5-HT2B receptor. [20]  
 TOXICOLOGICAL EFFECTS 
There is no sound evidence but it could reasonably be expected to cause 
neurological changes like MDA or MDMA because of the increased 
cytoplasmic monoamine concentrations and the oxidative stress that result 
particularly from dopamine. It seems rational to suppose that both 6-APB and 
APDB inhibit VMAT-2 and prevent vesicular uptake of monoamines, just as all 
monoamine releasers do.  
 
Serotonin syndrome: Forum users warn about the possibility of serotonin 
syndrome especially if combined with other serotonergic compounds and the 
outcome can be poor (1 in 10 death rate). The compounds include psychoactive 
compounds such as MDAT, MDAI, 5-IAI etc as well as medications such as 
MAOIs, SSRIs etc. However one user who was already on an SSRI 
antidepressant did not find any toxicity.  
The cardiovascular effects possibly result from sympathetic stimulation.  
 
1. Supra Ventricular tachycardia. 
2. Tachycardia for a long time. 
3. High blood pressure.  
4. Effect on liver (due to the presence of furans)  
5. Jaw or whole head shaking, sometimes involve the whole body 
6. It could have the potential to cause neurotoxicity.  
[11] [21] [22a][22b][23] [24]  
 DESIRED PSYCHOACTIVE EFFECTS 
 (Refer to the section on ‘Information on recreational use’) 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
The side-effects are similar to that of MDA but much more prominent than that 
of MDMA/ MDA. They occur as a result of sympathetic stimulation. These 
include:  
 Many users warn about neurotoxicity and brain damage 
 Severe nausea and sickness (‘violent vomiting’ ‘very distressing 
vomiting’ as described by some users) (very common - possibly due to 
serotonin release)  
 tachycardia  
 persistent (resting) tachycardia (even 2-3 days after ingestion) 
 high blood pressure  could lead to hypertensive crisis 
 high temperature 
 Severe sweating  
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 visual disturbance 
 severe headaches, not responding to analgesics  
 Agitation 
 Jaw and teeth clenching  
 Deep midline tongue ulcer (healed in 5 days) 
 Ulcers in the buccal mucosa, possibly due to bitting and clenching teeth 
 dry mouth  
 Extreme dry eyes 
 Insomnia 
 Loin pain 
 Prolonged diarrhoea  
 Sensitivity to light 
 drowsiness 
 hang over the next few days 
 clonus of hand and feet 
 [22b] [35] [36] 
 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Depression  
 Anxiety  
 Panic attacks  
 Insomnia for 3-4 days  
 Severe paranoid symptoms (lasting longer than that due to mephedrone) 
[25] [26] [27] [35] 
 CLINICAL ADVICE 
This molecule is postulated to be releasing serotonin from the nerve ending. 
Repetitive administration can cause serious serotonin dysfunction. Some forum 
user suggested that it could cause ‘serotonin syndrome’. Hence anyone with 
suspected overdose with 6APB could be treated as that of treatment for 
serotonin syndrome.  
 
The UK National Poisons Information Service reported that it received about 32 
telephone calls related to “Benzofury” toxicity. The symptoms were reported to 
be lasting more than 48 hours. Symptoms include hypertension, tachycardia and 
agitation.  
 
[20] [b] 
 
 RELATED FATALITIES  
The Sky news reported that Alex Herriot, 19, from Edinburgh, collapsed at the 
RockNess Festival after taking benzofury. Two other members in his group were 
treated in hospital. Alex died in the hospital on 11
th
 June 2012. The results of the 
post-mortem for confirmation of the substance are not yet available.  
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[28] [37]  
        YOU TUBE VIDEOS 
1. VMNews: Death of 19-year-old at Rockness festival linked to novel 
psychoactive substance 'Benzo Fury'  
2. Genuine Benzo Fury EZ Test  
3. Benzo Fury Official Distributors  
4. Reseach Drugs  
5. The Original Benzo Fury Monkey Dance  
6. Heat sealer working for foil bags BENZO FURY  
7. Benzo Fury in United Kingdom 
[28] [29] [30] [31] [32] [33] [34] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 6-APB, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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 6 APDB 
Web Search Interest for 6 APDB produced no result as there were not enough 
search volume to show graphs.  
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Chapter II: TRYPTAMINES 
 
As discussed in Chapter I, tryptamines belongs to the group of indole alkyl amines. 
Tryptamines are found in a wide variety of naturally occurring resources such as plants, 
fungi, animals (Jones, 1982; Scott et. al, 2006). Psilocybin, a phosphoryloxy ester of 
tryptamine, is a hallucinogen found in ‘magic mushrooms’. Traces of DMT found in 
Mimosa Hostilis plant (Meckes-Lozoya et. al, 1990) is another example.  
They are also found in the mammalian brain though at a very low concentrations
 
(Scott 
et. al, 2006; Boulton et. al, 1982) (0.1 – 100ng/g of tissue). Serotonin, a major 
neurotransmitter and melatonin, involved in the sleep-wake cycle are examples of 
tryptamine derivatives in the brain.  
 
Structure of tryptamine and 4-hydroxy tryptamine (Countyourculture, 2013)  
Its molecular structure shows the presence of an indole ring which is formed by a 
bicyclical fusion of a pyrrole and benzene rings. This indole ring is attached to the 
terminal amine (-NH2) group by α and β carbon side chain. Alteration of this molecule 
is done to produce compounds with hallucinogenic properties. The usual alteration 
occurs in the terminal amine (-NH2) or substitution at 4
th
 or the 5
th
 position of the ring.  
Replacement of the two hydrogen atoms of the terminal amine group with methyl, ethyl, 
isopropyl or methylisopropyl leads to the formation of DMT, DET, DiPT or MiPT 
respectively. Further alteration of the DMT molecule with hydroxy, acetoxy and 
phosphoryloxy moiety at the 4
th
 ring position gives rise to 4-HO-DMT (Psilocin), 4-
AcO-DMT (Psilacetin) and 4-PO-DMT (Psilocybin) respectively. In the same way, 
substitution occurs for DET, DiPT and MiPT to form their respective hydroxy, acetoxy 
and phosporyloxy conterparts. Substitution at the ring 5
th
 position also forms newer 
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compounds. A classification (Fantegrossi et. al, 2008) of designer tryptamines is given 
below:       
TRYPTAMINES 
 
  Ring un-substituted Ring 4-substituted   Ring 5-substituted 
           
Un-substituted 
at 4 position 
Free Phenol 
4-Hydroxy 
Acetate Ester 
4-Acetoxy 
Phosphoryloxy 
Ester 
4-Phosphoryloxy 
Ring 5-
substituted 
tryptamines 
  DMT 
Psilocin 
(4-HO-DMT) 
Psilacetin 
(4-AcO-DMT) 
Psilocybin 
(4-PO-DMT) 
 
(5-MeO-DMT) 
DET 
Ethocin 
(4-HO-DET) 
Ethacetin  
(4-AcO-DET) 
Ethocybin 
(4-PO-DET) 
 
 
DIPT 
Iprocin 
(4-HO-DiPT) 
Ipracetin 
(4-AcO-DiPT) 
Iprocybin 
(4-PO-DiPT) 
 
(5-MeO-DiPT) 
MIPT 
Miprocin 
(4-HO-MiPT) 
Mipracetin 
(4-AcO-MiPT) 
Miprocybin 
(4-PO-MiPT) 
 
(5-MeO-MiPT) 
 
  Classification based on Fantegrossi et al. 
Thus ring substitution, especially at the 4
th
 or 5
th
 position of the tryptamine molecule 
leads to the formation of psychoactive compounds. About seven of such compounds 
have been discussed below in separate technical folders:  
II. I  4-Hydroxy-di-isopropyl-tryptamine (4-HO-DiPT) 
II. II   4-Acetoxy-N, N-dimethyl tryptamine (4-AcO-DMT)  
II. III   4-Acetoxy-N, N-diethyltryptamine (4-AcO-DET) 
II. IV   4-Acetoxy-N, N-diallyl tryptamine (4-AcO-DALT) 
II. V   N, N-diallyl-5-methoxytryptamine (5-MeO-DALT) 
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II. VI  5-methoxy-diisopropyltryptamine (5-MeO-DiPT) 
II. VII  5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT)
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II. I 4-HO-DiPT 
 
 
4-HO-DiPT Report 
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 4-HO-DiPT   
 OVERVIEW 
 Chemical name: 4-Hydroxy-di-isopropyl-tryptamine 
Synonyms:  It is commonly referred as ‘Iprocin’ by the online users. Other street 
name include Ho-Dipped; Tangerine; Jitter; Phour; Aura 
 Active constituents: 4-Hydroxy-di-isopropyl-tryptamine  
Type: Research chemical – 4 substituted tryptamines  
Origin: Alexander Shulgin has described the synthesis of this compound in his 
book, TiHKAL. It is not clear if anyone else synthesised 4-HO-DiPT prior to 
this. 
 Status: Novel 
Chronology: TiHKAL was published in 1997. The compound was possibly 
known to the online community since 2004, as suggested by the Google Insight 
search. 
[a] [1] [2]  
 KEY POINTS 
 The 4- Substituted tryptamines possess some psychedelic activity. Most popular 
 among them are the classical Psilocin and Psilocybin. Esters can be attached to 
 the 4
th
 position of the indole ring giving rise to different compounds such as the 
 4-hydroxy or 4-acetoxy or 4-phosphoryloxy esters but with similar 
 pharmacological properties. A table lists the possible substitution at 4-ring 
 position and their examples. 
Un-substituted 
at 4 position 
Free Phenol 
4-Hydroxy 
Acetate Ester 
4-Acetoxy 
Phosphoryloxy Ester 
4-Phosphoryloxy 
DMT Psilocin Psilacetin Psilocybin 
DET Ethocin 
Ethacetin  
(4-AcO-DET) 
Ethocybin 
DIPT 
Iprocin 
(4-HO-DiPT) 
Ipracetin Iprocybin 
MIPT Miprocin Mipracetin Miprocybin 
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 Psilocin   4-HO-DiPT  
 
4-HO-DiPT is an example of such substitution.  
[b] [3] [4]           
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 3-[2-(diisopropylamino) ethyl]-1H-indol-4-ol  
Molecular weight: 260.38 g/mol 
Molecular formula: C16H24N2O 
CAS Number: 63065-90-7 
[5] [6]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product descriptions 
Chemical Shop Ltd, Cameroon 
Inquire now.  
[7]  
Want to buy 4-ho-dipt (Quantity: 250mg) 
Quantity Required: Contact Via Email  
[8] 
Supplier Location – China 
Click to post buying lead.  
[9] 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
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 None of the websites selling these compounds displayed the price and all of 
 them requested the buyer to contact them through email or leave a message 
 with contact details of the buyer in the advertising website.  [7] [8] [9]  
 MODALITIES OF INTAKE  
 4-HO-DiPT is usually taken orally at a dose of 15mgs or 20mgs and its effects 
 last longer than other routes. Nasal insufflation is another method and the effects 
 are felt within 5-10 minutes, but the total duration of action lasts for an hour. 
 Users reported that smoking this compound produced immediate effect which 
 wore off in about 10 minutes. [10] [11]  
 LEGAL STATUS 
4-HO-DiPT is a controlled substance in Sweden as on 1
st
 March 2005. It is also 
controlled in Japan.  
It is unscheduled in the USA. However, 4-HO-DiPT can be considered as an 
analogue of Psilocin and hence it can be covered through the Federal Analogue 
Act in the USA. 
The UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) “Any 
compound structurally derived from Tryptamine or from a ring-hydroxy 
Tryptamine by substitution at the nitrogen atom of a side-chain with one or more 
alkyl substituents but no other substituent”. This includes (quote) “mono- or di-
N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), 
and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) 
analogues.”  
This also extends to (quote) “ethers and esters of controlled substances, thereby 
embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-
Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others.” 
Hence 4-HO-DiPT is a class A substance in the UK. [c] [12] [13]  
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical. It is not intended for human consumption.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
In TiHKAL the dose range was mentioned as between 15mgs to 20mgs. The 
online users reported that a dose between 30mgs and 40mgs was reasonable.  
Come up: 20- 30 min  Peak: 1 hour  Come down: 2 to 3 hours 
[10] [11]  
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 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With alcohol and cannabis (the user had ‘cold chills’ and dyspnoea) 
 With 5-MeO-DiPT and diazepam  
 With 2C-E 
 With cannabis 
 With citalopram - a user reported that he was on citalopram 40mgs for about 
2 months. He ingested 10mgs of 4-HO-DiPT and found the experience was 
more intense and lasted longer than 3 hours. He suggested that the 
combination with citalopram (SSRI) could have potentiated the actions of 4-
HO-DiPT.   
[14] [15] [16] [17]  
 PHARMACOLOGICAL CHARACTERISTICS 
 4-HO-DiPT (4-Hydroxy-di-isopropyl-tryptamine) is 4-substituted tryptamine. 
 There is no documented information on pharmacokinetic or pharmacodynamic 
 characteristics on this compound. However, it is closely related to psilocin (4-
 Hydroxy-N,N-dimethyltryptamine), a partial 5HT2a agonist which is a well 
 studied compound.  
 TOXICOLOGICAL EFFECTS 
 Sudden loss of consciousness  
 Loss of consciousness fluctuation (on 24mgs) – needed treatment at the 
emergency department  
 Severe nausea 
 Constant clenching of muscles throughout the body (24mgs).  
 Hypertension   
 Tremors 
 ‘Painful’ tremors all over the body  
 Muscle spasm  
 Red and dilated pupils – blur vision  
 [18] [19] [20] [21] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Mild psychedelic effects 
 Mild high [22]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Insomnia 
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 Headache   [23]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Its effects are reported to be comparatively mild. Psychotic symptoms (paranoid 
 or visual hallucinations) are not reported by the users. 
 CLINICAL ADVICE 
 Users advice caution in measurement of the compound, as erroneously taken 
 high dose could lead to toxicity. [24] 
 RELATED FATALITIES  
 None. 
 YOU TUBE VIDEOS 
No You Tube videos are found on 4-HO-DiPT. 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 4-HO-DiPT, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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II. II  4-AcO-DMT  
 
 
4-AcO-DMT Report 
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 4-AcO-DMT  
 OVERVIEW 
 Chemical name: 4-Acetoxy-N, N-dimethyl tryptamine 
Synonyms:  O-Acetylpsilocin, psilacetin, 4-AcO-DMT  
Active constituents: 4-Acetoxy-N, N-dimethyl tryptamine 
Type: Research chemical - Tryptamines 
Origin: Forum users debate about the scientist who first synthesised this 
compound. Names such as Alexander Shulgin, David E. Nicholas and Hoffman 
were among the discussion. It is well documented in TiKAL that Shulgin 
synthesised 4-HO-DMT (psilocin) and he has commented about its ester, 4-
AcO-DMT but not sure if he had first synthesised this compound. 
Status: Novel 
Chronology: It is reported by the forum users that this compounds was available 
to buy online since 2007. 
[1] [2] [3] [4] 
 KEY POINTS 
 4-AcO-DMT is a psychedelic and hallucinogenic compound in the tryptamine 
 class similar to LSD and psilocybin. It is the acetylated form of psilocin (4-HO-
 DMT) and is a more stable compound than psilocin, and has a longer shelf life. 
 Forum users refer to this compound by the name "psilacetin". It is usually found 
 in crystalline or powder form and it is sold as a fumarate or a hydrochloride salt. 
 Dimethyl tryptamine (DMT), Diethyl tryptamine (DET) are examples of un-
 substituted tryptamines. Most popular among them are the classical Psilocin and 
 Psilocybin. Methylated psilocin is Psilacetin and phosphorylated psilocin is 
 psilocybin.  
 The 4- Substituted tryptamines possess psychedelic activity similar to psilocin 
 but in an attenuated form. Esters can be attached to the 4
th
 position of the indole 
 ring giving rise to different compounds such as the 4-hydroxy or 4-acetoxy or 4-
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 phosphoryloxy esters but with similar pharmacological properties. A table lists 
 the possible substitution at 4-ring position and their examples. 
Un-substituted 
at 4 position 
Free Phenol 
4-Hydroxy 
Acetate Ester 
4-Acetoxy 
Phosphoryloxy Ester 
4-Phosphoryloxy 
DMT Psilocin 
Psilacetin  
(4-AcO-DMT) 
Psilocybin 
DET Ethocin 
Ethacetin  
(4-AcO-DET) 
Ethocybin 
DIPT Iprocin Ipracetin Iprocybin 
MIPT Miprocin Mipracetin Miprocybin 
   
4-AcO-DMT    Psilocin  
 
4-AcO-DMT is an example of such substitution.     
[5] [6]    
 CHEMICAL CHARACTERISTICS OF ACTIVE CONSTITUENTS 
IUPAC name: 3-[2-(Dimethylamino) ethyl]-1H-indol-4-yl acetate 
Molecular weight: 246.3049 g/mol  
Molecular formula: C14H18N2O2   
CAS Number: 92292-84-7 
[7]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Progressive research (Canada) 
All compounds are priced very competitively but discounts are available on some 
compounds if you plan on purchasing multiple products. E-mail us to work out a price if 
you plan on making a larger order. All prices are in Canadian Dollars and all sales are 
final. Tax is included. Minimum order is $50 before shipping. [8]  
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Biochem Distribution 
19 June 2012 4-AcO-DMT Freebase / 2C-D / Specials / News 
We just received 4-AcO-DMT Freebase in stock. 4-AcO-DMT FREEBASE  
(NOT FUMARATE, 98.85% pure, color WHITE/PALE) [9]  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price varied among websites. It was also dependent upon the country of 
 delivery. One web quoted the following prices:  
 100mg for 13.99$; 250mg for 27.99$; 500mg for 54.99$; 1g for 99.99$; 3g for 
 275.99$ 
 Another website put a lower price as follows: 
 1 gram = $120; 5 grams = $400; 10 grams = $700 
 [8] [9] [10]  
 MODALITIES OF INTAKE  
 The most common modalities of intake are: 
 - oral ingestion by either swallowing the powder contained in capsules or 
 ‘bombing’ (wrapping the powder in paper/ foil and swallowing); some users 
 mixed the powder with juice and drink the mixture.   
 - nasal insufflation is another common method  
 Less common methods of administration include: 
 - Rectal administration  
 - Intra muscular injections 
 Rarely, few try eye-balling method.  
 [11]  
 LEGAL STATUS 
 4-AcO-DMT is unscheduled in the United States, but through the Federal 
 Analogue Act, possession could be prosecuted. 
 The UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) “Any 
 compound structurally derived from Tryptamine or from a ring-hydroxy 
 Tryptamine by substitution at the nitrogen atom of a side-chain with one or more 
 alkyl substituents but no other substituent”. This includes (quote) “mono- or di-
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 N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), 
 and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) 
 analogues.”  
 This also extends to (quote) “ethers and esters of controlled substances, thereby 
 embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-
 Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others.” Hence 4-
 AcO-DMT is a class A substance in the UK. [a]  
 CURRENT USE / MEDICINAL USE  
 None. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 It is smoother to come up. The usual starting dose is about 10 to 25mgs. At 
 higher doses (25mgs), body image was heavily distorted.  
 Come up: 30 – 40min  Peak: 2 hour  Come down: 4 - 6 hours 
 [12] [13]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With MXE  (Visuals candy, but more confusing) 
 With 4-HO-MET (considered self harming, visual hallucination of devil, 
angels and death cat) 
 With 4-ACO-MIPT (Paranoia) 
 With 2C-C-NBOMe and DXM 
 With 5-MeO-DMT 
 With 2C-T7 
 With 2C-E 
 With DMT 
 With alcohol, ketamine and nitrous oxide 
 With cannabis 
 With 6-APB 
 [14] [15]  
 
 
 PHARMACOLOGICAL CHARACTERISTICS  
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 The structural similarity with other well known compounds such as psilocin and 
 psilocybin is given below: 
        
 Psilocybin (4-PhosphorylOxy-DMT)  Psilocin (4-HydrOxy-DMT)
  
  
 Psilacetin (4-AcetOxy-DMT)  
 4-AcO-DMT is quickly de-acetylated in the liver to psilocin by the enzyme 
 Deacetylases. [16] [17]  
 TOXICOLOGICAL EFFECTS 
 Its action may be similar to that of psilocybin given the structural similarities. 
 However, there are no human toxicological studies and hence its harmful effects 
 are unknown. It is reported by few users that it may produce idiosyncratic  
 reactions. 
 Users warn other not to combine 4-Acetoxy-DMT with MAOI type of 
 antidepressants such as phenelzine, tranylcypromine, isocarboxazide and 
 moclobemide. [18]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria 
 Increased energy 
 Increased stimulation 
 Enhanced tactile sensations 
 Enhanced appreciation of music 
 Sense of spiritual insight and fulfilment 
 [19]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
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 Severe headache 
 Nausea 
 Temporary hypertension (elevated blood pressure) 
 Jaw clenching / gurning 
 Gastrointestinal discomfort (nausea, abdominal cramps, diahrrea) 
 Muscle weakness 
 Mydriasis (pupil dilation) 
 Compulsive yawning  
[20] [21]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Strong amplification of emotions (both positive and negative) 
 Altered perception of space and time (especially at high doses) 
 Inability to concentrate 
 Obsessive behaviour and random compulsions  
 Severe psychotic syndrome characterised by ‘ego death’, nihilistic / somatic 
delusions (belief that ‘internally bleeding’ and ‘contracted a fatal disease 
from the dog’ and ‘I’m going to die’). The user suffered severe symptoms 
and he vowed that he would not try research chemicals again.  
 Visual and auditory hallucinations 
 Accelerated but unfocussed thought processes 
 Emotional instability (sense of terror, paranoia, panic attacks, psychotic 
episodes) 
 Dysphoria and confusion (increased risk of inadvertent injury)   
[22] 23] 
 CLINICAL ADVICE 
 None. 
 RELATED FATALITIES  
 None. 
 YOU TUBE VIDEOS 
1. You Tube Video 1: 4-AcO-DMT 
2. You Tube Video 2: 4-AcO-DMT trip report 
3. You Tube Video 3: 4-AcO-DMT 
4. You Tube Video 4: Buy 4-AcO-DMT 
5. You Tube Video 5: 4-AcO-DMT M.S.D.S (Material Safety Data Sheet) 
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6. You Tube Video 6: trip report 80mgs 4-AcO-DMT 
  [24] [25] [26] [27] [28] [29] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 4-AcO-DMT, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 4-AcO-DET   
 OVERVIEW 
 Chemical name: 4-Acetoxy-N, N-diethyltryptamine 
Synonyms:  4-Acetoxy-DET, ethacetin, ethylacybin or 4-AcO-DET  
Active constituents: 4-Acetoxy-N, N-diethyltryptamine  
Type: Research chemical – Tryptamine class 
Origin: Albert Hofmann synthesised this compound first in 1958 in Sandoz 
laboratory. 
Status: Novel 
Chronology: Though the compound was synthesised long back, its use in the 
black market was known since 2001. 
[1]    
 KEY POINTS 
 DMT, DET are examples of un-substituted tryptamines. The 4- Substituted 
 tryptamines possess psychedelic activity. Most popular among them are the 
 classical Psilocin and Psilocybin. Esters can be attached to the 4
th
 position of the 
 indole ring giving rise to different compounds such as the 4-hydroxy or 4-
 acetoxy or 4-phosphoryloxy esters but with similar pharmacological properties. 
 A table lists the possible substitution at 4-ring position and their examples. 
Un-substituted 
at 4 position 
Free Phenol 
4-Hydroxy 
Acetate Ester 
4-Acetoxy 
Phosphoryloxy Ester 
4-Phosphoryloxy 
DMT Psilocin Psilacetin Psilocybin 
DET Ethocin 
Ethacetin  
(4-AcO-DET) 
Ethocybin 
DIPT Iprocin Ipracetin Iprocybin 
MIPT Miprocin Mipracetin Miprocybin 
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4-AcO-DET    Psilocin  
 
4-AcO-DET is an example of such substitution. [1] [2] [a]     
 CHEMICAL CHARACTERISTICS OF ACTIVE CONSTITUENTS 
IUPAC name: 3-(2-Diethylaminoethyl)-1H-indol-4-yl acetate  
Molecular weight: 273.36 g/mol 
Molecular formula: C16H22N2O2 
CAS Number: Unknown 
[3] [4]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description 
Best RC 
Strictly not for human consumption! 
If you are from Sweden, Finland... Customs in your country are very strict; packages/letters 
are being seized very often; notice that we do not take any responsibility for seizures. Think 
twice before you order. [5]  
Promos-Chem (Europe) 
This product can be delivered only via courier service. 
This product is NOT for human consumption! 
Can be used for laboratory purposes only!  
Contact us: sales@xxxxxx-xxxx.com  [6] 
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Progressive research (Canada) 
All compounds are priced very competitively but discounts are available on some 
compounds if you plan on purchasing multiple products. E-mail us to work out a price if you 
plan on making a larger order. All prices are in Canadian Dollars and all sales are final. Tax 
is included. Minimum order is $50 before shipping. [7]  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price varied among websites. It was also dependent upon the country of 
 delivery. One web quoted the following price:  100mgs costs €18; 500mgs €68; 
 1 gram €120; 5 grams €500 
 Another website quoted a lower price as follows: 5 grams €330; 25 grams €900 
 Another website quoted the following prices in dollars:  
4-AcO-
DET  
250 
mg  
500 
mg  
1000 
mg  
2000 
mg  
5000 
mg  
 
$70 $105 $182 $350 $725 
 [5] [6] [7] 
 MODALITIES OF INTAKE  
 The most common modalities of intake are: 
 - Oral ingestion by either swallowing the powder contained in capsules or 
 ‘bombing’ (wrapping the powder in paper/ foil and swallowing); some users 
 mixes the powder with juice and drink the mixture.   
 - Nasal insufflation is another common method  
 Less common methods of administration include: 
 - Rectal administration  
 - Intra muscular injections 
 [1] [8] 
 LEGAL STATUS 
 The UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) “Any 
 compound structurally derived from Tryptamine or from a ring-hydroxy 
 Tryptamine by substitution at the nitrogen atom of a side-chain with one or more 
 alkyl substituents but no other substituent”. This includes (quote) “mono- or di-
 N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), 
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 and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) 
 analogues.” This also extends to (quote) “ethers and esters of controlled 
 substances, thereby embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO 
 MIPT, the esters 4-Acetoxy DMT and 4-Phosphoryloxy DMT, and countless 
 others.” 
 4-AcO-DET is a 4-substituted acetate ester of tryptamine and hence a class A 
 substance in the United Kingdom.  
 It is unscheduled in the United States, but through the Federal Analogue Act, 
 possession could be prosecuted. [b]  
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The users report effects similar to that of psilocybin, but at a very milder 
 experience. Some users their dislike for this compound due to its lack of the 
 ‘depth’ of experience and the ‘magic’ experience of mushrooms.  The usual 
 starting dose is about 5 to 10mgs. At higher doses (25mgs), body image was 
 heavily distorted. The hang over could last for about 2 days.  
 Come up: 10 – 20min  Peak: 1 hour  Come down: 3 - 4 hours 
 [8] [9]   
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With Ketamine 
 With 2C-T2, salvia, mushroom and opium 
 With 4-Acetoxt-DiPT 
 With 5-MeO-DiPT 
 With MBDB 
 With nitrous oxide 
 With 2C-1 and oxycodon 
 [10]  
 PHARMACOLOGICAL CHARACTERISTICS 
 It is rapidly hydrolysed into 4-HO-DET by esterases. It has relatively short 
 duration of action.  
 [11]  
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 TOXICOLOGICAL EFFECTS 
 Extreme anxiety during the peak 
 Insomnia 
 Tiredness  
 [12] [13] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria 
 Body high 
 Sexual stimulation 
 Out of body experience 
 Out of touch with reality 
 Religious experience/ introspection  
 Overwhelming emotions 
 Good visuals  
[14] [15]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Palpitation 
 Increased body temperature 
 raised blood pressure 
 nausea 
 hypersalivation 
 reduced reaction of the pupils indicating mydriasis 
 increased reflexes 
 coordination disturbances 
 difficulty in speech articulation 
 dysphoria  
 restlessness 
 clouded consciousness  
 [16]   
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
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 4-AcO-DET produces psychopathological disturbances similar to that of 
 psilocin, LSD, and mescaline. The most frequent effects reported were:  
 distortion of body image (very common) 
 visual hallucinations (very common) 
 auditory hallucinations  
 paranoid delusions  
 time distortion 
 At higher doses, extreme psychotic symptoms - depersonalization, delirium, 
schizophrenia like symptoms (delusions/ hallucinations, catatonia). 
 [16] [17] [18] [19] [a]  
 CLINICAL ADVICE   
 None. 
 RELATED FATALITIES  
 None reported. 
 YOU TUBE VIDEOS 
 There are no you tube videos on 4-Ac0-DET. 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 4-AcO-DET, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 There was not enough volume to show regional interest. 
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 4-AcO-DALT  
 OVERVIEW 
 Chemical name:  4-Acetoxy-N, N-diallyl tryptamine 
Synonyms: 4-AcO-DALT, 4-Acetoxy-DALT 
Active constituents: 4-Acetoxy-N, N-diallyltryptamine; 3-[2-(Diprop-2-en-1-
ylamino) ethyl]-1H-indol-4-yl acetate 
Type: Research chemical – Tryptamines (Indole alkyl amine group)  
Origin: Shulgin gave the description for the preparation of 5-MeO-DALT. While 
exploring a number of changes to the 5 MeO DALT (Figure 1), he suggested 
relocation of the oxygen in the indole ring over to the 4
th
 position which gives 
rise to 4 MeO DALT. By hydrogenation the benzyl ether (Figure 2) another 
product 4-HO-DALT is formed, which is an analogue of Psilocin. Then by 
acetylation of 4-HO-DALT, this new compound (4-AcO-DALT) is formed. [1]  
         Figure 1      Figure 2 
5 MeO DALT     4 MeO DALT 
          Figure 3      Figure 4 
4 HO-DALT            4 AcO DALT 
Status: Novel 
 KEY POINTS 
4-AcO-DALT is a tryptamine and can be obtained by acetylation of its analogue 
4-HO-DALT. This is not a very popular compound and very little is known 
about it.     
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
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IUPAC name: 3-[2-(Diprop-2-en-1-ylamino) ethyl]-1H-indol-4-yl acetate  
Molecular weight: Not available 
Molecular formula: C18H22N2O2  
CAS Number: Not available [1] [2] 
  APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Al.khowahir.chemicals.trading.ltd 
Minumum order: 100grams 
Place of origin: Dubai, UAE [3] 
Gong Chang 
Min. Order Quantity: 10 Gram  
Port: Moscow   Price: 10-15   USD /Gram  
Payment Terms: Western Union, MoneyGram 
Delivery Time: 2 days, 3 days Maximum [4] [5]   
       
 AVAILABLE INFORMATION ON PURCHASE PRICE  
100mgs of 4 Aco-DALT cost €28.00/ 250 mgs costs €55.00/ 1gram costs 
€192.00 
Some websites do not offer any price but requests the buyers to contact them by 
email. [6]  
 MODALITIES OF INTAKE  
Oral ingestion is the usual mode of intake. Users complain about bitter taste 
which is persistent for long time.  
Very rarely, the IV route was tried. The psychoactive compound was mixed with 
citric acid in a saline solution and given as IV bolus. A smaller dose ½ to 1/3
rd
 of 
the original dose (15-20mg) was used. 
It can be smoked as well, but does not produce intense effect.   
Nasal route was also tried at 20mgs but no burning sensation was reported. 
 [7] [8] [9] [10] 
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 LEGAL STATUS 
 The UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) “Any 
 compound structurally derived from Tryptamine or from a ring-hydroxy 
 Tryptamine by substitution at the nitrogen atom of a side-chain with one or 
 more alkyl substituents but no other substituent”. This includes (quote) “mono- 
 or di-N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, 
 etc.), and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-
 DET, etc.) analogues.”  
 This also extends to (quote) “ethers and esters of controlled substances, thereby 
 embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-
 Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others”. Hence  4-
 AcO-DALT is a class A substance in the UK.  
 [a]  
 CURRENT USE / MEDICINAL USE  
One user suggested trying for cluster headaches, possibly due to the strong 5-HT 
agonistic effect.  
[11] 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
The usual start dose is 35mgs, although few users have found no effect til 
50mgs.  
Recreational, it the effects produced are comparable to those produced by 
mushrooms. 
Come up: 30min Peak: 2 hours  Come down: 6 hours (Oral use) 
Come up: Instant Peak: few minutes Come down: 60 min (IV use) 
[12] [13] [14] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
None reported.  
 PHARMACOLOGICAL CHARACTERISTICS 
 None available.  
 TOXICOLOGICAL EFFECTS 
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Re-dosing produced a feeling that the person was going to die.  
Smoking this compound could cause harm to the lungs due to the by produce, 
Psilocin. 
[14] [15] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Increased talkativeness 
 Mild raised sexual feelings 
 Euphoria; very playful  
 Mild visuals  [16] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Redness on face 
 Tachycardia 
 Intense anxiety (as if going to die) 
 Users described it as ‘a near death experience’ requiring emergency 
services to be altered and treated at the A&E department.  
 Violent vomiting 
 Clenching the jaws  
 Chest tightness similar to DMT 
 Joint laxity  [17]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Depression 
 Frequent crying  
 Huge release of emotions [18]  
 CLINICAL ADVICE 
It is a research chemical belonging to the class of Tryptamines. They seem to act 
on the 5-HT 2 receptors. Combinations with other compounds or antidepressants 
(MAOIs, TCAs, SSRIs) or overdose can produce the ‘serotonin syndrome’; so 
the users need to be cautious and avoid such combinations. 
 RELATED FATALITIES  
None reported so far. 
 YOU TUBE VIDEOS 
None available.  
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 GOOGLE INSIGHTS 
A search from 2004 to the present did not show graphs.  
 
 BIBLIOGRAPHY 
 [a] LKing LA, Forensic Chemistry of Substance Misuse: A Guide to Drug Control, RSC 
 Publishing. 2009. Available from: 
 http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1&section=20&structure=B 
 (Accessed May 25, 2012)  
 SITOGRAPHY 
[1]  http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=56#rxa5531 (Accessed 
 May 25, 2012) 
[2] http://isomerdesign.com/PiHKAL/explore.php?domain=tk&id=5531&name=4-
 Acetoxy-<i>N</i>,<i>N</i>-diallyltryptamine  (Accessed May 25, 2012) 
[3]  http://www.tradevv.com/chinasuppliers/khowahir_p_1c89d7/china-4-Aco-DMT-4-
 Aco-Dalt-5-Meo-Dmt-5-Meo-Dalt-4-AcO-MIPT-4-HO-DPT.html (Accessed May 25, 
 2012) 
[4] http://www.gongchang.com/4_Aco_DMT_4_Aco_Dalt_5_Meo_Dmt_5_Meo_Dalt_4_
 AcO_MIPT_4_HO_DPT-dp12100312/  (Accessed May 25, 2012) 
[5] http://www.gongchang.com/4_Aco_DMT_4_Aco_Dalt_5_Meo_Dmt_5_Meo_Dalt_4_
 AcO_MIPT_4_HO_DPT-dp12100312/  (Accessed May 25, 2012)  
[6]  http://buybestrc.com/62-4-aco-dalt  (Accessed May 25, 2012)  
[7]  http://www.erowid.org/experiences/exp.php?ID=66631 (Accessed May 25, 2012)  
[8]  http://www.drugs-forum.com/forum/showthread.php?t=45287 (Accessed May 25, 
 2012)  
[9]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-Thread 
 (Accessed May 25, 2012)  
[10]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-
 Thread/page4 (Accessed May 25, 2012)  
[11]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-
 Thread/page4 (Accessed May 25, 2012)  
[12]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-
 Thread/page4 (Accessed May 12, 2012)  
[13]  http://www.erowid.org/experiences/exp.php?ID=66631 (Accessed May 25, 2012)  
[14]  http://www.drugs-forum.com/forum/showthread.php?t=45287 (Accessed May 12, 
 2012) 
[15]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-Thread 
 (Accessed May 12, 2012) 
[16]  http://www.erowid.org/experiences/exp.php?ID=66631 (Accessed May 12, 2012)  
[17]  http://www.erowid.org/experiences/exp.php?ID=87218 (Accessed May 12, 2012) 
[18]  http://www.bluelight.ru/vb/threads/370771-The-Big-amp-Dandy-4-AcO-DALT-
 Thread/page3 (Accessed May 12, 2012)
161 
 
 
II. V   5-MeO-DALT 
 
5-MeO-DALT Report 
 
 
 
 
 
162 
 
 5-MeO-DALT  
 OVERVIEW 
 Chemical name: N, N-diallyl-5-methoxytryptamine 
Synonyms:  5-MeO-DALT, 5-Methoxy-DALT; Tryptamine, N, N-diallyl-5-
methoxy; N,N-Diallyl-5-methoxytryptamine; Indole, 3-[2-(diallylamino)ethyl]-
5-methoxy; 3-[2-(Diallylamino)ethyl]-5-methoxyindole 
Active constituents: N, N-diallyl-5-methoxytryptamine 
Type: Research chemical – Tryptamine (Psychostimulant)  
Origin: Shulgin gave the description for the preparation of 5-MeO-DALT in 
2004. [1a]      
 
5 MeO DALT    
Status: Novel 
 KEY POINTS 
5 MeO DALT is, surprisingly not a popular compound possibly due to its low 
intensity of psychedelic experience. It is unique in that it has got rapid onset of 
action and very quick duration of action with peak occurring in minutes and the 
total duration lasts only several minutes. It is rapidly absorbed from the stomach 
and metabolised rapidly. [1a] 
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: N-allyl-N-[2-(5-methoxy-1H-indol-3-yl) ethyl] prop-2-en-1-
amine 
Molecular weight: 270.375 g/mol 
Molecular formula: C17H22N2O 
CAS Number: 928822-98-4 [1b] [2] 
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
GKM Global Chemicals 
We have available 5-MeO-DALT research chemical 
A fine white powder 
Contact us for more details  [3] 
Herbal Shop 
The full chemical name of N,N-diallyl-5-methoxytryptamine is N-allyl-N-[2-(5-methoxy-1H-
indol-3-yl)ethyl]prop-2-en-1-amine. 5-MeO-DALT has a strong structural relationship to DALT 
and 5-MeO-DPT. Its chemical formula is C17H22N2O and molecular 
ON SALE! 
$8.00 tax incl.   [4] 
Bulk Research Chemicals  
Our 5-Meo-Dalt is certified at 99%+ Purity. You can buy 2g from this page; free standard 
delivery is included with this product. 
£44.00 tax incl.  [5]  
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
The price varied mjariginally from different vendors. One website quoted a price 
of £40 for 3 grams of 5 Meo DALT and another quoted £44 for 2 grams. [6] [7]   
 MODALITIES OF INTAKE  
Most common methods: 
Oral ingestion is the usual way but this compound can be inhaled by 
vaporisation (though a water pipe). 
Another poplar method is known as ‘Bombing’ – rolling the powder in a rizla 
paper and then orally ingesting the bomb.  
Least common:  
They include nasal insufflations and IV route.  
[8a] [8b] [8c]  
 LEGAL STATUS 
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Some users argue that 5-MeO-DALT (N, N-diallyl-5-methoxytryptamine) is a 
derivative of tryptamine which is legal in the UK. Their debate is based on the 
following: The (UK) law requires the alkyl group (CnH2n+1) to be present in 
the Tryptamine to make it illegal. In this compound the alkyl group is 
substituted by the allyl group (H2C=CH-CH2R) to make it legal.    
However, the UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) 
“Any compound structurally derived from Tryptamine or from a ring-hydroxy 
Tryptamine by substitution at the nitrogen atom of a side-chain with one or more 
alkyl substituents but no other substituent”. This includes (quote) “mono- or di-
N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), 
and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) 
analogues.”  
This also extends to (quote) “ethers and esters of controlled substances, thereby 
embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO MIPT, the esters 4-
Acetoxy DMT and 4-Phosphoryloxy DMT, and countless others”.  
Hence 5-MeO-DALT is a class A substance in the UK.  
[a] [8d] [8e] 
 CURRENT USE / MEDICINAL USE  
None. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
This compound is very short acting one and hence it is a preferred compound for 
people who work, as the total experience can be completed within 2 hours. The 
usual dose is between 12 to 20mgs.  
Come up: 15 minutes   Peak: 60 minutes Come down: 2-4 hours  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
As the effects produced can be mild, the forum users suggest combining with 
cannabis to get psychedelic effects similar to LSD. 
Combination of JWH-018 and JWH-073 with 25 mgs of 5 Me0-DALT produced 
extreme tachycardia and intense fear of dying. Also another combination with 
JWH-250 was reported.  
 It is also combined with salvia to intensify the effects.   
 The combination with 2C-C was to intensify the euphoria, but precipitated 
 severe  anxiety.  [9] [10] [11a] [11b] 
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 PHARMACOLOGICAL CHARACTERISTICS 
 An animal experiment (Nonaka, et al 2007) revealed that 5-MeO-DALT was 
 highly potent and achieved G-protein activation through 5HT1 receptor. 
 However it did not have any effect on dopamine or norepinephrine system.  
 [b]  
 TOXICOLOGICAL EFFECTS 
 Retrograde amnesia 
 Violent vomiting  
 Tightness of chest and difficulty in breathing 
 Seizure; required treatment at the A&E department  
 [12] [13] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoric rush 
 Empathy 
 Dissociative state (as described as +++) can be extremely fearful  
 [14]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Burning sensation under the tongue 
 Nausea 
 Vomiting  [15] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 The compound causes altered sensorium, dream like state   
 Anxiety  
 Transient paranoid delusions 
 Transient auditory hallucinations [16] 
 CLINICAL ADVICE 
The forum users warn not to use with other compounds as the effects and 
toxicity is more pronounced and also not go above the dose of 20mgs.  
 RELATED FATALITIES  
None.  
166 
 
 YOU TUBE VIDEOS 
None.  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 5-MeO-DALT, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 5-MeO-DiPT  
 OVERVIEW 
 Chemical name: 5-methoxy-diisopropyltryptamine (5-MeO-DiPT) 
Synonyms: Foxy; Foxy methoxy; 5-MeO-DiPT 
Active constituents: 5-methoxy-diisopropyltryptamine  
Type: Research chemical – Ring position 5- substituted tryptamine 
Origin: Shulgin synthesised 5-MeO-DiPT and published it in 1981. It was also 
included in his book, TiHKAL, published in 1997.  
Status: Novel 
Chronology: It was reported to be a very popular compound among online users 
from 1999 to 2003. However, subsequent to its ban in 2003 in the USA, the sale 
had gone down. Yet it is still available on line for purchase. 
[1]  
 KEY POINTS 
5-MeO-DiPT is a psychedelic tryptamine which is formed by attaching a 
methoxyl group at position 5 of the tryptamine ring. Generally, its effects are 
greater when compared with un-substituted tryptamine.    
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: N-[2-(5-methoxy-1H-indol-3-yl) ethyl]-N-propan-2-ylpropan-2-
amine 
Molecular weight: 274.40114   
Molecular formula: C17H26N2O 
CAS Number: 4021-34-5  
 [2] [3] [4] [5] 
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Buy Best RC 
WE DID NOT CREATE this list. This list does not have in common with legality in each countries 
etc. We got this list from a third party company and we are FORCED to comply with it. Buyers are 
responsible to check legality before making a purchase! 
5-MeO-DiPT: No shipping to: Germany, Denmark, Sweden, Greece, USA [6] 
Tiger food 
We are now able to accept bulk orders- please have a look at the available products. 
None of the products sold on this site are intended for human consumption. All sales are for over 18's 
only. [7] 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Most websites requested the buyer to contact them through email or leave a 
 reply message on their advertising website or message board. One website 
 quoted the following price for 5-MeO-DiPT: 100mg €18; 250mgs €35; 500mgs 
 €68; 1g €120; 2g €225; 3g €330.   [6] [7]  
 MODALITIES OF INTAKE  
Oral ingestion is the common method of consumption.  
Smoking - unlike other synthetic tryptamines such as DMT or 5-MeO DMT, the 
effects of 5-MeO-DiPT gradually build up and last longer. 
It can be injected intra venously or intra muscularly. The users advice to start at 
a very low dose (lower than the oral dose – 4mgs). The injection was reported to 
be very painful.  
A case report mentioned per rectal administration of aqueous solution of 5-
MeO-DiPT. [b] [4] [8] [9]  
 LEGAL STATUS 
In the USA, 5-MeO-DiPT was placed under temporary scheduling along with 
AMT (alpha methyl tryptamine) in 2003 and then permanently under Class 1 of 
the Controlled Substances Act in 2004. 
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The UK Misuse of Drugs Act (Part 1 Class A drugs) states that (quote) “Any 
compound structurally derived from Tryptamine or from a ring-hydroxy 
Tryptamine by substitution at the nitrogen atom of a side-chain with one or more 
alkyl substituents but no other substituent”. This includes (quote) “mono- or di-
N-substitution (e.g. DPT, DIPT, NMT, NET, MET, MPT, MIPT, EIPT, etc.), 
and their ring hydroxy (4-HO-DET, 4-HO-DIPT, 4-HO-MIPT, 5-HO-DET, etc.) 
analogues.” This also extends to (quote) “ethers and esters of controlled 
substances, thereby embracing the ethers 5-MeO-DET, 5-MeO-DIPT, 5-MeO 
MIPT, the esters 4-Acetoxy DMT and 4-Phosphoryloxy DMT, and countless 
others.” Hence 5-MeO-DiPT is a class A substance in the UK. 
It is a controlled substance in countries such as Germany, Greece, Denmark, 
Japan, Singapore and Sweden.  
[d] [10] [11]  
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical and not intended for human consumption.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 It has a strong smell and taste (due to indole) and hence it could be unpleasant to 
 take  it orally. Users blend it with juice and drink the mixture. The usual dose 
 is between 6mgs and 12 mgs.  
Come up: several minutes Peak: 2 hours  Come down: 4 to 6 hours 
[4] [12]   
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With MDMA and alprazolam (unconfirmed death report on this 
combination) 
 With 2C-B (severe sickness and increased body load) 
 With ketamine (very unpleasant and anxiety provoking  
 [12] [13]   
 PHARMACOLOGICAL CHARACTERISTICS 
 5 MeO-DiPT is a synthetic tryptamine discovered recently by the online drug 
 misuse communities. A study showed that 5 MeO-DiPT inhibited the re-uptake 
 of monoamines such as dopamine, serotonin and norepinephrine, but it had very 
 little effect on their release. [f] 
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 TOXICOLOGICAL EFFECTS 
 Temporary paralysis of limbs and mild hallucinations 
 Flash backs  
 Acute cardiac failure 
 Neurotoxicity 
 Rhabdomyolysis and possibly serotonin syndrome  
 [a] [c] [e] [14]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Mild euphoria  
 Empathy 
 Sexual stimulation 
 [b] [15] [1] [1] [1] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Excess salivation 
 Severe nausea and vomiting, especially doses more than 12mgs 
 Visual and auditory distortions 
 Insomnia   
 [b] [16] [17] [4]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 It causes paranoia and hallucinations.   
 A case of hallucinogen-persisting perception disorder was   reported in Japan. It 
 was characterised by transient recurrence of perceptual disturbances experienced 
 as flash back phenomenon even after terminating the use of 5-MeO-DiPT. This 
 experience was similar to the well established LSD induced flash backs.   
 [b] [e] [18]  
 CLINICAL ADVICE 
 None. 
 RELATED FATALITIES  
A confirmed case of death in Japan following ingestion of 5-MeO-DiPTwas 
published. The user died as a result of ingestion of a mixture of 5-MeO-DiPT, 5-
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OH-DiPT and 5-MeO-NiPT. The urine and blood samples collected about 4 
hours after ingestion showed the level of 5-MeO-DIPT, 5-OH-DIPT and 5-
MeO-NIPT in blood and urine was 0.412, 0.327 and 0.020 micrograms /ml, and 
1.67, 27.0 and 0.32 micrograms/ml, respectively. The autopsy finding revealed 
periarteritis nodosa in heart and liver, myocardial ischaemia, pulmonary 
congestion and pulmonary alveolar haemorrhage and periprostatic 
haemorrhage.There are several unconfirmed death reports available online.    
[a] [8] [19] [1] [1] 
 YOU TUBE VIDEOS 
 5-MeO-DiPT (foreign language video) 
 Terence Mckenna - 5-MeO-DMT & nnDMT 
[20] [21]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 5-MeO-DiPT, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 5-MeO-MiPT  
 OVERVIEW 
 Chemical name: 5-methoxy-N-methyl-N-isopropyltryptamine 
Synonyms: Moxy; Moxie; 5-MeO-MIPT; Tryptamine ecstasy; MDMA 
Tryptamine; N-isopropyl-5-methoxy-N-methyl 
Active constituents: 5-methoxy-N-methyl-N-isopropyltryptamine 
Type: Research chemical – Ring 5-substituted Tryptamine 
Origin: Alexander Shulgin has narrated the synthesis of 5-MeO-MiPT in his 
book, TiHKAL. It is not clear if he was the first one to synthesise this 
compound. 
Status: Novel 
[1] [2] [3] [4]  
 KEY POINTS 
5-MeO-MiPT is a 5-substituted tryptamine where the methoxy group is attached 
to position 5 of the tryptamine ring. It has psychedelic and hallucinogenic 
properties. Structurally, it is quite similar to compounds such as 5-MeO-DiPT, 
DiPT, and MiPT. It is frequently used as a "replacement" for 5-MeO-DiPT and 
is commonly referred by the street name "Moxy" or "Moxie". 
[1] [2] [3] [4]          
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: N-[2-(5-methoxy-1H-indol-3-yl) ethyl]-N-methylpropan-2-amine 
Molecular weight: 246.35 g/mol 
Molecular formula: C15H22N2O  
CAS Number: 96096-55-8 
[1] [2] [3] [4]  
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Buy best RC 
Strictly not for human consumption! 
If you are from Sweden, Finland... Customs in your country are very strict; packages/letters are being 
seized very often; notice that we do not take any responsibility for seizures. Think twice before you 
order. [5]  
Promos-Chem (Europe) 
This product can be delivered only via courier service. 
This product is NOT for human consumption! 
Can be used for laboratory purposes only!  
sales@xxxxx-xxxx.com  [6] 
Cayman Chemical  
5 mg  See a distributor in your region for pricing [7] 
 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price varied among websites. It was also dependent upon the country of 
 delivery. One web quoted the following price: 500mgs costs €62.20 
 Another website put up the price as follows: 5g €310; 10g €500; 25g €825 
[5] [6] [7] [8] 
 MODALITIES OF INTAKE  
 The most common modalities of intake are: 
 - oral ingestion by either swallowing the powder contained in capsules or 
 ‘bombing’ (wrapping the powder in paper/ foil and swallowing); some users 
 mixes the powder with juice and drink the mixture.   
 - nasal insufflation is another common method  
 Less common methods of administration include: 
180 
 
 - Rectal administration  [9]  
 LEGAL STATUS 
5-MeO-MiPT, a methoxy ester of tryptamine is a class A substance in the 
United Kingdom. It was made illegal in Romania in January 2011. It is 
unscheduled in the USA.   
[a] [2] [10] [11]   
 CURRENT USE / MEDICINAL USE  
None. It is a research chemical.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The dosage is between 4mgs to 6mgs.  
 Come up: 15 to 20 min. Peak: 2-3 hours Come down:  4- 6 hours 
 A typical experience is as follows: 
 T+0:15: Tachycardia and dizziness started.  
 T+0:25: Heart rate slows down.  
 T+0:30: Dizziness again accompanied with irregular heartbeat; blood pressure 
 increased; feeling nauseous.  
 T+0:35: Mild euphoria with good appreciation of music. 
 T+0:45: Irregular pulse (unpredictably varied between 75 and 95).  
 T+1:15: Pulse rate raised over 100 beats per minute.  
 T+1:30: Body temperature drops to 95.6 degrees Fahrenheit.  
 T+2:00: Pulse rate continued to be high (107 beats per minute) and temperature 
 is 96.5 F (still slightly reduced).  
 T+2:25: Very slight visuals continue to come and go.  
 T+2:30: Pulse continued to be raised (105 beats per minute).  
 T+3:00: Pulse rate dropped (92 beats per minute) and temperature rose to 97.2 F.  
 T+3:30: Pulse rate dropped further (85 beats per minute); faint traces of visual 
 activity.  
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 T+4:50: The effects wore off slowly; agitation and uncomfortable feeling 
 continued; pulse rate was back to normal (82 beats per minute).  
 T+5:30: Back to baseline.  
[12] [13] [14]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With 2C-I (improved euphoria) 
 With Methylone – it potentiates the effects / toxicity of 5-MeO-MiPT and a 
case report confirms it.  
 With 4-AcO-DMT (cross tolerance was noted and also users warn other to 
carefully titrate from smaller doses) 
 With cannabis 
 With MDMA 
 With 2C-B and 2C-C 
 With LSD, MDMA and cannabis 
 With ketamine and cannabis 
 With 4-HO-MET, MXE and 2C-C 
[b] [15] [16] [17] [18] [19] 
 PHARMACOLOGICAL CHARACTERISTICS 
 5-MeO-MiPT inhibits monoamine re-uptake but it has narrow effect on 
 monoamine release. It is metabolised by the liver enzyme, cytochrome P-450 
 through de-methylation which is followed by conjugation with glucuronide or 
 sulphide.  
 [c] [d] 
 TOXICOLOGICAL EFFECTS  
 Muscle spasm especially the jaw and neck muscles as well as back, legs 
and they were stiff even after 48 hours after ingesting 5mgs of 5-MeO-
MiPT. This patient attended the emergency department and was given 
lorazepam which helped.  
 Missed heart beats and pain in the cardiac area lasting for a week. 
[20] [21]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria 
 Relaxing effects 
 Positive mood 
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 Increased sexual feelings  
[22]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Unsteady gait 
 Whole body tremor 
 Headache lasting for more than 24hours 
[23]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Anxiety/ fear 
 Emotional lability 
 At high doses (25mgs) it precipitated psychotic episode which required 
admission to emergency service and the symptoms lasting for few days 
but complete resolution took place only after few months.  
[24] [25]  
 CLINICAL ADVICE 
 Since higher doses produce psychopathological disturbances and other physical 
 side effects, it is important to weigh the doses carefully and use it cautiously. 
 Also with combined effects with other psychoactive compounds, the chances of 
 toxicity are significantly higher.  
 RELATED FATALITIES  
 None reported. 
 YOU TUBE VIDEOS 
1. Moxie [5-MeO-MiPT], Tryptamine MDMA? 
2. Moxy (5-meo-mipt) (foreign language) 
3. buy 5-MeO-MiPT 
[26] [27] [28]   
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
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 includes a graph with the search volume, indicating interest over time (GMT) for 
 5-MeO-MiPT, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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Chapter III: PIPERAZINES 
 
Unlike the tryptamines, there are no examples of piperazines available in nature (Hill 
and Thomas, 2011). All these compounds were synthesised for its various applications. 
Initially, synthetic preparations were available as anti-helminthic agents as early as the 
1950s. It was used as an antidepressant (trazodone, nefazodone etc) in the 1970s as well 
as typical antipsychotic medications (fluophenazine, perphenazine, trifluoperazine etc). 
Recently, the piperazine group forms part of the newer antipsychotic medications 
(aripiprazole, olanzapine).    
 
Structure of piperazine  
Piperazine ring contains two nitrogen atoms in opposite positions as seen in this 
diagram. It is classified into: a) benzyl piperazines (MBZP, MDBZP) and b) phenyl 
piperazines (mCPP, pFPP). Substitutions at the nitrogen level leads to formation of 
newer compounds which have been used for recreational purposes. About six of such 
compounds are presented in technical folders:  
III.I   1-methyl-4-benzylpiperazine (MBZP) 
III.II    methylenedioxy benzyl piperazine (MDBZP) 
III.III   1-(4-bromo-2, 5-dimethoxybenzyl) piperazine (2C-B-BZP)  
III.IV   meta-Chlorophenylpiperazine (mCPP)  
III.V   1-(4-Fluorophenyl) piperazine (4-FPP) or para-Fluorophenyl piperazine 
  (pFPP)  
III.VI  para-Methoxyphenylpiperazine (MeOPP)  
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III.I   1-methyl-4-benzylpiperazine (MBZP) 
 
 
MBZP Report 
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 MBZP     
 OVERVIEW 
 Chemical name: 1-methyl-4-benzylpiperazine  
 Synonyms:  Party pills 
 Active constituents: 1-methyl-4-benzylpiperazine  
 Type: Research chemical – Piperazine group 
 Origin: The synthesis and origin of MBZP is unknown. 
 Status: Novel 
 Chronology: Piperazine compounds were sold as ‘party pills’ in New Zealand 
 until its ban in 2008. It was later known in other parts of the world. The party 
 pills contain various piperazine compounds such as BZP, MeoPP, TFMPP, 
 PFPP, MBZP etc. mixed with other substances such as caffeine, cathinone. 
[1] [2] [3] 
 KEY POINTS 
MBZP is a synthetic piperazine derived from Benzylpiperazine by the addition 
of methyl group to the benzene ring at position 1. It is reported to have similar 
characteristics of benzylpiperazine but with weaker effects and less side effects 
and toxicity. It has simulant properties (amphetamine like effects) and sold as a 
replacement for ‘Ecstasy’ tablets in countries where ‘Ecstasy’ was banned. 
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS  
 IUPAC name: 1-benzyl-4-methylpiperazine  
 Molecular weight: 190.294 g/mol  
 Molecular formula: C12H18N2 
 CAS Number: 374898-00-7  
[1] [2] [3]  
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 APPEARANCE OF COMMERCIAL PRODUCTS  
Product description 
Spice Store 24/7 
MBZP - Methylbenzylpiperazine is a derivate of bezylpiperazine. Effect of MBZP is stronly 
euphoric. MBZP has been sold as ingredient in very popular party pills in New Zealand. Buy 
MBZP for your research today and get your parcel delivery for free. [4] 
Re Chem Co 
1-Benzyl-4-methylpiperazine hydrochloride  
Chemical properties: White crystal powder  
In case of contact with eyes immediately thoroughly rinse with water and seek medical 
advice. Wear suitable protective clothing at work. This product is intended for research and 
forensic applications. [5] 
Karayak 
Mbzp (HCL Salt) Sample Size 10g - Only up to 50g samples can be sent at this time. (The 
product is a HCL, hydrochloride salt piperazine) 
Price: $180.00 
Product Code: MBZP-10G  
In Stock: 25 [6] 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price of MBZP given in a website is as follows: 500 for €1.44 each; 1000 
 for €0.48 each; 3000 for €0.36 each; 50000 for €0.24 each. It did not display any 
 information on the quantity of ‘each’. 
 In another website 10g was sold for $180.00; 20g for $265.00 and 50g for 
 $560.00.  
 Spice store sold ‘one unit’ of MBZP for €24.95 and the quantity was not 
 mentioned in their website. 
[4] [5] [6]  
 MODALITIES OF INTAKE 
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 Oral ingestion of the pills is the common mode of intake.  
 It can be smoked. MBZP was usually mixed with TFMPP (ration 4:1) and ‘blue 
 lotus’ resin smoked to get more stimulation. [7] 
 LEGAL STATUS  
MBZP is classified as Class C substance in 2010 in the UK. 
In New Zealand, MBZP is placed under Schedule 3 (of Class C controlled 
drugs) along with other piperazine compounds such as BZP, TFMPP, pFPP, 
MeOPP and mCPP on 1
st
 April 2008.    
It is unscheduled in the USA. However, MBZP can be covered through the 
Federal Analogue Act in the USA. 
[8] [9] [10] [a] 
 CURRENT USE / MEDICINAL USE  
 Historically, piperazine compounds were used as antihelminths and (older 
 generation) anti depressants. In the last decade synthetic piperazine 
 compounds were synthesised  in clandestine laboratories and sold on websites 
 worldwide. They lack any medicinal  value. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Users compare the effects of MBZP with BZP. The overall opinion is that 
 MBZP is weaker than BZP but do not possess any major side effects of BZP.  
 Some users have commented that mBZP failed to produce euphoria similar to 
 ecstasy. Some commented they did not get any hang over the next day when the 
 dose was below 200mgs to 300mgs. 
 In a study, 26 psychoactive compounds (‘novel psychoactive substances’) were 
 bought from 5  different websites over 6 month period. The products were 
 analysed for the presence of the exact compound specified in the product. In 
 75% of the compounds, it contained the same compound advertised. However a 
 quarter of the samples did not contain the specified compound. For example, 
 MBZP was substituted for BZP or vice versa. 
 In another study, NMR technique was used to identify the (piperazine based) 
 compounds advertised in various products in the UK. The result showed most of 
 them contained BZP,TFMPP, DBZP, mCPP, pCPP and caffeine in addition to 
 MBZP.  
 Table [C]: UK products containing MBZP  
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Product name Supplier Content (NMR) Date published 
Socialite Red Eye Frog MBZP April 2008 
Head Rush AM-HI-CO MBZP, TFMPP, 
CPP (m / p) 
Feb 2009 
Xtacy AM-HI-CO MBZP, TFMPP, 
CPP (m / p) 
Feb 2009 
Exotix Super 
Extra 
Strength 
AM-HI-CO MBZP, BZP, 
DBZP 
Feb 2009 
Space Trips AM-HI-CO MBZP, TFMPP Feb 2009 
Cherries 
RetroPills 
Red Eye Frog MBZP, TFMPP, 
Caffeine 
Feb 2009 
  
[b] [c] [11] [12] [13] [14] [15] 
 USE IN COMBINATION WITH OTHER COMPOUNDS   
 With pFPP (to augment the effects of MBZP) [16]  
 PHARMACOLOGICAL CHARACTERISTICS  
 MBZP is sympathomimetic stimulant belonging to synthetic piperazine group. It 
 has similar effects to BZP but in an attenuated form. No information is available 
 on it pharmacokinetics.  
 TOXICOLOGICAL EFFECTS  
 It is reported to be devoid of any serious toxicity if used under 200mgs. Typical 
 side effects of BZP such as severe headache and nausea are less common with 
 MBZP. However, it produces toxicity similar to BZP in higher doses.  
 DESIRED PSYCHOACTIVE EFFECTS  
 Rapid mood elevation  
 Enhanced sociability  
 Repetitive thought patterns  
 "Rushing" sensation 
 Mild euphoria 
 Time Dysmorphia 
 However, some users have commented that MBZP failed to produce euphoria 
 similar to ecstasy. [17] [18] 
 PHYSICAL / MEDICAL UNTOWARD EFFECTS  
 Headache (less intense than that due to BZP) 
 Nausea (less intense than that due to BZP) 
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 Hangover (at high doses usually)  
 Fatigue  
 Insomnia  
 Confusion  
 Loss of appetite  
 Changes in body temperature  
 Palpitation  
 Dilation of pupils and blurring of vision  
 Decreased appetite  
 Mild to moderate synesthesia 
 Skin tingling  
 Temporary impotence 
[19] [20]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 MBZP could cause paranoid psychosis in large doses similar to BZP. 
 CLINICAL ADVICE  
 None. 
 RELATED FATALITIES  
 None reported. 
 YOU TUBE VIDEOS  
 There are no You Tube videos found on MBZP. 
 GOOGLE INSIGHTS  
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 MBZP, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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III.II   Methylenedioxy benzyl piperazine (MDBZP) 
 
 
 
MDBZP Report 
 
 
 
 
 
195 
 
 MDBZP   
 OVERVIEW 
 Chemical name: methylenedioxy benzyl piperazine 
Synonyms:  MDBZP; 1-piperonylpiperazine  
Active constituents: 1-(3, 4-methylenedioxybenzyl) piperazine  
Type: Research chemical - Piperazine 
Origin: Unknown 
Status: Novel 
Chronology: Unknown 
 KEY POINTS 
   
MDMA     MDBZP 
 
Structurally, MDMA and MDBZP have the same benzene ring with the 
substitution (methylene dioxy). However it has not been reported that MDBZP 
has any ‘ecstasy’ like activity. It is worthy to note that the prediction of the 
activity of a compond entirely based upon the structure is unreliable.  
 
There are some animal studies to suggest that MDBZP counters the neurotoxic 
effect induced by MDMA. 
 
[1]      
 
CHEMICAL CHARACTERISTICS OF ACTIVE 
CONSTITUENTS 
IUPAC name: 1-(1,3-benzodioxol-5-ylmethyl) piperazine  
Molecular weight: 220.268 g/mol 
Molecular formula: C12H16N2O2 
CAS Number: 32231-06-4   
[2]  
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Catapharma (India) Pvt. Ltd. India 
Minimum Order Quantity: 200 Kilogram 
Send your message to this supplier.  [3] 
Clearsynth Labs Pvt. Ltd. India 
Send enquiry / get a quote [4] 
Guide Chem 
Click to post buying lead [5] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Almost all the websites advertising the sale of this compound do not provide any 
 information on the price in their websites. Rather they either request to contact 
 the seller through email or to leave a message on their site.  
 MODALITIES OF INTAKE  
 Oral ingestion is the common mode of intake. Information on other possible 
 routes of intake is not available. 
 LEGAL STATUS 
It is legal in most of the countries including the UK.  
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
It has been tried by users who report that it is either non active (without any 
psychedelic action) or very mildly stimulant. One user reported no effect up to 
500mgs while others have found some activity (stimulation but no euphoria) at 5 
to 10mgs.  
[6] [7]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
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 With MDMA (to augment its effects) [8]  
 PHARMACOLOGICAL CHARACTERISTICS 
 The metabolism of Methylenedioxy benzyl piperazine (MDBP) is described 
 as follows: Initially demethylenation takes place to form N-(4-hydroxy-3-
 methoxybenzyl) piperazine which undergoes either partial glucuronidation or 
 sulfation. Finally the piperazine moiety is converted to N-(3,4-
 methylenedioxybenzyl) ethylenediamine and 3,4-methylenedioxy  benzylamine 
 and N-dealkylation to piperazine.   
 [a] 
 TOXICOLOGICAL EFFECTS 
 Animal studies suggest that MDMA induced neurotoxicity was antagonised by 
 the effects on MDBZP. 
 Systematic Toxicological Analysis (STA) performed using Gas Chromatography 
 and  Mass Spectrometry (GC/MS) on rat urine showed the presence of 
 MDBZP after single dose. The author concluded that STA could be used for 
 detection of MDBZP in human urine sample.  
[a] [b] [c] [d] [8]  
 DESIRED PSYCHOACTIVE EFFECTS 
 MDBZP is reported to be a very mild stimulant and users speculate that there 
 might be some activity in very high doses (in grams). [9]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Cold hands and feet 
 Headache 
 Dizziness 
 Nausea 
 Convulsions 
  [8] [10]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 No information available. 
 CLINICAL ADVICE 
 None. 
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 RELATED FATALITIES  
 None reported. 
 YOU TUBE VIDEOS 
 There are no You Tube videos on MDBZP. 
 GOOGLE INSIGHTS 
 There is not enough search volume to show graphs.  
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III.III  1-(4-bromo-2, 5-dimethoxybenzyl) piperazine (2C-B-
  BZP)  
 
 
 
2C-B-BZP Report 
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 2C-B-BZP   
 OVERVIEW 
 Chemical name: 1-(4-bromo-2, 5-dimethoxybenzyl) piperazine 
Synonyms:  2C-B-BZP  
Active constituents: 1-(4-bromo-2, 5-dimethoxybenzyl) piperazine 
Type: Research chemical – Piperazine 
Origin: Unknown. It is claimed to be seized for the first time in Germany in 
2009 and using instrumentation such as Gas Chromatography Mass 
Spectroscopy, the compound was confirmed to be 2C-B-BZP.  
Status: Novel 
Chronology: The first confirmed sample was in 2009. However it may have 
appeared on novel psychoactive substance market earlier than that. 
[a] [b] 
 KEY POINTS 
The molecular structure of 2C-B-BZP (piperazine) may appear as an extension 
of 2C-B (phenyl ethylamine), however they both are unrelated belonging to 
different class of compounds with entirely different effects. It is claimed to be a 
stimulant without much psychedelic effects due to lack of 5HT-2a receptor 
stimulation.  
      
2C-B- BZP       2C- B  
[a] [b] [1] 
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 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 1-(4-bromo-2, 5-dimethoxybenzyl) piperazine 
Molecular weight: 315.2085 g/mol 
Molecular formula: C13H19BrN2O2 
CAS Number: Unknown  
[2] [3] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
No information available. 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 No information available. 
 MODALITIES OF INTAKE  
Oral ingestion is the common mode of intake.   
 LEGAL STATUS 
It is legal in the USA, UK and rest of Europe. 
 CURRENT USE / MEDICINAL USE  
None. It is a research chemical. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The usual dose is between 50mgs to 75mgs. However some users have used it 
 up to 200mgs. It lasts between 3 to 6 hours.   
 [4] [5] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 Since it lacks psychedelic activity, it is usually combined with other compounds 
 to get euphoria.  
 With Methylone 
 With 2C-B 
 With 2C-E 
 With MDMA  
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 [6] [7] 
 PHARMACOLOGICAL CHARACTERISTICS 
 See Key points above. No further information is available.  
 TOXICOLOGICAL EFFECTS 
 No information available. 
 DESIRED PSYCHOACTIVE EFFECTS 
 It is not a very popular compound because of little psychedelic activity (see 
 above). 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Headaches (above 150mgs) 
 Nausea  
 [8] [9] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 No information available. 
 CLINICAL ADVICE 
       No information available. 
 RELATED FATALITIES  
 None reported.  
 YOU TUBE VIDEOS 
 There were no videos available on this compound.  
 GOOGLE INSIGHTS 
 There was not enough search volume to show graphs on this compound as on 1
st
 
 August 2012. 
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III.IV  meta-Chlorophenylpiperazine (mCPP)  
 
 
mCPP Report 
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 mCPP     
 OVERVIEW 
 Chemical name: meta-Chlorophenylpiperazine 
Synonyms: mCPP, 1-3-CPP, 3Cl-PP, 3CPP, 1-(m-Chlorophenyl) piperazine, 3-
Chlorophenyl piperazine, ‘Explosion’ (Netherlands), X4  
Active constituents: meta-Chlorophenylpiperazine 
Type: Research chemical - Piperazine 
Origin: There are references to this compound in the literature since the 1960s. 
Their effect as an appetite suppressant through 5HT1b/2c receptor agonism was 
extensively studied in 1970s. There is no information available on the web about 
its first synthesis.  
Status: Novel 
Chronology: It was reported to be first identified in ‘street shops’ by the Drug 
Information and Monitoring System in Netherlands in 2005.  
[a] [b] [c] [d] [1] [2] 
 KEY POINTS 
mCPP is a phenyl piperazine with stimulant and hallucinogenic properties 
comparable to MDMA. It exerts agonistic effects on serotonergic receptors (5-
HT1a/1b/1d, 5-HT2a and 5-HT2c) and antagonistic action on 5-HT3 receptor. It 
was sold as ecstasy replacement in New Zealand, Europe and USA.  
[d] [e] [f] [g] [1] [2] [3]        
  
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 1-(3-chlorophenyl) piperazine  
Molecular weight: 196.676 g/mol  
Molecular formula: C10H13ClN2  
CAS Number: 51639-49-7 
[1] [2]  
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
Legal Party Drug 
Sun Rise mCPP powder: 1-(meta-chlorophenyl) piperazine (mCPP) is a 5HT releaser 
that possesses mixed 5HT2A/2C receptor agonist/ antagonist actions. It shares several 
pharmacological properties with MDMA (ecstasy). 
In laboratory administration studies, individuals with prior experience of the drug ecstasy 
reported that mCPP in doses from 17.5 to 52.5 mg/70kg body weight produced MDMA 
(ecstasy)-like stimulant and hallucinogenic effects. However, unlike MDMA, no increase 
in blood pressure and heart rate were recorded. Other studies have confirmed these 
findings in other groups of ecstasy user and cocaine dependent individuals. mcPP is legal 
in the USA. [4] 
Best buy API 
Chemical Name:1-(2-chlorophenyl) piperazine HCl 
Package:25KGS/Card Board Drum  [5] 
Look chem: Junkai (Tianjin) Chemical Co., Ltd. 
CAS No.:6640-24-0 
Name: 3-Chlorophenyl piperazine 
Formula:C10H13ClN2 [6] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price of mCPP differed depending upon the sale of the country of delivery. 
 1gram  costs £18 in the UK. The price in the USA is as follows: 10gram cost 
 $186.20; 100g for $325.85; 500g for $510.72; 1kg for $851.20. [4] [5] [6]  
 MODALITIES OF INTAKE  
 Oral ingestion of the pill or powder is the common route of intake. Nasal 
 insufflation or IV injections were rarely used.  
[7] [8] [9] [10] 
 LEGAL STATUS 
mCPP is still legal in many countries including the UK. It is unscheduled in the 
USA. However, this compound could be covered through the Federal Analogue 
Act in the USA. 
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In New Zealand, mCPP was placed under Schedule 3 (of Class C controlled 
drugs) of The Misuse of Drugs Act 1975 along with other piperazine compounds 
such as BZP, TFMPP, MeOPP and pFPP on 1
st
 April 2008.     
It was made a controlled substance in other countries such as Denmark, 
Belgium, Czech Republic, Malta and Hungary.   
[h] [i] [j] [11] [12]   
 CURRENT USE / MEDICINAL USE  
 Due to its agonistic effects on serotonin receptors, it was used as a challenge 
 drug in research. It was evaluated to study the central serotonergic function 
 among adolescents. mCPP is an active intermediate metabolite of Trazodone. It 
 is postulated that mCPP may contribute to the antidepressant activity of 
 Trazodone, though it has not been proved. Its use as a treatment for migraine 
 was also tried but failed. [k] [13] [14]  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE  E.U. (OR ELSEWHERE)  
 mCPP is sold in powder or capsule form. 50mgs is the usual starting dose. A 
 typical  user’s experience is described below:  
 T0:00 : 50mgs of mCPP swallowed 
 T0:30 : Mild euphoria started 
 T1:30 : Intense nausea.  
 T2:00 : Short term memory loss.  
 T5:00 : Body load started to reduce.   
 T8:00 : Passed out.  
 Next day: Tired with headache 
 Studies from Netherlands report that mCPP has been sold  either  on its own or 
 in combination with MDMA and it is very difficult to distinguish these two 
 types of tablets by the appearance. It has been tried as a non-neurotoxic 
 alternative to MDMA but the users review has predominantly been negative.   
 NMR technique was used to identify the (piperazine based) compounds 
 advertised in various products in the UK. The result showed most of them 
 contained BZP, TFMPP, DBZP, MBZP, pCPP and caffeine in addition to 
 mCPP.  
 Table. UK products containing mCPP 
Product name Supplier Content (NMR) Date published 
Socialite Red Eye Frog MBZP April 2008 
Head Rush AM-HI-CO MBZP, TFMPP, Feb 2009 
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CPP (m / p) 
Xtacy AM-HI-CO MBZP, TFMPP, 
CPP (m / p) 
Feb 2009 
Exotix Super 
Extra 
Strength 
AM-HI-CO MBZP, BZP, 
DBZP 
Feb 2009 
Space Trips AM-HI-CO MBZP, TFMPP Feb 2009 
Cherries 
RetroPills 
Red Eye Frog MBZP, TFMPP, 
Caffeine 
Feb 2009 
 
 [l] [za] [zb] [15]   
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With MDMA (very common) 
 With GBL (no stimulation) 
 With BZP, TFMPP, GHB (psychotic episode) 
 With alcohol (severe nausea and headache) 
 With cannabis (intense shivering and visual hallucinations) 
 With MeOPP 
[16] [17] [18] [19] [20] [21] 
 PHARMACOLOGICAL CHARACTERISTICS 
 The earliest studies on mCPP focused on the median lethal  dose of mCPP which 
 was found to be (LD50) 185mgs/kg. Since then there were enormous interest on 
 the pharmacology of mCPP and several studies have been published.  
 The metabolism of mCPP initiated with hydroxylation of  the aromatic ring 
 followed by the degradation of the piperazine moiety to ethylenediamine. The 
 active metabolite of the antidepressant, Trazadone is mCPP. A study reported 
 that mCPP was metabolised in the liver by the liver microsomal enzyme 
 (Cytochrome P450 3A4). Another study suggested mCPP was metabolised by 
 Cytochrome P450 2D6.  
There are several studies to suggest that mCPP exert its effects through 
serotonergic pathways. It is confirmed that mCPP causes agonism at 
5HT1a/1b/1d, 5HT2c receptors and antagonistic action on 5-HT3 receptor.  
 In healthy human volunteers, mCPP produced 5HT receptor hypersensitivity at 
 low dose (0.25mg/Kg) and 5HT receptor hyposensitivity at higher doses 
 (0.5mg/Kg). Also panic attacks were observed in more subjects at higher doses. 
 A randomised double blind study on human volunteers involving daily infusions 
 of mCPP as a dose of 0.08mg/Kg induced physical symptoms of anxiety as well 
 as elevated biochemical parameters (plasma ACTH, cortisol, prolactin).   
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Another study showed that in comparison with d-fenfluramine, mCPP was a 
5HT releasor but did not cause long term 5HT depletion. 
An experimental study aimed to find out its effect on pituitary hormones. It 
reported that ACTH, prolactin and cortisol were significantly raised following 
mCPP infusion. However it produced unpleasant side effects such as extreme 
fear, tremor, increased sensitivity to sound and light. The study concluded that 
mCPP is not a suitable compound for challenge tests.  
[m] [n] [o] [p] [q] [r] [s] [t] [u]  
 TOXICOLOGICAL EFFECTS 
 A study conducted on healthy as well as panic disorder patients showed mCPP 
 induced panic attacks in almost half the patients and more than a quarter of 
 healthy subjects. 
 Study on healthy and patients with history of migraine attacks showed mCPP 
 induced more migraine at a dose of 0.5mg/kg on both groups of patients. This 
 also confirmed the actions of mCPP on 5HT2b, 5HT2c and 5HT1a receptors 
 which are consistent with pathophysiology of migraine.  
 Accidental ingestion of 300mgs of mCPP produced continuous vomiting for 
 more than 4 hours. It also produced migraine, palpitation, muscle cramps, severe 
 body tremor and raised body temperature. The episode ended when he fell 
 unconscious for few hours.  
 [v] [w] [22] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria (less than that produced by MDMA) 
 Empathy 
 Music appreciation 
[23] [24]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Stomach discomfort 
 Nausea 
[25]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
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 Psychotic episode 
 Intense anxiety (through post synaptic 5HT2c agonism) (Gibson et al, 1994) 
[x]  
 CLINICAL ADVICE 
 Even a single dose (0.5mg/Kg body weight) of mCPP could precipitate 
 ‘serotonin syndrome’ in psychiatric patients consisting of  cognitive symptoms 
 (confusion, irritability, tiredness), autonomic hyperactivity (tachycardia, 
 hyperthermia, nausea, vomiting, diarrhoea) and neuromuscular symptoms 
 (hyper-reflexia, rigidity, myoclonus).  
[j] [y] [z] 
 RELATED FATALITIES  
 There has been no death reports directly linked to use of mCPP. However there 
 are confirmed deaths due to Trazodone toxicity, but it is unclear whether, mCPP, 
 an intermediate metabolite of Trazodone, played a role in it.  
 A case report described toxicity from mCPP (three tablets) overdose 
 (Kovalevaet al, 2008). The concentration of mCPP was 320ng/mL (plasma) and 
 2300ng/mL (urine). The patient was on regular Trazadone (antidepressant) 
 medication and had also ingested other substances (amphetamine, 
 benzoylecgonine, alcohol). The concentration of mCPP was six times higher 
 than normal (56ng/mL). She presented with tachycardia, anxiety, sedation, 
 agitation and visual disturbances.  
[j] [zc]  
 YOU TUBE VIDEOS 
 There are videos on piperazine compounds in general, but no videos found on 
 mCPP  on You Tube. 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across  specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 mCPP, plotted on a scale from 0 to 100; the totals are indicated next to bars 
 by the search term, a break  down of how the categories are classified, lists of 
 the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with  defined regions, cities and towns.   
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III.V    1-(4-Fluorophenyl) piperazine (4-FPP)  
 
 
 
4-FPP / pFPP Report 
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 pFPP or 4-FPP  
 OVERVIEW 
 Chemical name: 1-(4-Fluorophenyl) piperazine 
Synonyms: pFPP; 4-FPP; Fluoperazine; Flipiperazine; Party pills; the Big Grin; 
Mashed; Extreme Beans (New Zealand); Fantasy – incense (Canada) 
Active constituents: 1-(4-Fluorophenyl) piperazine 
Type: Research chemical - Piperazine 
Origin: pFPP was reported to be discovered unintentionally whilst investigating 
the properties of a sedating antihistamine, niaprazine in 1982. pFPP was formed 
as an intermediate metabolite which failed to cause any sedation but produced 
serotonergic stimulation.  
Status: Novel 
Chronology: pFPP was later re-discovered in 2003 as a potential drug of misuse 
and was sold as ‘party pills’ in New Zealand until its ban in 2008. It was later 
known in other parts of the world and was sold as ecstasy tablets in other 
countries. The party pills contain various piperazine compounds such as BZP, 
MeoPP, TFMPP, pFPP, MBZP etc. mixed with other substances such as 
caffeine, cathinone. 
[a] [b] [1]  
 KEY POINTS 
4-FPP or pFPP is a synthetic piperazine which is reported to have strong 5HT2a 
agonistic properties and weaker 5HT2b and 5HT2c agonism. Although it does 
not produce effects similar to ecstasy, it became popular as a substitute for 
ecstasy in countries where it was banned.  
 
[2]      
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 1-(4-fluorophenyl) piperazine  
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Molecular weight: 180.222 g/mol  
Molecular formula: C10H13FN2  
CAS Number: 2252-63-3; 64090-19-3   
[3] [4]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
Intatrade Chemicals GmbH,  Germany 
Contact now [5] 
Mol Port 
Request custom quote [6] 
Sunrise (pFPP)  
WE ARE CURRENTLY OUT OF STOCK OF PFPP. SORRY FOR THE INCONVENIENCE. 
[7] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Most of the websites do not display a price, but they can be contacted for price. 
 However, a website quoted the prices as 1gram for £18, but they were out of 
 stock as on 25
th
 July 2012.  
 [5] [6] [7] [8]  
 MODALITIES OF INTAKE  
 Oral ingestion is the popular method of intake. Forum users post warning 
 messages against using 4-FPP intravenously or by insufflation. In general they 
 advise not to use any piperazine based compounds by these modes.  
 [1]  
 LEGAL STATUS 
pFPP is still legal in many countries including the UK. It is unscheduled in the 
USA. However, pFPP can be covered through the Federal Analogue Act in the 
USA. 
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 In New Zealand, pFPP was placed under Schedule 3 (of Class C controlled 
drugs) along with other piperazine compounds such as BZP, TFMPP, MeOPP 
and mCPP on 1
st
 April 2008.  
[c]  
 CURRENT USE / MEDICINAL USE  
 None. It is a research chemical and not intended for human consumption. 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Though ecstasy-like pills are commonly reported to contain a combination of 
 BZP/TFMPP around the world, a seizure (12 red Playboy bunny tablet) in 
 California showed the presence of pFPP by Gass Chromatography/ Mass 
 Spectrometry method.  
The online users commonly use the term ‘pFPP’ to refer to 1-(4-Fluorophenyl) 
piperazine rather than 4-FPP. The usual starting dose is 20mgs. Experienced 
users have tried up to 90mgs or more.  
Come up: 20 to 30min Peak: 1-5 hours Come down: 5 – 7 hours 
A typical user’s experience is given below:  
T+0 Oral ingestion of 24.1mgs of pFPP weighed in a five digit analytical scale.  
T+20m The effect started.  
T +30m Mild nausea and sweating noted 
T +1h Peak effect. The effect lasted for few hours 
T +5h Return to baseline started.  
T+5:45h Mild headache. 
T +6:30h Baseline reached.  
T +1day Tired and sleept extra long hours; also loss of appetite. 
[d] [9] [10] [11]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With MDMA (the user believed that this combination would prevent 
serotonin syndrome)  
[12]   
 PHARMACOLOGICAL CHARACTERISTICS 
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 One animal study showed that pFPP reduced the uptake of 5-HT and NA uptake 
 in vitro. It also reduced the turn over of 5-HT and DA in rat brains. However the 
 application of this information on human subjects has not been tested.  
 A rapid method of synthesis of 1-(4-Fluorophenyl)  piperazine was developed. 
 This compound was used as a precursor in (18F) labelling for PET studies.  
 [a] [e] 
 TOXICOLOGICAL EFFECTS 
 None reported. 
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria, elation (less extent only) 
 Enhanced sociability  
 Repetitive thought patterns, incoherence   
 Decreased appetite  
 "Rushing" sensation 
 Mild to moderate synesthesia 
 Tactile sensation 
[13] [14]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Sometimes the effects are unpredictable, even though the dose was carefully 
measures on a precision scale 
 Head aches 
 Jaw clenching and  
 Tenderness in facial muscles. 
 Large dilated pupils. 
 Powerful appetite suppression   
 Insomnia 
 Increased heart rate  
 Hang over symptoms – prolonged tiredness (hence users may not be able to 
use it regularly)  
[14] [15]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Confusion 
 Hallucinations with music 
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[14]  
 CLINICAL ADVICE 
 None.  
 RELATED FATALITIES  
 None reported. 
 YOU TUBE VIDEOS 
 There are no You Tube videos as on 25
th
 July 2012. 
 GOOGLE INSIGHTS 
 There is not enough search volume to produce a graph as on 25
th
 July 2012. 
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III.VI   para-Methoxyphenylpiperazine (MeOPP)   
 
 
MeOPP Report 
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 MeOPP  
 OVERVIEW 
 Chemical name: para-Methoxyphenylpiperazine 
Synonyms:  MeOPP; pMPP; 4-MeOPP; pMeOPP; 4-MPP (in Japan); 
Paraperazine; Party pills (New Zealand); Methoxyphenylpiperazine; p-
methoxyphenylpiperazine; 1-(4-Anisyl) piperazine. It is sold as ‘Ecstasy’ 
replacement (‘PEP’ / ‘Twisted’) usually in combination with other piperazine 
compounds such as BZP/ TFMPP/ MBZP etc. Please note that these street 
names are not exclusive only for MeOPP.   
Active constituents: para-Methoxyphenylpiperazine  
Type: Research chemical - Piperazine 
Origin: There are no available data on its origin or synthesis.  
Status: Novel 
Chronology: Although the exact year of its appearance on the online market is 
unknown, it is thought to be available on the online market since 2000. The first 
confirmed seizure of MeOPP was in 2006 in the USA. 
[a] [b]  
 KEY POINTS 
MeOPP is a synthetic piperazine which is a mild hallucinogen and a mild 
stimulant. A study reported that MeOPP inhibited the reuptake of dopamine, 
serotonin and norepinephrine as well as facilitated their release.  Orth (2-
MeOPP) and para (4-MeOPP) positional isomers exist for 
Methoxyphenylpiperazine. However, only the par isomer (4-MeOPP) is reported 
to be active. [a] [b]          
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 1-(4-methoxyphenyl) piperazine  
Molecular weight: 192.258 g/mol 
Molecular formula: C11H16N2O  
CAS Number: 38212-30-5 (free base) [a] [1] [2]  
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
BZP Shop 
1-(4-Methoxyphenyl) piperazine (meOPP) is an interesting piperazine that some users claim that it 
gives them a similar empathy as MDMA (ecstasy) does.  
Piperazines can interact with anti depressant medication. If you have a history of mental health 
issues, heart disorders or high blood pressure problems or are currently on any other medication 
please do not purchase this product.  
We can’t ship this product to Greece or Sweden or people under the age of 18. Please check your 
local laws before ordering. [3] 
New Chemicals 
CAS: 38212-30-5 
IUPAC: 1-(4-methoxyphenyl)piperazine 
Appearance: white to off-white powder [4]  
Legal Party Drugs  
SunRise  
MeOPP powder - 1 gram 
meOPP is a relaxing Piperazine which is used as a recreational drug. 
The effects of 4-methoxyphenylpiperazine (meOPP) powder is similar to ecstasy. Users report mild 
euphoric rushes with a sense of well being and relaxation. Users report a ratio of meOPP 1:1 with 
BZP can bring a warming sense of empathy to the regular BZP experience. 
Please check your local laws before ordering. We don’t sell meOPP to Denmark or any country 
where it is illegal.[5] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price for 1 gram of MeOPP varies between £18 and £22 (BZP shop) in the 
 UK. In rest of the Europe the price is given below (New Chem): 1g for €15.5; 3g 
 for €28.12; 25g for €84.00; 100g for €199.50; 500g for €666.00; 1000g for 
 €1079.00.   
 Although discussion on price is not allowed in web fora, one user posted that 
 he bought MeOPP 25g for €51,65.  
[3] [4] [5] [6] 
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 MODALITIES OF INTAKE  
 Oral ingestion is the usual mode of intake. It can be insufflated nasally or 
 smoked. [a] [7]  
 LEGAL STATUS 
MeOPP was classified as Class C substance in 2010 in the UK along with other 
substituted piperazines (mCPP, pCPP, mMPP, pMPP, TFMPP, pFPP etc).  
In New Zealand, MeOPP is placed under Schedule 3 (of Class C controlled 
drugs) along with other piperazine compounds such as BZP, TFMPP, pFPP, 
MBZP and mCPP on 1
st
 April 2008.    
It is unscheduled in the USA. However, MeOPP can be covered through the 
Federal Analogue Act in the USA. 
MeOPP was banned in Denmark along with BZP, TFMPP and mCPP in Dec 
2005. [c] [d] [8] 
 CURRENT USE / MEDICINAL USE  
 No information available. MeOPP is a research chemical and not intended for 
 human  consumption.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
There are a range of products available in the market sold as ‘herbal’ pill as an 
alternative to illegal drugs. They have been advertised as safe alternatives. The 
ingredients are dubious and may contain several compounds including some 
herbs and could contain several unknown and untested compounds. MeOPP 
could be one of the ingredients. The product can also contain vitamins and 
supplements. Online users post warning messages against using such chemicals.  
Generally, MeOPP can be sold in powder or pill (tablet / capsule) form. The 
dose varies between 100 to 500mgs.   
 [a] [9] [10] [11]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With mCPP (provided with low mood, confusion and discomfort) 
 With BZP, pFPP and hydrocodone 
 With BZP and TFMPP 
 With BZP and TFMPP and pFPP 
[12] [13] [14] [15] 
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 PHARMACOLOGICAL CHARACTERISTICS 
 There are only limited pharmacological data available for MeOPP.  
 In an animal study (Staack et al, 2004), MeOPP was reported to be metabolised 
 to 1-(4-hydroxyphenyl) piperazine (4-HO-PP) by demethylation and the 
 piperazine moiety was degraded.  There was also involvement of polymorphic 
 CYP2D6 (cytochrome P450 enzyme) in the demethylation.  
 Another study (Nagai et al, 2007) found that MeOPP inhibited the monoamine 
 re-uptake (dopamine, 5HT, and norepinephrine) and accelerated their release. 
 Hence one could expect an interaction with similar compound that have an effect 
 on the  monoamine pathways such as the SSRI antidepressants as well as drugs 
 with misuse potential (‘Ecstasy’). The risk of development of ‘Serotonin 
 Syndrome’ could be a possibility when combining MeOPP with SSRIs. [b] [e]  
 TOXICOLOGICAL EFFECTS 
 Most users believe that most of the compounds belonging to the piperazine 
 family do not cause toxicity. Some users believed that only doses above 
 1000mgs could cause toxicity. The usual doses (100 to 500mgs) were reported 
 not to cause any significant toxicity in the short term. Any long term toxicity of 
 these compounds have not been discussed or documented. However, other users 
 warn that piperazine compounds are more toxic compounds than other 
 scheduled drugs.   
 The argument that was made against the notion that ‘piperazines are relatively 
 safer compounds’ is this: TFMPP, a piperazine compound, was removed from 
 scheduling in the USA. This is because of the low potential for misuse due to 
 lack of euphoria and stimulation. This did not necessarily mean it was a safe 
 drug to use. Piperazines are reported to cause seizures, hypothermia, coma and 
 death.  
  [16] [17]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria  
 Appreciation of music  
 Relaxation / anxiolyitc / ‘calming effect’ 
 Closed eye visuals (weak).  
 [18]  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Nausea.  
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 Loss of appetite.  
 Headache.  
 High body temperature  - could cause hyperthermia 
 [19] [20]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 MeOPP along with other similar piperazines can cause psychosis rarely in high 
 doses or in combinations. [21] [22]  
 CLINICAL ADVICE 
 As MeOPP imparts its (agonistic) effect through the monamine system, 
combinations with serotonergic compounds are not advised. Its synergistic 
combination could potentially cause ‘Serotonin Syndrome’.  
 The presence of several piperazine based compounds such as MeoPP, BZP, 
TFMPP, MDBZP, mCPP could be identified and quantified using Gas 
Chromatography and Mass Spectrometry (GC/MS) method using human 
plasma.  
 Recently a relatively rapid method of determination of the presence of 
MeOPP in the urine has been described. [f] [g]  
 RELATED FATALITIES  
 No death report has been recorded due to MeOPP as on 1
st
 Aug 2012.  
 YOU TUBE VIDEOS 
 MeOPP mCPP 
 Piperazine pill effects 
 [23] [24] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 MeOPP, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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Chapter IV: MISCELLANEOUS COMPOUNDS 
 
Several synthetic cannabinoids are sold as ‘herbal incense’ online. Professor J W 
Huffman and many other scientists have synthesised over 450 synthetic cannabinoid 
compounds which are several folds potent than natural cannabis. They act on CB1 
and/or CB2 receptors. They are classified (Howlett et. al, 2002; Thakur et. al, 2005; 
Advisory Council on the Misuse of Drugs, 2009) according to their molecular structure 
as follows:  
1. Classical cannabinoids (THC and their synthetic analogues e. g. HU‐210, 
AM‐906, AM‐411, O‐1184). 
2. Nonclassical (cyclohexylphenols or 3‐arylcyclohexanols CP‐47,497). 
3. Hybrid (classical and non‐classical cannabinoids,e. g. AM‐4030). 
4. Aminoalkylindoles (AAIs): naphtoylindoles (e. g. JWH‐018, JWH‐073, 
JWH‐210); phenylacetylindoles (e. g. JWH‐250); naphthylmethylindoles and 
benzoylindoles (e. g. pravadoline, AM‐694, RSC‐4). 
5. Eicosanoids (endocannabinoids such as anandamide) and others.  
3-MeO-PCP has been used recreationally recently. Thus seven of the miscellaneous 
compounds are given below:  
IV.I  1-pentyl-3-(1-naphthoyl) indole (JWH-018) 
IV.II   naphthalen-1-yl-(1-butylindol-3-yl) methanone (JWH-073) 
IV.III   4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)  methanone (JWH-210)  
IV.IV   1, 1-dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210) 
IV.V   2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl) phenol     
  (CP-47,497)  
IV.VI  (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone      
  (UR-144)  
IV.VII  3-Methoxy Phencyclidine (3-MeO-PCP) 
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 JWH-018 or AM-678  
 OVERVIEW 
 Chemical name: 1-pentyl-3-(1-naphthoyl) indole 
Synonyms: Fake marijuana, K2, Spice, Red Magic, Smoke XXXX, Diesel, 
Serenity, and Blueberry Medication,  
Active constituents: 1-pentyl-3-(1-naphthoyl) indole  
Type: Research chemical – synthetic cannabinoid compound 
Origin: JWH-018 was first synthesised by John W. Huffman, Professor at 
Clemson University. The name is given by the initials of J W Huffman. 
Status: Novel 
Chronology: Professor J W Huffman began his research into synthetic 
cannabinoid in 1984. Over two decades of research has produced more than 450 
analogues and metabolites of delta-9-tetrahydrocannabinol (THC) which is one 
of the main ingredients of cannabis.  
[1] [2] [3] [4] [a] 
 KEY POINTS 
JWH-018 or AM-678 is popularly thought to belong to the cannabis group but it 
is not. Structurally it belongs to the family of amino alkyl indole 
(naphtholyindole) and not related to THC. It acts on CB1 and CB2 receptors and 
produces effects similar to that of cannabis.  It had been one of the ingredients of 
the ‘Spice’ or ‘herbal incense’ before its ban. Interestingly, following its ban, 
JWH-018 was replaced by JWH-073 in many such products. [b]   
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: naphthalen-1-yl-(1-pentylindol-3-yl) methanone 
Molecular weight: 341.45 g/mol 
Molecular formula: C24H23NO  
CAS Number: 209414-07-3  [5] [6] [7] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
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Product Description 
Tiger Food 
We have recently invested in developing a manufacturing establishment in China and are now 
able to provide, interested buyers, bulk products at low prices with free worldwide shipping. 
All goods are shipped via courier straight from our lab in China. Minimum order quantity is 
20g. 
 Most of the products are jwh, am series and other research chemicals that are well known 
worldwide. [8]  
Canna Zine 
JWH-018 is the laboratory-synthesized substance which has been designed 'from the ground 
up', just to get people high. At least that was the explanation JW Huffman gave it. He's the 
fella who invented this stuff as well as the man who put the JWH in JWH-018. [9]  
Kogged 
With the research chemical JWH-018 increasing in popularity, it becomes important for 
independent researchers to have access to JWH-018 and chemicals alike. I have dealt with my 
fair share of JWH-018 distributors and the majority of the companies seem “flaky” and 
unreliable; however, I have finally found a solid and reliable company that delivers at a fair 
price.[10]  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Only few websites actively promote the sale of these compounds. The price 
 given in one website is as follows: 20 g for £ 320; 50 g for £ 550; 100 g for £ 
 850; 200 g for £ 1300; 500 g for £ 2200; 1000 g for £ 3500.  
 Some other websites display catalogue of compounds available, but buyers need 
 to contact them about the price information. Yet few more websites just 
 advertise and request the buyer to leave a comment. So the buyers leave their 
 email address and through this possibly the vendors contact them for the price 
 and delivery information. [11]  
 MODALITIES OF INTAKE  
 JWH-018 can be smoked or the vapour from the aluminium foil is inhaled.  
  Rarely, it can be cooked to make brownies and eaten along with food.  
 Forum users’ advised to start at very low dose of 0.5 mgs to 1milligram. The 
 usual dose is between 2 to 4 milligrams.   
 Forum users discuss about accurate measurement of the JWH-018 powder. 
 Some users approximately measure minute quantity (visually) and do not use 
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 measuring scales. This is known as “eye balling” the sample. The popular belief 
 is that eye balling method does not result in overdoses. This assumption is not 
 true, as the amount eye balled depends on the density of the material used and 
 not the volume of the measured mass.  
 [12] [13] [14] 
  LEGAL STATUS 
 ‘Spice’ (which contains a mixture of cannabinoid substances including JWH-
 018, JWH-073 and HU-210) was classified under Class B in 2009 in the UK.   
 It is claimed to be uncontrolled in Canada. JWH-018 was scheduled as Class 1 
 drug in the USA on 1
st
 March 2012. 
 Although JWH-018 is not explicitly listed, ‘Spice-type’ of products are 
 controlled in many countries such as Austria, Argentina, Belarus, Brazil, 
 Channel islands, Chile, Estonia, France, Netherlands, New Zealand, Germany, 
 Italy, Ireland, Latvia, Luxembourg, Romania, Poland, Russia, Sweden, South 
 Korea etc.  
 [15] [16] [17] [18] [d]  
 CURRENT USE / MEDICINAL USE  
 The intention of Huffman and his team is to explore the properties of these 
 synthetic cannabinoid compounds and the cannabinoid brain and peripheral 
 receptors. They have been studied for its treatment in nausea, glaucoma and as 
 appetite suppressant. [19]  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Sexual stimulation 
 Euphoria  
 [20]  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With 5Meo-DMT (it caused extreme nausea, anxiety and respiratory 
depression) 
 With 2C-E, MDPV and Mephedrone 
 With JWH-073 
 With alprazolam 
 [21] [22] 
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 PHARMACOLOGICAL CHARACTERISTICS 
 JWH-018 acts as a full agonist at CB1 (Cannabinoid) receptors and CB2 
 receptors. The binding affinity which is represented by Ki for CB1 and CB2 
 receptors are 9.00±5.00 and 2.94±2.65 nM, respectively. This shows the 
 greater affinity for CB2 receptors than CB1 receptors (the lower the Ki value, 
 the greater the affinity).   
 [23] [24] 
 TOXICOLOGICAL EFFECTS 
 A user claimed to have received an email from Professor John W. Huffman. In 
 that email Professor JWH affirmed that there are no data on the long term effects 
 of this compound on animals (apart from anecdotal data from Der Spiegel) and 
 certainly there are no data regarding its effects in humans.  
 Anecdotal reports suggest that it is likely to produce seizures in higher doses.  
 [24a] [24b] [c]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Sexual stimulation 
 Euphoria 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Headaches  
 Tachycardia 
 High blood pressure 
 Dizziness 
 Vomiting  
 Increased muscle tone  
 Dysphoria 
 Dry mouth 
 Itchy skin 
 Photophobia  
  [25] [26] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Marijuana like side effects 
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 Intense paranoia and recurring psychotic episodes requiring admission to 
emergency departments 
 Severe anxiety and fear lasting for a month on regular use 
 Panic attacks 
 Auditory hallucinations 
 Visual hallucinations 
 Distortion of time (e.g, 2 hours seem like 2 days) 
 Visual distortions (colour/ objects) 
 Numbness of whole body  
 Insomnia  
 Heavy body load 
 [27] [28] [29] [30] [31] 
 CLINICAL ADVICE 
 The dose of JWH-018 is very low and it is frequent for users to overdose on it as 
 they do not use sophisticated balance to weigh them accurately. Hence it is 
 advised to measure them accurately and use low doses (as small as 0.5 to 1 
 milligram). 
 It is not detected by conventional urine drug testing. Red Wood Toxicology 
 offer urine drug testing and this substance can be detected up to 72 hours in the 
 urine and up to 48 hours in the saliva. [32] 
 RELATED FATALITIES  
 L J, a 19 year old University student died of ‘multi organ failure’ after 
ingesting synthetic cannabinoid. It was reported that he had consumed 
‘Tease – a herbal incense’. It is alleged that one of the ingredients was JWH-
018.   
 L K, died on 8th Jan 2012. It was reported in the autopsy report that the blood 
samples contained JWH-018 and JWH 2201. It showed the levels of JWH-
018 as 0.53 ng/ml and AM-2201 as 9.0 ng/ml.  
 [33] [34] [35] 
 YOU TUBE VIDEOS 
 There are numerous videos in English and other languages. Few examples are 
 given below:  
1. Neurosoup  
2. JWH-018 synthesis 
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3. You tube trip  
4. Buy JWH-018 online 
 [36] [37] [38] [39] 
 GOOGLE INSIGHTS 
Google Insight for Search shows search volume patterns for specific key words 
across specific regions and time frames since 2004. The screenshot below  includes 
a graph with the search volume, indicating interest over time (GMT) for JWH-018, 
plotted on a scale from 0 to 100; the totals are indicated next to bars  by the search 
term, a break down of how the categories are classified, lists of the  top searches 
and top rising searches, a world heat map graphically displaying the  search 
volume index with defined regions, cities and towns.   
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 JWH-073   
 OVERVIEW 
 Chemical name: naphthalen-1-yl-(1-butylindol-3-yl) methanone 
Synonyms: Numerous street names are available and sold as ‘herbal incense’. 
Spice, K2, Yucatan Fire and Genie, Banana Cream Nuke (combination of JWH-
073 and JWH-018) are few of such examples. 
Active constituents:  naphthalen-1-yl-(1-butylindol-3-yl) methanone 
Type: Research chemical – synthetic cannabinoid compound 
Origin: JWH-073 was first synthesised by John W. Huffman, Professor at 
Clemson University. The name is given by the initials of J W Huffman. It is 
considered 3 to 5 times as potent as cannabis. 
Status: Novel 
Chronology: Professor J W Huffman began his research into synthetic 
cannabinoid in 1984. Over two decades of research has produced more than 450 
analogues and metabolites of delta-9-tetrahydrocannabinol (THC) which is one 
of the main ingredients of cannabis. JWH-073 is one of those compounds he 
synthesised. 
[1] [2] [3] [4] [a] 
 KEY POINTS 
JWH-073 is popularly thought to belong to the cannabis group but it is a 
synthetic cannabinoid and structurally it belongs to the family of amino 
alkylindole (naphtholyindole). It acts on CB1 and CB2 receptors and produces 
effects similar to that of cannabis. It is generally regarded a 3-5 times more 
potent than cannabis. 
  
‘Spice’ or ‘herbal incense’ contained JW-018 and JWH-073 and subsequent to 
the ban on JWH-018, this compound was replaced by JWH-073. 
[5] [6] [b]         
 
242 
 
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: naphthalen-1-yl-(1-butylindol-3-yl) methanone 
Molecular weight: 327.42 g/mol 
Molecular formula: C23H21NO   
CAS Number: 208987-48-8  
[7] [8] [9]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Tiger Food 
We have recently invested in developing a manufacturing establishment in China and are now 
able to provide, interested buyers, bulk products at low prices with free worldwide shipping. All 
goods are shipped via courier straight from our lab in China. Minimum order quantity is 20g. 
 Most of the products are jwh, am series and other research chemicals that are well known 
worldwide. [10]  
Tradevv 
JWH-073: 1-Butyl-3-(1-naphthoyl)indole  
naphthalen-1-yl-(1-butylindol-3-yl)methanone 
CAS 208987-48-8  Formula C23H21NO  
Mol. mass 327.42 g/mol   Purity: 99%min [11]  
Bridgat 
Contact now.  
[12]  
Research Chemical:  
JWH-073 Sample 
Price: €20.00 
[13] 
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 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Only few websites actively promote the sale of this compound. The price given 
 in one website is as follows: 
 50 g - €700; 100 g - €1000; 500 g - € 4000; 1Kg - € 7000; 3 Kg - € 19,500;  
 5 Kg – € 30,000; 10 Kg - € 50,000; 20 Kg - € 80,000  
 Some other websites display catalogue of compounds available, but buyers need 
 to contact them about the price information. Yet few more websites just 
 advertise and request the buyer to leave a comment. So the buyers leave their 
 email address and through this possibly the vendors contact them for the price 
 and delivery information. [14] [15] 
 MODALITIES OF INTAKE  
 The popular method of using JWH-073 seems to be inhaling the vapour from the 
 aluminium foil.  
 Oral ingestion is another common method. The powder is placed in a gel cap 
 and swallowed.  
 Rarely, users make their own blend of ‘Spice’. For examples, JWH-073 is 
 dissolved in acetone and smoked with tobacco; or it is dissolved in alcohol and 
 mixed with mint. 
 The usual dose for first time user is between 4 to 6 milligrams. It has cross 
 tolerance with cannabis and so for a regular cannabis user a dose of 10-20 
 milligrams is suggested by the users.   
 Forum users discuss about accurate measurement of the JWH-073 powder. 
 Some users approximately measure minute quantity (visually) and do not use 
 measuring scales. This is known as “eye balling” the sample. The popular belief 
 is that eye balling method does not result in overdoses. This assumption is not 
 true, as the amount eye balled depends on the density of the material used and 
 not the volume of the measured mass.  
 [16] [17] [18] [19] [20]  
 LEGAL STATUS 
 ‘Spice’ (which contains a mixture of cannabinoid substances including JWH-
 018 and JWH-073) was classified under Class B in 2009 in the UK. JWH-073 
 was scheduled as Class 1 drug in the USA on 1
st
 March 2012.  
 Although JWH-073 is not explicitly listed, ‘Spice-type’ of products are 
 controlled in many countries such as Austria, Argentina, Belarus, Brazil, 
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 Channel islands, Chile, Estonia, France, Netherlands, New Zealand, Germany, 
 Italy, Ireland, Latvia, Luxembourg, Romania, Poland, Russia, Sweden, South 
 Korea etc. 
 It is claimed to be uncontrolled in Canada.  
 [21] [22] [23] [24] [25] [f]  
 CURRENT USE / MEDICINAL USE  
 The intention of Huffman and his team is to explore the properties of these 
 synthetic cannabinoid compounds and the cannabinoid brain and peripheral 
 receptors. They have been studied for its treatment in nausea, glaucoma and as 
 appetite suppressant.  
 [26]  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Sexual stimulation 
 Euphoria  
 Thought provoking  
 Come up: few minutes Peak: 1 hour   Come down: 3 hours 
 [27] [28] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 JWH-073 is usually combined with JWH-018 in a ration of 2:1  
 The forum users take vote for the best ratio for combining the following: 
JWH-018 + JWH-073 + JWH-081 + JWH-250 ratios:  
JWH-
018 
JWH-
073 
JWH-
081 
JWH-
250  
JWH-
018 
JWH-
073 
JWH-
081 
JWH-
250 
Total 
 
1 1 2 2 
 
10mgs 10mgs 20mgs 20mgs 60mgs 
 
1 2 1 2 
 
10 20 10 20 60 
 
1 2 2 1 
 
10 20 20 10 60 
 
2 2 1 1 
 
20 20 10 10 60 
 
2 1 2 1 
 
20 10 20 10 60 
 
2 1 1 2 
 
20 10 10 20 60 
 
1 1 1 1 
 
15 15 15 15 60 
 
2 1 1 1 
 
24 12 12 12 60 
 
1 2 1 1 
 
12 24 12 12 60 
 
1 1 2 1 
 
12 12 12 12 60 
 
1 1 1 2 
 
12 12 24 24 60 
 
 [29] [30] [31]  
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 PHARMACOLOGICAL CHARACTERISTICS 
 JWH-073 has a Ki valus of 8.9 for CB1 receptors and 28 for the CB2 receptors. 
 This shows greater affinity for CB1 receptors than CB2 receptors (the lower the 
 Ki value, the greater the affinity).  Hence it has intermediate to high affinity for 
 CB1 receptors in brain which accounts for most of its adverse effects.  
 [32] [c] [d] 
 TOXICOLOGICAL EFFECTS 
 It possesses cross tolerance with other THC compounds. Hence those who 
 smoke cannabis regularly (for at least 2 years), the first time use of JWH-073 
 is reported to be well tolerated, where as for those who have not been used to 
 cannabis, it could be toxic even on the first use. Hence the forum users warn the 
 first time user to be cautious.    
 It is also suggested by the forum users that it could possess carcinogenic 
 properties.   
 When naphthalene undergoes metabolism, epoxides are produced which are 
 carcinogenic. These products could interact with DNA molecule. During the 
 metabolism, (see figure below), cytochrome 450 breaks down C=C into a simple 
 bond, C-C, which then joins the Oxygen molecule to produce epoxide. Some of 
 these epoxides are metabolised into non toxic products. However, some still 
 remain un metabolised and could, theoretically, interact with DNA and proteins 
 causing carcinogenesis.    
 [33] [34] [35] [36]   
 DESIRED PSYCHOACTIVE EFFECTS 
 Sexual stimulation 
 Extreme Euphoria 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 The most commonly occurring side effects, as discussed by the forum users, are 
 given below:  
 Headaches  
 Tachycardia 
 Normal pupil size, but lateral gaze nystagmus 
 Tremor  
 High blood pressure 
 Dizziness 
 Vomiting  
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 Increased muscle tone  
 Dysphoria 
 Dry mouth 
 Itchy skin 
 Photophobia 
 It causes or aggravates pre-existing lung condition 
  [37] [38] [39] [40] [e]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Marijuana like side effects 
 Intense paranoia and recurring psychotic episodes requiring admission to 
emergency departments 
 Anxiety and fear (but less than JWH-018)  
 Intense panic attacks 
 Auditory hallucinations 
 Visual hallucinations 
 Distortion of time  
 Visual distortions (colour/ objects) 
 Numbness of whole body  
 Insomnia  
 Heavy body load 
 [41] [42] [43] [44] [45] [46] [47] [48] 
 CLINICAL ADVICE 
 JWH-073 is not detected by conventional urine drug testing. Red Wood 
 Toxicology offer urine drug testing and this substance can be detected up to 72 
 hours in the urine and up to 48 hours in the saliva.  
 [49] [50]  
 RELATED FATALITIES  
 L J, a 19 year old University student died of ‘multi organ failure’ after 
 ingesting synthetic cannabinoid. It was reported that he had consumed ‘Tease – 
 a herbal incense’ which was alleged to contain ingredients such as JWH-018, 
 JWH-073.  
 [51] 
 YOU TUBE VIDEOS 
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 There are numerous videos in English and other languages. Few examples are 
 given below:  
1. Neurosoup  
2. JWH-073 
3. Buy JWH 
4. Citizens Against Banning Legal Substances 
 [52] [53] [54] [55] 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 JWH-073, plotted on a scale from 0 to 100; the totals are indicated next to bars 
 by the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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 JWH-210   
 OVERVIEW 
 Chemical name: 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone 
Synonyms: Numerous street names are available for these synthetic 
cannabinoids. Ace of spades, atomic bomb, baby J are few examples. 
Active constituents:  4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone  
Type: Research chemical – synthetic cannabinoid compound 
Origin: JWH-210 was first synthesised by John W. Huffman, Professor at 
Clemson University. The name is given by the initials of J W Huffman.  
Status: Novel 
Chronology: Professor J W Huffman began his research into synthetic 
cannabinoid in 1984. Over two decades of research has produced more than 450 
analogues and metabolites of delta-9-tetrahydrocannabinol (THC) which is one 
of the main ingredients of cannabis. JWH-210 is one of those compounds he 
synthesised. 
[1] [2] [3] [4] [a] 
 KEY POINTS 
JWH-210 is popularly thought to belong to the natural cannabis group but it is a 
synthetic cannabinoid and structurally it belongs to the family of amino 
alkylindole (naphtholyindole). It acts on CB1 and CB2 receptors as a potent 
agonist and produces effects similar to that of cannabis but more potent.  
‘Spice’ or ‘herbal incense’ contains various synthetic compounds such as JW-
018, JWH-073, JWH-210, HU-210 etc.  
[5] [6] [7] [8] [b] [c]        
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone  
Molecular weight: 369.498 g/mol  
Molecular formula: C26H27NO  
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CAS Number: 824959-81-1 [7] [9] 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Details / description 
Nanjing KaiKai Technology Co.,LTD  
China 
Tel :86-25-8630xxxx    Fax : 86-25-6866xxxx 
Attn : Mr. Kevin Peng    Mobile :86-1391389xxxx 
Email :xxxx aitech@gmail.com     [10]   
Kangshuo Biochem  
Address: China 
Contact us  [11]  
Research Chemicals Direct 
JWH-210 50g 
Price: €700.00 [12] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Only few websites actively promote the sale of this compound. The price given 
 in one website is as follows: 
 50 g - €700; 100 g - €1000; 500 g - € 4000; 1Kg - € 7000; 3 Kg - € 19,500;  
 5 Kg – € 30,000; 10 Kg - € 50,000; 20 Kg - € 80,000  
 The price of JWH-210 is the same as that of JWH-073.  
 Few other websites display catalogue of compounds available, but buyers need 
 to contact them about the price information. Yet few more websites just 
 advertise and request the buyer to leave a comment. So the buyers leave their 
 email address and through this possibly the vendors contact them for the price 
 and delivery information. [12] [13]  
 MODALITIES OF INTAKE  
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 JWH-210 is a very white crystalline non-sticky powder. The popular method of 
 using it seems to be inhaling the vapour from the aluminium foil preferably 
 through a small pipe.  
 Oral ingestion is another common method. The powder is placed in a gel cap 
 and swallowed.  
 Rarely, users make their own blend of ‘Spice’. For examples, JWH-210 is 
 dissolved in acetone and smoked with tobacco; or it is dissolved in alcohol and 
 mixed with mint. 
 The usual dose for first time user is between 4 to 6 milligrams. It has cross 
 tolerance with cannabis and so for a regular cannabis user a dose of 10-20 
 milligrams is suggested by the users.   
 Forum users discuss about accurate measurement of the powder. Some users 
 approximately measure minute quantity (visually) and do not use measuring 
 scales. This is known as “eye balling” the sample. The popular belief is that 
 eye balling method does not result in overdoses. This assumption is not true, as 
 the amount eye balled depends on the density of the material used and not the 
 volume of the measured mass.  
 [13] [14] [15] [16] [17]  
 LEGAL STATUS 
 Although JWH-210 is not explicitly listed, ‘Spice-type’ of products are 
 controlled in many countries such as Austria, Argentina, Belarus, Brazil, 
 Channel islands, Chile, Estonia, France, Netherlands, New Zealand, Germany, 
 Italy, Ireland, Latvia, Luxembourg, Romania, Poland, Russia, Sweden, South 
 Korea etc.  
 ‘Spice’ (which contains a mixture of cannabinoid substances including JWH-
 018, JWH-073, JWH-210 and HU-210) was classified under Class B in 2009 in 
 the UK. It was banned on 1
st
 Oct 2010 in Sweden. JWH-210, as a compound, is 
 unscheduled in the USA.  
  [18] [19] [20] [21] [d]  
 CURRENT USE / MEDICINAL USE  
 The intention of Huffman and his team is to explore the properties of these 
 synthetic cannabinoid compounds and the cannabinoid brain and peripheral 
 receptors. They have been studied for its treatment in nausea, glaucoma and as 
 appetite suppressant. [22]  
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 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Sexual stimulation 
 Euphoria  
 Thought provoking  
 Sensory distortions  
 Come up: few minutes Peak: 1 hour  Come down: 2-3 hours 
 A users experience is given below:   
 T 0:00 Smoked through small wooden pipe (about100-120 mg of herbs 
 containing 5-6 mg of JWH-210 
 T 0:10 effects comparable to cannabis. 
 T 0:15 great high, euphoria, tranquility, heightened sensory perception (music 
 and taste), slight body buzz with pleasant muscle relaxation.  
 T 0:40-1:20 strong plateau.  
 Т 1:30-2:00 Effects are fading out.  
 T 2:00-3:00 Baseline reached.  
  
 [23]   
  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 
 With Phenazepam (4mgs) and MXE (30mgs) and suffered a psychotic 
episode 
 With AM-2201 – suffered side effect from this combination such as unstable 
gait, dizziness, extreme dry mouth, and palpitations.  
 [24] [25] 
 PHARMACOLOGICAL CHARACTERISTICS 
 JWH-210 has a Ki valus of 0.46nM for CB1 receptors and 0.69nM for the CB2 
 receptors. This shows a potent affinity for both CB1 and CB2 receptors (the 
 lower the Ki value, the greater the affinity). [d] [26] 
 TOXICOLOGICAL EFFECTS 
 It possesses cross tolerance with other THC compounds. Hence the forum users 
 warn the first time users.    
 It is also suggested by the forum users that it could possesses carcinogenic 
 properties.  
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 When naphthalene undergoes metabolism, epoxides are produced which are 
 carcinogenic. These products could interact with DNA molecule. During the 
 metabolism, (see figure below), cytochrome 450 breaks down C=C into a simple 
 bond, C-C, which then joins the Oxygen molecule to produce epoxide. Some of 
 these epoxides are metabolised into non toxic products. However, some still 
 remain un metabolised and could, theoretically, interact with DNA and proteins 
 causing carcinogenesis.   [27]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Sexual stimulation 
 Extreme Euphoria 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 JWH-210 is a research chemical and is not intended to human consumption, as 
 there are not enough data to support safe use in people.  
 Headaches  
 Tachycardia 
 Normal pupil size, but lateral gaze nystagmus 
 Tremor  
 High blood pressure 
 Dizziness 
 Vomiting  
 Increased muscle tone  
 Dysphoria 
 Dry mouth 
 Itchy skin 
 Photophobia 
 It causes or aggravates pre-existing lung condition 
[28] [29] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Marijuana like side effects including the following: 
 Intense paranoia and recurring psychotic episodes requiring admission to 
emergency departments 
 Less anxiety and fear than JWH-018    
 Auditory hallucinations 
 Visual hallucinations 
 Distortion of time  
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 Visual distortions (colour/ objects) 
 Numbness of whole body  
 Insomnia  
 Heavy body load 
 [30] [31] [32] [33]  
 CLINICAL ADVICE 
 JWH-210 is not detected by conventional urine drug testing. Red Wood 
 Toxicology offer urine drug testing and this substance can be detected up to 72 
 hours in the urine and up to 48 hours in the saliva. [34] [35]  
 RELATED FATALITIES  
 Lamar Jack, a 19 year old University student died of ‘multi organ failure’ 
after ingesting synthetic cannabinoid. It was reported that he had consumed 
‘Tease – a herbal incense’ which was alleged to contain ingredients such as 
JWH-018, JWH-073, JWH-210 etc. [36]  
 YOU TUBE VIDEOS 
 There are a number of videos in English for the sale. Few examples are given 
 below:  
1. Where to buy JWH-210? 
2. Buy JWH-210 
 [37] [38]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 JWH-210, plotted on a scale from 0 to 100; the totals are indicated next to bars 
 by the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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 HU-210   
 OVERVIEW 
 Chemical name: 1, 1-dimethylheptyl-11-hydroxytetrahydrocannabinol  
Synonyms: HU210, H7909_sigma,  Chembi: 213285 and also all other street 
names of ‘Spice’ as HU-210 is considered to be one of its ingredients.  
Active constituents: 1, 1-dimethylheptyl-11-hydroxytetrahydrocannabinol 
Type: Research chemical – synthetic cannabinoid 
Origin: HU-210 was first synthesised from a compound (1R, 5S-Myrtenol) by 
Professor Raphael Mechoulam and his team who worked at the Hebrew 
University in 1998. The name ‘HU’ is the abbreviation of Hebrew University.  
Status: Novel 
Chronology: This compound was originally used in basic scientific research to 
identify cannabinoid receptors in the brain and its application in the medical 
field (e.g, treatment of nausea, treatment of dementia). However, it was illegally 
sold as a recreational compound. The first confirmed seizure was in 2008 at 
Wilmington, Ohio by the U.S. Customs and Border Protection. The individual 
pouches (see below) were names as ‘Spice Diamond’; ‘Spice Artic Energy’; 
‘Spice Gold’; ‘Genie’ and ‘Yucatan Fire’. The laboratory investigation 
confirmed the presence of HU-210 in them. [a] [1] 
 KEY POINTS 
 HU-210 is reported to be about 100 to 800 times more potent than Tetra Hydro 
 Cannabinol (THC) from natural cannabis and has longer duration of action. HU-
 210 is the 1, 1-dimethylheptyl homologue of 7-hydroxy- Δ6- 
 tetrahydrocannabinol. It is considered to be the most potent cannabinoids ever 
 known.  
 [b] [2]      
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-
2-yl)- 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol  
Molecular weight: 386.567 g/mol 
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Molecular formula: C25H38O3 
CAS Number: 112830-95-2 [3] [4]   
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Cayman Chem 
To ask for assistance with one of our products please contact a Technical Support Scientist. 
This product requires special processing and/or additional information before it can be 
shipped. A Customer Service representative will contact you within 24 hours of receipt of 
your order. 
Warning This product is not for human or veterinary use. [5]  
Tocris 
This product is a Home Office controlled substance and is not available for purchase online in 
your territory (UK). Please contact us to place your order. Orders for Home Office controlled 
substances will incur a £28 / €33 administrative fee to cover licence expenses. [6] 
Pseudoephedrine Inc. 
HU-210, Buy HU-210, HU-210 For Sale, High Quality HU-210 
Phone: +44-703-592-XXXX [7] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 Most websites display catalogue of compounds available, but buyers need to 
 contact them about the price information. Yet few more websites just advertise 
 and request the buyer to leave a comment. So the buyers leave their email 
 address and through this possibly the vendors contact them for the price and 
 delivery information. The one above has given a mobile number to call and get 
 further information. In one (rare) website the price was given: 
 UK: 5 mg for £105 (In stock) and 25 mg for £435 (In stock) [7] [8] 
 MODALITIES OF INTAKE  
 HU-210 can be smoked or orally ingested. It is not water soluble, but dissolves 
 well in pure acetone or alcohol. The vapour can be inhaled from a foil. [9]  
 LEGAL STATUS 
 ‘Spice’ (which contains a mixture of cannabinoid substances including JWH-
 018, JWH-073 and HU-210) was classified under Class B in 2009 in the UK.   
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 It is claimed to be uncontrolled in Canada. HU-210 was scheduled as Class 1 
 drug in the USA.  
 Although HU-210 is not explicitly listed, ‘Spice-type’ of products are controlled 
 in many countries such as Austria, Argentina, Belarus, Brazil, Channel islands, 
 Chile, Estonia, France, Netherlands, New Zealand, Germany, Italy, Ireland, 
 Latvia, Luxembourg, Romania, Poland, Russia, Sweden, South Korea etc. 
 [10] [11] [12] [13] [14] 
 CURRENT USE / MEDICINAL USE  
 It is hypothesised that HU-210 and various other synthetic cannabinoids could 
 be used for the treatment of Alzheimer’s disease. Numerous scientific studies 
 have been conducted on this subject for many years. Recently, Chen and his 
 team concluded that HU210 had no beneficial effects on neuropathology and 
 behavioural deficits of Alzheimer’s disease. It also cautioned on using HU-210 
 as a treatment because it could potentially cause ‘some detrimental effects’.
 [c] [15] 
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 It is reported to be one of the ingredients of ‘Spice’ and hence it is difficult to 
 assess its individual effects. However, it has a slower onset of action but longer 
 duration of action when compared with JWH-018.  
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With JWH-018 
 ‘Spice’ is popularly known to contain JWH-018, JWH-073, HU-210 and CP-
47497  
 [16] [17] 
 PHARMACOLOGICAL CHARACTERISTICS 
 As described in the introduction, HU-210 is reported to be about 100 to 800 
 times more potent than THC from natural cannabis and has longer duration of 
 action.  
 TOXICOLOGICAL EFFECTS 
 It is a hypothesis that marijuana intake causes modifications in various mental 
 functions including memory deficits in memory formation. A strong finding in 
 terms of the memory is the deficit in working and short term memory. For 
 memory formation there must be intact pre frontal cortex and hippocampus 
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 which contain abundant CB1 receptors. It was postulated that administration of 
 exogenous cannabinoid agonists impairs memory formation by affecting its 
 coding process.  
 A recent animal experiment was conducted to find out the effect of cannabinoid 
 on memory and hippocampal activity. HU-210 was used as an exogenous 
 synthetic cannabinoid agonist. The finding confirmed that the deficits in 
 memory as well as effects on anxiety, motor activity and spatial learning. The 
 presence of cannabinoid antagonists (SR141716A or AM281) did not reverse 
 the memory deficits.The mechanism for spatial memory deficit was due to the 
 abnormality in hippocampal cell firing. 
 [d][e]   
DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria  
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Tolerance develops on regular use and forum users also reported withdrawal 
 symptoms on stopping after prolonged use. The various side effects are listed 
 below: 
 Migraine / headaches – very severe and long lasting, even for weeks 
 Tachycardia 
 Normal pupil size, but lateral gaze nystagmus 
 Tremor  
 High blood pressure 
 Dizziness 
 Vomiting  
 Increased muscle tone  
 Dysphoria 
 Dry mouth 
 Itchy skin 
 Photophobia 
 It causes or aggravates pre-existing lung condition 
 [18] [19] [20] [21] [22] [f] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 HU-210 is a synthetic cannabinoid and several times more potent than THC. It 
 action is similar to that of cannabis and hence it produces Marijuana like side 
 effects: 
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 Intense paranoia and recurring psychotic episodes requiring admission to 
emergency departments 
 Anxiety and fear  
 Intense panic attacks 
 Auditory hallucinations 
 Visual hallucinations 
 Distortion of time  
 Visual distortions (colour/ objects) 
 Numbness of whole body  
 Insomnia  
 Heavy body load 
 [23] [24] [25] [26] [27] [28] [29] [30] 
 CLINICAL ADVICE 
 HU-210 is a research chemical and is not intended to human consumption, as 
 there are not enough data to support safe use in people.  
 RELATED FATALITIES  
 Lamar Jack, a 19 year old University student died of ‘multi organ failure’ after 
 ingesting synthetic cannabinoid. It was reported that he had consumed ‘Tease – 
 a herbal incense’. It is alleged that one of the ingredients was HU-210. [31]  
 YOU TUBE VIDEOS 
1. HU-210  
2. 2011 BEST HERBAL INCENSE REVIEW 
3. Spice Products and Synthetic Cannabinoids 
4. The K2 Diaries (Intro) Pt. 1 
 [32] [33] [34] [35] 
 GOOGLE INSIGHTS  
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 HU-210, plotted on a scale from 0 to 100; the totals are indicated next to bars by 
 the search term, a break down of how the categories are classified, lists of the 
 top searches and top rising searches, a world heat map graphically displaying the 
 search volume index with defined regions, cities and towns.   
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 CP-47497   
 OVERVIEW 
 Chemical name: 2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl) 
 phenol 
Synonyms: CHEBI: 369647; CP-4497; (+/-)-CP 47497  
Active constituents: 2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl) 
phenol 
Type: Research chemical – synthetic cannabinoid 
Origin: Since the identification of the structure of delta 9-tetra hydro cannabinol 
(Δ9-THC) in 1964, numerous synthetic analogues have been developed. In 1980s 
a team at Pfizer Company explored the synthesis of analgesics using (-)-9-nor-
9β-hydroxyhexahydrocannabinol (HHC) as template and synthesised CP-47497.  
Status: Novel 
Chronology: It has been used for research in the medical field. However, 
recently it has appeared as a drug of misuse due to its more potent action on 
cannabinoid receptors. There are numerous products available online as ‘herbal 
incense’ which seem to contain a mixture of various chemicals predominantly 
synthetic cannabinoids. A recent report analysed various samples of these 
‘herbal’ products and have confirmed the presence of at least 19 cannabinoids in 
those preparations. CP-47497 is one among them which was first identified in 
2008. However some forum users report that CP-47497 was available from 
2004. 
[a] [b] [c] [d] [1] 
 KEY POINTS 
  
 Δ9-THC      CP-47497 
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CP-47497 is a non-classical cannabinoid belonging to the family of 
cyclohexylphenols and synthesised by removing the oxygen containing the 
pyran ring in the Δ9-THC molecule and keeping the phenolic hydroxyl group of 
the THC and 9-hydroxyl group of HHC. It is about 3 to 28 times more potent 
than Δ9-THC. [2]      
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: 2-[(1R, 3S)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl) 
phenol 
Molecular weight: 318.49346 g/mol 
Molecular formula: C21H34O2  
CAS Number: 70434-82-1 and 70434-92-3 (C8 homologue) 
[3] [4] [5]  
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description 
This product is a Home Office controlled substance and is not available for purchase 
online in your territory. Please contact us to place your order. Orders for Home Office 
controlled substances will incur a £28 / €33 administrative fee to cover licence 
expenses. [6]  
Cayman Chem Cambridge Bioscience Ltd. 
See a distributor in your region for pricing  
United Kingdom 
Voice: 01223 316 xxx 
Fax: +44 (0)1954 781 xxx 
sales@bioscience.co.ukxxx [7]  
Groups Gmail advertisement 
Research_Work At Safe-mail dot Netravent 
Please read everything before placing an order! [8] 
 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 In couple of (rare) website the price was given as follows: 
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 UK: 10 mg for £79 (in stock) and 50 mg for £329 (in stock)  
 USA: 100mg for $55 and 500mg for $110 
 Some other websites display catalogue of compounds available, but buyers need 
 to contact them about the price information. Yet few more websites just 
 advertise and request the buyer to leave a comment. So the buyers leave their 
 email address and through this possibly the vendors contact them for the price 
 and delivery information. [8] [9]  
 MODALITIES OF INTAKE  
 CP-47497 as one of the ingredient of various ‘herbal incense’ can be smoked as 
 a joint or in a water pipe, according to a survey carried out in Germany. Another 
 popular method is inhalation of the vapour which has the quickest mode of 
 action. [10] [e] 
 LEGAL STATUS 
 ‘Spice’ (which contains a mixture of cannabinoid substances including JWH-
 018, JWH-073, CP-47497, HU-210 etc.) was classified under Class B in 2009 in 
 the UK.   
 It is claimed to be uncontrolled in Canada. CP-47497 was scheduled as Class 1 
 drug in the USA as on 1
st
 March 2012.  
 Although CP-47497 is not explicitly listed, ‘Spice-type’ of products are 
 controlled in many countries such as Austria, Argentina, Belarus, Brazil, 
 Channel islands, Chile, Estonia, France, Netherlands, New Zealand, Germany, 
 Italy, Ireland, Latvia, Luxembourg, Romania, Poland, Russia, Sweden, South 
 Korea etc. [11] [12] [13] [14] [f]  
 CURRENT USE / MEDICINAL USE  
The intention of Huffman and his team was to explore the properties of these 
synthetic cannabinoid compounds and the cannabinoid brain and peripheral 
receptors. They have been studied for its treatment in nausea, glaucoma and as 
appetite suppressant. [15]  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 CP-47497 produces less euphoria than cannabis but the effects lasts longer. 
 Come up: 1/2 to 1 hour Peak: about 4hours Come down: 6-8 hours  
 An experienced cannabis user reported to have used between 10mgs to 25mgs. 
 However caution was given for a new user and the usual starting dose was 5mgs.  
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 [16] [17] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 It is one of the main ingredients of spice products.  
 It is not very popular for combined use.  
 PHARMACOLOGICAL CHARACTERISTICS 
 CP-47497 has a Ki value of 2.1nM for CB1 receptors. This shows strong 
 agonistic action at CB1 receptors (the lower the Ki value, the greater the 
 affinity).    
 [f] [g] [h]  
 TOXICOLOGICAL EFFECTS 
 A user claimed to have received an email from Professor John W. Huffman. In 
 that email Professor JWH affirmed that there are no data on the long term effects 
 of this compound on animals (apart from anecdotal data from Der Spiegel) and 
 certainly there are absolutely no data regarding its effects in humans.   
 [18] [19]  
 DESIRED PSYCHOACTIVE EFFECTS 
 It is weaker than JWH-018, but produces similar effects and the effects last 
 longer (4-6 hours). 
 [20] [21] 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 CP-47497 is a research chemical and is not intended to human consumption, as 
 there are not enough data to support safe use in people.  
 Headaches  
 Tachycardia 
 Normal pupil size, but lateral gaze nystagmus 
 Tremor  
 High blood pressure 
 Dizziness 
 Vomiting  
 Increased muscle tone  
 Dysphoria 
 Dry mouth 
 Itchy skin 
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 Photophobia 
 It causes or aggravates pre-existing lung condition 
[22] [23] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Marijuana like side effects including the following: 
 Intense paranoia and recurring psychotic episodes requiring admission to 
emergency departments 
 Less anxiety and fear than JWH-018    
 Auditory hallucinations 
 Visual hallucinations 
 Distortion of time  
 Visual distortions (colour/ objects) 
 Numbness of whole body  
 Insomnia  
 Heavy body load 
[24] [25] [26]  
 CLINICAL ADVICE 
 The presence of CP-47497 is difficult to establish from specimen of urine or 
 saliva. It is not detected routinely by conventional urine drug testing. It is also 
 not detected by Red Wood Toxicology or NMS labs.  
 [27] [28]  
 RELATED FATALITIES  
Sixteen-year-old Chase Burnett drowned after smoking the synthetic marijuana, 
spice. THCPharm which is one of the companies in Germany producing spice 
included two compounds JWH-018 and CP 47,497 as the main ingredient in 
spice. [29]  
 YOU TUBE VIDEOS 
 There were no You Tube videos specific to CP-47497. However there are 
 numerous videos on spice and related products.  
 GOOGLE INSIGHTS 
 There was not enough volume to show graphs on CP-47497.  
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 UR-144    
 OVERVIEW 
 Chemical name: (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) 
 methanone 
Synonyms: UR144, KM-X1, CHEMBL571773, CHEBI:679643, S10-0058,  
Active constituents: (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) 
methanone  
Type: Research chemical - synthetic cannabinoid compound  
Origin: It was supposed to be first synthesised at Abbott laboratories in the USA 
while carrying out research on neurological diseases.   
Status: Novel 
Chronology: It has become a popular compound recently and available online 
for sale from the ‘Smart shops’ since 2011.    
[a] [1]  
 KEY POINTS 
UR-144 is a synthetic cannabinoid having stronger agonistic action on CB2 
receptors than CB1 receptors. It has gained popularity recently, as ‘Spice’ herbal 
blends were made controlled in many countries.      
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name: (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone 
Molecular weight: 311.46106 g/mol      
Molecular formula: C21H29NO 
CAS Number: 1199943-44-6 
[1] [2]  
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 APPEARANCE OF COMMERCIAL PRODUCTS 
Product description  
Buy Research Chemicals UK 
500mg UR-144 for £12.00 
Availability: Out of stock 
500mg of high purity UR-144 - a UK legal, synthetic cannabinoid that is perfect for novel 
laboratory research. [3] 
Buy Any Chem 
The research chemical UR-144, also known as KM X-1 and has the IUPAC name (1-
pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone can now be ordered 
here at Buyanychem one of UK & Europe’s most trusted and leading research chemical 
suppliers.[4] 
VIP Legals 
UR-144 is a new synthetic cannabinoid ideal for laboratory research in the UK. 
Our UR-144 is a very slightly off white crystalline powder with a purity of over 99%. 
Buy UR-144 today to ensure you get the highest quality chemicals at the most competitive 
prices. 
UR-144 is strictly not for human consumption.[5] 
  
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 UR-144 is available for purchase online from several websites. The price from 
 most of these websites remains the same as follows: 500mgs for £12; 1g for 
 £20; 2g for £35; 5g for £70; 10g for £125; 25g for £250; 100g for £750; 500g 
 for £2,750; 1Kg for £4,950. [3] [4] [5]  
 MODALITIES OF INTAKE  
 UR-144 can be smoked either alone or in combination (with JWH or AM series 
 of compounds as herbal incense). The inhalation of vapours from UR-144 is also 
 a common method of use. 
 Oral consumption is rare as it is not active when taken orally. 
[6] [7] [8] [9]  
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 LEGAL STATUS 
It is a legal compound in the UK. It is not a controlled substance in the USA, 
through it could be covered by the Federal Analog Act. It has been temporarily 
controlled in New Zealand from 6
th
 April 2012.  
 [10] [11] [12]  
 CURRENT USE / MEDICINAL USE  
 UR-144 is a research chemical and is not intended for human consumption. It 
 has been primarily been synthesised for potential use in neurological and pain 
 disorders. [a]  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 The popularity of UR-144 is mainly due to its availability as a legal replacement 
 after the ban on ‘Spice’ type of herbal incense containing JWH and HU series of 
 compounds in the UK and the USA.  
 UR-144 is described as a ‘dirty white’ grainy powder which is odourless and 
 tasteless. It is not water soluable and is dissolved in 100% acetone. The usual 
 starting dose is between 0.5 to 1mg. It has shorter duration of action compared 
 with JWH or AM series of compounds.  
 Users report that UR-144 and its related compound, 5F-UR-144 exhibit similar 
 effects.  
 Come up: 1-2 minutes Peak: few minutes Come down: 1-3 hours  
 A typical users’ experience is described below:  
 T 0.00: Smoked 8mg of UR-144  
 T 0. 01: Euphoria, appreciation of colour, palpitation 
 T 0.05: Euphoria 
 T 0.20: Blurred vision. 
 T 0.25: Taste appreciation. 
 T 1.50: The effects start to fade.  
 T 2.00: returned to baseline.  
 [13] [14] [15] [16] [17] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
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 With Mary Joy herbal incense (in 70:30 ratio) 
 With 5F-UR-144 
[18] 
 PHARMACOLOGICAL CHARACTERISTICS 
 The major actions of cannabinoids are mediated through two types of receptors: 
 cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2). The CB1 
 receptor mediated analgesic effects are well documented, but their therapeutic 
 use is limited by their motor, cognitive and psychotropic side effects. UR-144 
 has been investigated for its potential use as an analgesic in the field of 
 medicine. UR-144 contains potent agonistic effect on CB2 receptors. A study 
 investigated the receptor affinities of UR-144. The Ki value for CB2 receptor is 
 1.8nM where as the Ki value for CB1 receptor is 150nM. Thus it exhibits a 
 potent agonistic effect on CB2 receptors and its affinity for CB2 receptors is 
 about 80 times more than for CB1 receptors.  
 The online users contest the old hypothesis that CB2 receptors are located 
 mainly on peripheral sites and argue that CB2 exert its effects on the central 
 nervous system as well which are currently being investigated by the research 
 scientists.  
 [19] [b] [c] [d]  
 TOXICOLOGICAL EFFECTS 
 A case of generalised seizure was reported by the online user (with 5F-UR-144). 
 The long term toxicity of this compound is not available. 
[20] [21]  
 DESIRED PSYCHOACTIVE EFFECTS 
 Euphoria 
 Music appreciation 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 Seizure (wit 5F-UR-144) 
[20] [21]  
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Paranoia 
283 
 
 Anxiety  
[22] [23]  
 CLINICAL ADVICE 
 None. 
 RELATED FATALITIES  
 None reported.  
 YOU TUBE VIDEOS 
1. How to make herbal potpourri incense with brand new (UR-144)  
2. Herbal Incense UR-144 (for sale)  
3. New for 2013 Ur-144 wax honey oil  
4. Buy ur-144 
5. UR-144 (for sale) 
[24] [25] [26] [27] [28]  
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across  specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time 
 (GMT) for UR-144, plotted on a scale from 0 to 100; the totals are indicated 
 next to bars by the search term, a break down of how the categories are 
 classified, lists of the top searches and top rising searches, a world heat map 
 graphically displaying the search volume index with defined regions, cities and 
 towns.   
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 3-MeO-PCP   
 OVERVIEW 
 Chemical name: 3-Methoxy Phencyclidine  
Synonyms: 3-MeO-PCP 
Active constituents: 3-Methoxy Phencyclidine  
Type: Research chemical – Psychostimulant (Dissociative) 
Origin: Although popularly thought to be synthesised by Shulgin, it was not the 
case.  
Status: Novel 
Chronology: Phencyclidine was synthesised in 1926 and patented in 1952 by 
Parke-Davies pharmaceutical company, but the synthesis of its analogue, 3-
MeO-PCP remains unknown. [1]  
 KEY POINTS 
3-Methoxyphencyclidine (3-MeO-PCP) belongs to a heterogenous group of 
compounds known as ‘Dissociatives’. They act as antagonist at the NMDA (N-
Methyl D- Aspartate) receptor of the excitatory neurotransmitter, glutamic acid 
in the brain. They belong to ‘Arylcyclohexylamines’ – the best known examples 
in this class are Phencyclidine, Ketamine and Nitrous oxide. Historically they 
were used and some are still used as anaesthetic agents. 
 
These compounds have been used for ‘recreational’ purposes when used in sub 
anaesthetic concentration. At this dose they induce a psychotomimetic state 
resembling some of the symptoms of Schizophrenia. Typically, dissociatives 
produce more of impaired reality testing but less of visual hallucinations which 
make them a separate class from the Hallucinogens.  
 
Phencyclidine (PCP) was used as intravenous anaesthetic agent but due to its 
various complications (prolonged delirium) it was abandoned as an anaesthetic. 
The symptoms produced by PCP resemble both the positive (delusions and 
hallucinations) and the negative (apathy, flat affect etc) symptoms of the 
schizophrenia, so it could work as a good pharmacological model for 
schizophrenia.  
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3-MeO-PCP, a derivative of PCP, is less potent (by weight) than PCP. It is more 
potent as an NMDA antagonist but presents with the same potency as a 
dopamine reuptake inhibitor. [a] [b] [2]  
 CHEMICAL CHARACTERISTICS OF ACTIVE 
 CONSTITUENTS 
IUPAC name:  1-[1-(3-methoxyphenyl) cyclohexyl]-piperidine 
Molecular weight:  273.412 g/mol  
Molecular formula:  C18H27NO 
CAS Number:  72242-03-6 and 91164-58-8 (hydrochloride)  
[3] [4] [5]  
 
 APPEARANCE OF COMMERCIAL PRODUCTS 
Product Description 
Joyschem 
3-meo-pcp: This chemical is meant for research purposes only; with placing an order you 
declare that you are using these products for research purposes only. 
Please send your message to us. [6]  
Promos-Chem 
3-Methoxyphencyclidine 
CAS: 91164-58-8 
This product can be delivered only via courier service. 
This product is NOT for human consumption! 
Can be used for laboratory purposes only![7] 
Benzo-Fury 
3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative anaesthetic drug with hallucinogenic 
and sedative effects. It is around the same potency as phencyclidine, but has slightly different 
effects due to its altered binding profile at various targets, particularly being somewhat more 
potent as an NMDA antagonist while having around the same potency as a dopamine reuptake 
inhibitor.[8] 
 AVAILABLE INFORMATION ON PURCHASE PRICE  
 The price varies considerably depending on the websites and the location. 
 Promos website sells 2grams for €140 and 5gram for €300; benzofury website 
 sells 1gram for £225 and 500mgs for £117 (which includes a 10% off from 
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 £130). Some websites do not offer a price, but information can be obtained by 
 contacting them through email. [9] [10] 
 MODALITIES OF INTAKE  
 Oral ingestion. 
 Intravenous route, experimented by many reported that 6mgs of 3-MeO-PCP 
(IV) is roughly equivalent to 20 to 30mgs of Ketamine (IM).  
 [11] [12] [13]  
 LEGAL STATUS 
It is legal to sell and possess 3-Meo-PCP in the United Kingdom and rest of the 
Europe. [14] 
 CURRENT USE / MEDICINAL USE  
 None.  
 INFORMATION ON RECREATIONAL USE/ MISUSE IN 
 THE E.U. (OR ELSEWHERE)  
 Users describe a dose of 6mgs to 10mgs to get good effect. As with the 
 characteristics of ‘dissociatives’, this compound produces introspection, self 
 reflection, empathy etc.  
 Come up: 30minutes          Peak: 1- 2 hours  Come down: 3 hours 
 A rough equivalence is given as:  
 ~15mg of 3-MeO-PCP = ~100mg of 4-MeO-PCP = ~50mg of Methoxetamine  
 Users suggest keeping the dose below 15 mgs to avoid psychopathological 
 disturbances (psychotic episode).  
 [15] [16] 
 USE IN COMBINATION WITH OTHER COMPOUNDS 
 With LSD and Methoxetamine – loss of emotions and disorientation in 
time. 
 With LSD and Ketamine: It increases the strength of Ketamine and this 
combination could be very dangerous.  
 With Ketamine alone.  
 [17] [18] 
291 
 
 PHARMACOLOGICAL CHARACTERISTICS 
 No information available.  
 TOXICOLOGICAL EFFECTS 
 Hypertension in acute phase: It was noted (169/111mmHg) for a user who 
tried at 17.5mgs 
 Another user was found to have high blood pressure (230/150mmHg)  
[19] [20] 
 DESIRED PSYCHOACTIVE EFFECTS 
 Introspection  
 Self reflection 
 Empathy 
 PHYSICAL/ MEDICAL UNTOWARD EFFECTS  
 High blood pressure 
 [19] [20] 
 PSYCHOPATHOLOGICAL DISTURBANCES 
 ASSOCIATED WITH ITS USE   
 Acute psychotic episode: At a higher dose (50mgs IM) it causes signs and 
symptoms similar to Schizophrenia. The user presented with florid psychotic 
symptoms and physically his blood pressure was very high during the acute 
phase (230/150mmHg). He was then admitted to a psychiatric ward under 
relevant section for 4 weeks.  
 Few more patients presented with acute psychotic episode requiring 
admission in a psychiatric inpatient unit.  
 [20] 
 CLINICAL ADVICE 
 These are extremely dangerous compounds whose sub therapeutic doses are 
 used by the drug misuse community as a ‘dissociative’, but when the high doses 
 are administered, it can lead to serious physical complications (seizures, coma 
 and death). The overdoses can be treated along the lines of treating a PCP 
 overdose. Benzodiazepines are the good drug of choice in such cases.   [c]  
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 RELATED FATALITIES  
 None.  
 YOU TUBE VIDEOS 
 None. 
 GOOGLE INSIGHTS 
 Google Insight for Search shows search volume patterns for specific key words 
 across specific regions and time frames since 2004. The screenshot below 
 includes a graph with the search volume, indicating interest over time (GMT) for 
 3-MeO-PCP, plotted on a scale from 0 to 100; the totals are indicated next to 
 bars by the search term, a break down of how the categories are classified, lists 
 of the top searches and top rising searches, a world heat map graphically 
 displaying the search volume index with defined regions, cities and towns.   
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 Review paper and case report  
 
Proof of submission (Appendix D) 
Title: Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone 
hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (Benzofury/ 6-APB) 
and NRG-2 with review of available evidence based literature 
J Jebadurai, Schifano F, Deluca P 
Human Psychopharmacology: Clinical & Experimental; article in press 
March 2013    
Alcohol and recreational substances has been an inseparable part of human 
society for centuries across the globe. The widespread availability of evidence 
based literature for such commonly used substances such as cannabis, opioids, 
cocaine etc. provides information on their toxicities and guides in their 
management. However, a collection of novel psychoactive substances (NPS) 
produced by clandestine laboratories have appeared on the market (Henderson, 
1988). In the mid-1980s’, enormous quantities of ecstasy or MDMA, were sold 
in the USA (Collin and Godfrey, 1997). Even though MDMA was permanently 
banned in 1988, there was a great demand for chemicals that were similar to 
ecstasy, but were not legally banned. Alexander Shulgin published his books, 
PiHKAL (Shulgin and Shulgin, 1991) and TiHKAL (Shulgin and Shulgin, 1997) 
in the 1990s which described about 230 compounds (phenethylamines and 
tryptamines) synthesised in his laboratory. Since then, such newer psychoactive 
substances have gained enormous popularity and have appeared in the drug 
market over the last few years (e.g., 2C-T7; 2C-I; DOB etc). 
 
These substances could be analogues of the controlled substances but are not 
usually controlled in many countries. They generate biological responses not 
only similar to but are also enhanced as compared to the parental compounds 
(Cooper, 1988). It is intriguing to understand how the molecules are modified to 
form a new molecule which may become a legal substance with altered function. 
Phenethylamine, a derivative of the amino acid phenylalanine, forms the basic 
skeletal structure from which hundreds of compounds could be derived by 
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simple alteration of the molecules. N-α-methyl substitution in the terminal amine 
group of phenethylamine results in the formation of amphetamine (α-
methylphenethylamine). The stimulant property of amphetamine requires the 
presence of unmodified aromatic ring, α-carbon with methyl group (-CH3) and 
the terminal amino group (-NH2)
 
and results in the release of catecholamines, 
mainly dopamine (Nichols, 1994).  
       
 Phenylalanine   Phenethylamine   Amphetamine 
The ‘novel’ substitution could occur in a number of possible ways either in 
phenethylamine or amphetamine leading to altered or enhanced psychoactive 
properties (Cooper, 1988; Nichols, 1994; Hill and Thomas, 2011). For example, 
substitution of the aromatic ring of phenethylamine leads to 2C- series of 
compounds (2C-B, 2C-I etc) where as substitution of the aromatic ring of 
amphetamine leads to the formation of D- series of compounds (DOB, DOC, 
DOI etc). This D-series compounds, also known as ‘hallucinogenic 
amphetamines’, act via 5HT2A agonism (5-hydroxytryptamine) (Nichols, 1994; 
Acuna-Castillo et al., 2002) and possess several folds of hallucinogenic 
properties compared to the ‘parent’ amphetamine molecule.       
Amphetamine    Mephedrone (Cathinone)  
A naturally occurring shrub, Khat contains an alkaloid, cathinone which 
possesses amphetamine-like simulant properties (Brenneisen et al, 1990). 
Cathinone can be synthesised by the addition of ketone group to the β-carbon of 
amphetamine molecule. Further alteration would result in a number of 
compounds such as mephedrone (4-methylmethcathinone), flephedrone (4-
fluoromethcathinone) etc. The presence of β-ketone group increases the polarity 
of the molecule and there by reduces entry into CNS (Hill and Thomas, 2011; 
Gibbons and Zloh, 2010). Hence re-dosing or use of high doses are common to 
gain entry into central nervous system for ‘psychedelic effects’, but with toxic 
peripheral effects and higher mortality (Hill and Thomas, 2011). Thus a 
countless novel psychoactive compounds have been emerging which are 
available for sale through the online market.  
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This study forms a part of the Recreational Drugs European Network (ReDNet 
project, 2012), a multi-site research project which uses the existing Psychonaut 
[Early Warning System] project database together with information from 
available literature and online searches to develop accurate information on new 
recreational drugs and to inform harm reduction strategies in research. This 
project has identified several hundreds of psychoactive compounds and aims to 
disseminate the information to professionals and young people about such novel 
psychoactive compounds.  
In this paper, the symptomatology displayed by a user who experimented with 
mephedrone, NRG-1, NRG-2, NRG-4, Benzofury etc. is discussed with the 
review of available evidence based literature as well as information obtained 
from web forums.  
Method 
The methodology was adopted from the literature (Deluca and Schifano, 2007). 
Internet searches were carried out using Google and Yahoo using key words: 
“Phenethylamine misuse forum” “Piperazines misuse forum” “Tryptamines 
misuse forum” and “Synthetic herbs/ plants forum”. For each set of key words, 
the first 100 websites identified by Google and Yahoo were fully assessed, 
together with a further 5% of random samples selected by the website (Research 
randomizer, 2012) of the remaining websites. Thus a list of unique websites/ 
web forums was identified.  Qualitative information was extracted from various 
web forums discussing about naphyrone (NRG-1), benzofury (6-APB/ 6-APDB) 
and NRG-2.  
1.1 Naphyrone (NRG-1) 
Naphyrone (IUPAC name: (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-
one) is the pyrrolidine derivative of cathinones and it structurally resembles 
compounds such as pyrovalerone and mephedrone. Thus, a minor structural 
alteration produces significant changes in the neurobiological response and 
behavioural effects.  
1.2 Availability of NRG-1 
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The identity of products sold as NRG-1 remains dubious. Following the ban of 
mephedrone in April 2010, a replacement product (known as NRG-1) was sold 
online. However, only few products sold as NRG-1 contained naphyrone as 
advertised and many others contained cathinone derivatives such as mephedrone 
(4-methylmethcathinone), butylone, 4-methyl-N-ethylcathinone (4-MEC), 
flephedrone and MDPV (3,4-methylenedioxypyrovalerone) (Brandt et al., 2010; 
Wood et al., 2011). Furthermore, there have been two structural isomers (alpha 
and beta-naphthyl isomers) sold online and it is usually the beta-naphthyl isomer 
which is well known and published but descriptions on the alpha-naphthyl 
isomer is very limited (Brandt et al., 2010).  
1.3 Legal status of NRG-1  
In the UK, several cathinones such as mephedrone and MDPV were placed as 
Class B under the Misuse of Drugs Act 1971 on 16
th
 April 2010 (Home Office, 
2010). However, Naphyrone was not included under this ban. Hence a number 
of websites reported the sale of Naphyrone as a mephedrone replacement. 
Subsequently, on 12
th
 July 2010, Naphyrone was made a class B drug in the UK. 
In the USA, The Drug Enforcement Administration requested for medicinal 
information on naphyrone on April 2011 but had not been controlled until early 
2012 (U.S. Department of Justice, 2011). It is also not a controlled substance in 
other EU countries (Drugs forum
1
, 2012).  
1.4 Route of administration of NRG-1 
Nasal insufflation appears to be the common mode of intake. It can also be 
ingested orally. Users report that NRG-1 was inactive when smoked (Bluelight
1
, 
2012). Rarely it was taken intra venously which produced the same effects as 
nasal insufflation.  
1.5 Pharmacology of NRG-1  
The synthesis of naphyrone and other pyrovalerone analogues were illustrated in 
a study (Meltzer et al., 2006) which compared the ability of these compounds to 
affect the reuptake of the monoamine neurotransmitters such as serotonin, 
dopamine and norepinephrine by interacting with the serotonin transporter 
(SERT), dopamine transporter (DAT), and norepinephrine transporter (NET). 
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This study concluded that naphyrone was the only compound which had the 
ability to inhibit the reuptake of all the three neurotransmitters (‘triple reuptake 
inhibitor’) at very low concentrations.  
A similar study showed (Simmler et al., 2012) that naphyrone acts as a non-
selective monoamine reuptake inhibitor similar to cocaine. It was also found that 
the permeability of the blood-brain was high in an in vitro model.   
Recently, it has been shown that naphyrone is one of the most potent inhibitors 
of DAT with a Ki value of 53nM. This study quantitatively measured the Ki 
value of NET and SERT at 200nM and 235nM respectively (Iversen et al, 2013). 
Moreover, the micromolar affinities for 5-HT2B could explain the risk of cardio 
toxicity with long term use of naphyrone (Setola et al, 2003; Roth, 2007; 
Droogmans et al, 2007; Iversen et al, 2013). 
1.6 Effects of NRG-1  
The web forum members buy NRG-1 online and personally experience its 
euphoric effects. The dose, any combinations, mode of intake, its effects and 
toxicity are discussed in the web forums. It takes several minutes to come up 
with a peak about 3 to 4 hours and come down to base line in about 7 to 10 
hours or even longer. NRG-1 is reported to be potent at a very low dose (25mgs) 
which is at least 10 times lower than the usual dose of mephedrone. Hence web 
forum users warn not to consume NRG-1 at the same dose as mephedrone since 
NRG-1 was sold as ‘mephedrone replacement’ following its ban (April 2010). 
Hence the chances of potential overdose and toxicity are high.  
The physical side effects could last more than 24 hours (Drugs-forum
2
, 2012) 
and include sweating, tachycardia (>145/ minute) (on doses above 200mgs), 
hypertension, increased body temperature, cold blue/ purple arms, knees and 
extremities, pins and needle sensation over extremities, loss of appetite and jaw 
stiffness. Paranoia, visual hallucinations (lasting for 48 hours), intense anxiety, 
depression, obsessive symptoms, disorganised thoughts, short term memory 
loss, lack of motivation, low self esteem, poor concentration, insomnia (> 5 
days) were the psychopathological disturbances observed after its use 
(Bluelight
2
, 2012; Bluelight
3
, 2012; Erowid, 2012). A web forum user suffered 
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with depression and anxiety for 6 months following regular use of NRG-1 for a 
year and was treated with anti depressant medication (Bluelight
4
, 2012).   
1.7 Toxicity of NRG-1 
There are no human toxicological data. However, there are several reports 
patients experiencing toxic effects and attending Emergency Departments (News 
release, 2010). This could be due to the effects of NRG-1 at a very low dose 
compared with mephedrone. A patient presented with acute sympathomimetic 
toxicity following ingestion of 100 mgs of NRG-1 (Derungs et al., 2011). He 
displayed restlessness, insomnia, anxiety, and hallucinations lasting for two 
days. A blood sample analysed by Gas Chromatography with Mass 
Spectrometry (GC/MS) showed a concentration of 0.03mg/L and 0.02 mg/L, 40 
h and 60 h after drug intake, respectively.   
Another major concern among online users was the carcinogenicity of 
naphyrone. Since naphyrone has not yet been studied on human or animal 
models, the closest match would be pronethalol which was investigated on 
animal model. The epoxidized naphyrone, which formed due to the oxidation of 
naphthalene ring, was reported to be a carcinogen. Since naphyrone possesses 
similar naphthalene ring, it is speculated that it could trigger carcinogenesis on 
long term (Drugs-forum
3
, 2012; Bluelight
5
, 2012).   
1.8 Fatalities of NRG-1 
There are several reports of toxicity and few death reports linked to the 
consumption of NRG-1(News release, 2010). However there has not been any 
coroner’s report to confirm deaths linked to NRG-1 (ACMD, 2010).    
2.1 Benzofury (6-APB)  
David Nichols with team synthesized 6-APB (IUPAC Name: 6-(2-aminopropyl) 
Benzofuran) in 1993 whilst investigating non-neurotoxic MDMA analogues. 6-
APDB (IUPAC name: 1-(2, 3-dihydro-1-benzofuran-6-yl) propan-2-amine 
hydrochloride) is often confused with 6-APB which is a derivative of 6-APDB 
(Monte et al., 1993). 
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It is an analogue of MDA where the heterocyclic 4-position oxygen from the 3, 
4-methylenedioxy ring has been replaced with a methylene group (Drugs-
forum
4
, 2012).  
2.2 Availability of 6-APB 
It's a tan grainy type of powder which is supposed to be pure. The pellet form 
contains varying doses of 6-APB mixed with caffeine and potentially another 
trivial stimulant (from analysis) or mixed with magnesium stearate as a cutting 
agent. The prices have fallen almost to half (£72 to £32 for 1gram) in 2012.  
2.3 Legal status of 6-APB  
6-APB is currently legal in the UK and rest of Europe except Sweden (Sweden 
Parliament, 1999). It is also uncontrolled in the USA.  
2.4 Route of administration of 6-APB  
Usual mode of use is oral ingestion. Few users have tried nasal route which was 
reported to be a very painful experience (Bluelight
6
, 2012). 
2.5 Pharmacology of 6-APB  
6-APB inhibited norepinephrine transporter (NET) and dopamine transporter 
(DAT) at Ki value of 117nM and 150nM respectively (Iversen et al, 2013). Such 
powerful inhibitions of norepinephrine uptake could account for the 
sympathomimetic effects on the cardiovascular system (Wood et al, 2011).   
It is reported that the activation of 5-HT2B receptors in MDMA users and the 
consequential proliferation of cardiac valvular interstitial cells was linked to 
increased prevalence of valvular heart disease among MDMA users (Setola et al, 
2003; Roth, 2007; Droogmans et al, 2007). 6-APB exhibited strong (<100nM) 
affinities and full agonistic function for 5-HT2B receptors. Therefore it is 
reasonable to expect cardio toxicity with long term use of such compounds 
(Iversen et al, 2013).  
2.6 Effects of 6-APB  
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The side-effects are similar to that of MDA but much more prominent than that 
of ecstasy or MDA. They occur as a result of sympathetic stimulation. These 
include: tachycardia, agitation, high blood pressure (could lead to hypertensive 
crisis characterised by high temperature, severe sweating, severe headaches not 
responding to analgesics and persistent (resting) tachycardia). Many users warn 
about neurotoxicity and brain damage. Severe nausea and sickness occur 
commonly possibly due to serotonin release. The psychopathological 
disturbance (Bluelight
7
, 2012; Bluelight
8
, 2012; Bluelight
9
, 2012; Bluelight
10
, 
2012) included depression, anxiety, panic attacks, insomnia, severe paranoid 
symptoms (lasting longer than that due to mephedrone). Forum users reported 
(Bluelight
10
, 2012; Bluelight
11
, 2012) other side effects such as jaw and teeth 
clenching, deep midline tongue ulcer, ulcers in the buccal mucosa possibly due 
to bitting and clenching teeth, dry mouth, extreme dry eyes, insomnia, loin pain, 
prolonged diarrhoea, sensitivity to light, drowsiness, hang over the next few 
days, clonus of hand and feet.    
2.7 Toxicity of 6-APB  
There is no sound evidence but web forum users’ debate that it could potentially 
cause neurotoxicity similar to ecstasy.  
Forum users warn about the possibility of serotonin syndrome (Bluelight
12
, 
2012; Bluelight
13
, 2012) especially if combined with other serotonergic 
compounds and the outcome can be poor. The compounds include psychoactive 
compounds such as MDAT, MDAI, 5-IAI etc as well as medications such as 
MAOIs, SSRIs etc.  
The cardiovascular toxicities possibly result from sympathetic stimulation and 
possible activation of 5-HT2B receptors which include tachycardia, supra 
ventricular tachycardia, high blood pressure, effect on liver (due to the presence 
of furans), Jaw or whole head shaking, sometimes involve the whole body 
(Bluelight
12
, 2012; Bluelight
13
, 2012; Bluelight
14
, 2012; Iversen, 2013).  
2.8 Fatalities of 6-APB 
The news (Sky news, 2012) reported that A H, 19, from Edinburgh, collapsed 
and died at the RockNess Festival after taking benzofury in June 2012. Two 
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other members in his group were treated in hospital. The results of the post-
mortem for confirmation of the substance are not yet available.  
3.1 NRG-2 
NRG-2 is also known as Energy2, Eric-2, E-2 etc. It appears to be a mystery 
product among web forum users. The majority of vendors advertised the product 
as (2α, 5α)-epithio-11α-benzyl-12β-one and add that it was not related to 
naphyrone (NRG-1) but ‘an upgrade from the original’. Web forum users 
acknowledge the uncertainty of the product NRG-2. Some forum users believed 
that 5-IAI is a synonym for NRG-2 while many others did not. It was also 
confirmed from a chemical analysis (Ayres and Bond, 2012) of online products 
that 5-IAI contained 5-iodo-2-aminoindane which was consistent with the 
vendors description of 5-IAI. Other websites use a different name for NRG-2 
which is (2α,3α)-epithio-17α-methyl-17β-ol-N-Benzyloxycarbonyl-d-proline 
(Legal iii’s, 2012; Bluelight15, 2012) which appears to be a counterfeit name to 
evade the laws.  
There were only few studies available which investigated the novel psychoactive 
substances sold online using standardised procedures such as gas 
chromatography mass spectrometry. Immediately following the ban on 
mephedrone (a cathinone) in April 2010, 24 products (NPS) were purchased 
online about 6 weeks (Brandt et al., 2010). The results showed four samples 
contained 4-methyl-N-ethylcathinone (4-MEC) out of the seven NRG-2 
products. Two others showed the presence of mephedrone and the last sample 
contained only benzocaine and caffeine. Only one sample confirmed the 
presence of naphyrone out of 13 NRG-1 products. Rest of them showed various 
cathinones including mephedrone. The author suggested that the manufacturers 
continued to sell mephedrone mislabelling them as NRG-1 or NRG-2 to clear 
the stock after immediate ban on cathinones. Interestingly, another product sold 
as DMC (dimethocaine) contained only lidocaine and caffeine (Brandt et al., 
2010). It is also worthy to note that caffeine augments the hyperthermic response 
to substances such as MDMA that possess seronergic and norepinephric 
activities. Most of the novel psychoactive substances are thought to act via 
serotonergic and catecholaminergic pathways. It is reported that the presence of 
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caffeine also increases the toxicity of psychostimulants which include changes 
in body temperature regulation, cardiotoxicity and lowering of the seizure 
threshold. Caffeine also influences the stimulatory, discriminative and 
reinforcing effects of psychostimulant substances. (Vanattou-Saïfoudine et al 
2010; Vanattou-Saïfoudine et al 2012)  
During the latter months of 2012, seven samples were analysed by Fourier 
Transform Infrared (FTIR) and gas chromatography-mass spectrometry (GC-
MS) but six of them did not contain the specified product but enormous amounts 
of caffeine (Baron et al., 2011). Another study analysed samples sold as “NRG-
2” using fully validated chromatographic methods and identified two 
mephedrone derivatives, 4-methyl-N-ethylcathinone (4-MEC) and 4-methyl-N-
benzylcathinone (4-MBC) (Khreit et al., 2012). Another recent study (Ayres and 
Bond, 2012) also showed two products from different websites, sold as “NRG-
2”, contained mephedrone and 4-MEC despite the ban of cathinone derivatives 
in 2010.   
Thus, with the available evidence based literature, we conclude that most 
products do not contain the ingredients as advertised. In addition, these products 
contain substances that are already controlled in the UK (e.g, NRG-2 products 
containing mephedrone) and hence it could lead to criminal investigations.   
Case report 
A 49 year old man worked in public sector for about 27years. He had no past 
psychiatric or positive family history of substance misuse or mental disorders. 
He purchased mephedrone (IUPAC name: 2-methylamino-1-p-tolylpropan-1-
one) in 2009 by ordering from a specific vendor website (Plant feed chemicals, 
2010). He described the most typical appearance of the product as having an off-
white appearance and granular consistency. For several months, he snorted 
about 1-2 grams of mephedrone once every week. Although he was experiencing 
euphoria, he developed paranoid delusions accompanied by visual hallucinations 
on doses above 750 mgs per day. Most of these symptoms typically disappeared 
within 24 hours with exception of the paranoia which persisted for several 
weeks.  
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He continued to use mephedrone until it was controlled in the UK (April 2010). 
Within a few days after its ban, he allegedly received an e-mail from the same 
online vendor, and was offered with a ‘legal replacement of mephedrone’, 
popularly known as ‘Energy’ or ‘NRG-1’ (1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-
pentanone hydrochloride; naphthylpyrovalerone hydrochloride). He described 
the consistency and appearance of NRG-1 similar to that of mephedrone. He 
purchased and snorted two grams of NRG-1 and immediately following this, he 
developed paranoid delusions and hence he called the police for his own safety. 
He was then brought to the A&E department, where he presented with 
tachycardia and paranoia. The levels of CPK were very high (1,195.0 U/litre; 
normal values: 0- 170U/litre), whilst CRP values were mildly elevated (12.0 
mg/litre; normal values: 0-5mg/litre). All other blood tests were within normal 
limits. The ECG confirmed presence of tachycardia and sinus rhythm. As for the 
routine urine drug test, it was negative for all substances such as cocaine, heroin, 
and cannabinoids. He was assessed to have developed paranoid delusions and 
hallucinations, possibly secondary to the intake of NRG-1. He was prescribed 
few doses of diazepam and discharged. However, he reported having insomnia 
and both auditory and visual hallucinations which lasted for at least a week after 
his discharge.  
A few months later (July 2010), however, NRG-1 was made a controlled drug in 
the UK. The same vendors (Plant feed chemicals, 2010) started advertising the 
availability for sale of a larger range of novel legal highs. He randomly placed 
an order for £95, which allegedly contained the following: 1g of NRG-2 
(IUPAC name: (2α, 5α)-epithio-11α-benzyl-12β-one) (price £17); 2g of 
dimethocaine (DMC; IUPAC: 3-diethylamino-2,2-dimethylpropyl)-4-
aminobenzoate)  (price £28); 5g of NRG-4 (supposed IUPAC (Bluelight
16
, 
2012): 2-(3-(4-Methoxybenzyl)-4-bromophenyl)-6-hydroxymethyl tetrahydro-
2H-pyran-3,4,5-triol) (price £50); 1g of Benzo fury (6-APB) (IUPAC: 6-(2-
aminopropyl) benzofuran) which was provided free of cost. 
He reported that all these products appeared very similar to each other, so that he 
was unable to differentiate among them. He consumed them one after the other 
with few hours in between them. He experienced some euphoria, lasting for few 
hours. He eventually reported lethargy, loss of appetite and sleep. About 3-4 
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days later, he started feeling intensely paranoid whilst experiencing strong 
auditory and visual hallucinations very similar to those previously experienced. 
He presented to the A&E department showing profuse sweating and tachycardia. 
He was assessed by the psychiatric team and discharged with the prescription of 
diazepam for a few days. All his symptoms disappeared within a week.  
This case report provides an application of the findings so far in a wider context. 
It highlights a range of clinical issues relating to legal highs and may suggest 
that at least some of the legal highs possess both stimulant and psychotomimetic 
properties, hence raising a number of legal as well as public health concerns. 
Vulnerable individuals and young people may buy these drugs online easily. 
Furthermore, it seems from this report that whenever an index legal high is 
being made a controlled drug, the vendors immediately start aggressively 
promoting the sale of other, ‘legal’  psychoactive substances (i.e.: NRG-1; 
NRG-2; NRG-4 and 6-APB).     
The acute and long-term clinical effects of these novel psychoactive substances 
on the human body may be largely unknown. A 10-fold higher than normal 
concentrations of CPK, an enzyme typical of cardiac/skeletal muscles and brain 
tissues (Barohn, 2007), was here identified. Any damage or toxicity to these 
tissues would produce an elevation of CPK.  
It is not surprising that the urine drug tests performed turned out to be negative 
for the search of misusing drugs. In fact, the laboratory kits for the identification 
of novel psychoactive substances are still unavailable. Moreover, one could 
wonder about the costs of testing for potentially hundreds (Schifano et al., 2002) 
of psychoactive compounds. As a consequence, it may be essential for clinicians 
to obtain a full clinical and toxicological history when assessing clients 
presenting with psychopathological symptoms (Carrus and Schifano, 2012; 
Schifano et al., 2011b).  
Given the extreme paucity of peer reviewed material relating to both the 
pharmacodynamics and pharmacokinetics of these compounds, one could 
speculate about the best pharmacological treatment for patients presenting with 
levels of clinical and/or behavioural toxicity associated with the intake of 
unknown compounds, which are often taken in combination and as such may 
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present with untoward synergistic effects with classical antipsychotics and 
antidepressants. From this point of view, benzodiazepines were here prescribed 
because they may provide levels of sedation without interacting with the 
arguably already imbalanced dopaminergic, noradrenergic and serotonergic 
neurotransmitter pathways (Schifano et al., 2011a).    
In addition, although the psychoactive products offered for sale allegedly 
contain specific ingredients, it is very difficult to confirm this, unless the product 
is tested in a research laboratory. He had in fact purchased over time a range of 
NRG products (NRG-1; 2; 4) from the same vendor, but concluded that both 
their appearance and taste were indistinguishable from each other. However, 
people purchasing these compounds do not have access to testing facilities and 
rely on the vendor’s descriptions / instructions and discussion forums to learn 
how to use them. On the other hand, it is understandable that those dissident 
scientists who are allegedly synthesizing novel psychoactive molecules would 
not be keen to disclose the chemical structure of these chemicals (Power and 
Parry, 2010). From the recent literature (Brandt et al., 2010; Baron et al., 2011; 
Khreit et al., 2012), we understand that NRG-1 was marketed as a ‘replacement 
product’ immediately after the ban on mephedrone (2010) to circumvent the law, 
although these products contained mephedrone which could suggest that the 
retailers continued to sell the backlog of mephedrone stock in 2010. However, in 
2012, products sold as “NRG-2” still contained cathinone derivatives which are 
controlled in the UK and hence potential legal consequences.  
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Discussion 
  
Huge numbers of NPS are available for sale worldwide. The users’- generally 
seek for substances which maximise their psychedelic or stimulant experience 
but devoid of any potential toxicity. They prefer NPS which are legal, cheap, 
easy to purchase, produce more euphoria with little or no side effects and less 
contamination with adulterants
32
 (Measham et. al, 2010; Carhart-Harris et al, 
2011).    
The clandestine laboratories and vendors meet this demand by synthesising 
newer NPS and distributing them in discreet packing to several countries. The 
characteristics of these substances are largely unknown and are not possibly 
without side effects or serious toxicity.  
The NPS can be easily ordered online from any part of the world. The NPS is 
usually packed dicreetly with words such as 'Plant food' or 'Not for human 
consumption' to evade the law and to be conveniently delivered by post. The 
users needs Internet access and a payment method (Debit/ credit card or Pay pal 
or direct bank transfer) (Legal iii’s website1, Trilogy products LLC, 2013). 
Companies / distributors based in the UK use the Royal Mail for recorded 
delivery of the NPS. A next day special delivery before 9am is also available. 
Interestingly, for International delivery, the options include: Royal Mail Airsure, 
Royal Mail International signed for, Secure Trackable Post as well as DHL or 
FedEx courier service (Jefferyblant36, 2013; Research chemicals London, 
2013). However, the user has no knowledge about the NPS received by post and 
so many users share their knowledge using various web fora.  
The users regularly post their experience on these fora and gradually build up an 
online community which has a strong identity and group cohesion. They have a 
strong sense of shared experience (Davey et al, 2012).    
Although numerous web fora exist, the number of studies on drug related web 
fora is limited (Davey et al, 2012). In this research, about 84 unique web fora 
were identified. Drugs Forum (DF) is an example of such fora. A brief 
description about one of such web fora is given below:  
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The website is hosted by Shock Media B.V., located in Almelo, OV, 
Netherlands. It was established on 14th June 2002. The administrator of drugs 
forum, ALPHA (nick named 'productive insomniac'), described himself as a 97 
year old from Netherlands, has studied psychopharmacology from an University. 
He has contributed 26,999 posts as on 25.04.13.  
He quoted in DF website that he was addicted to a chemistry forum, Hive which 
discussed about the chemistry of new substances, but he missed a community 
feeling. Hence he started DF in 2002. During the early days, there were very few 
members and only couple of posts were posted in one day but he would 
carefully post a reply. He added that respect and knowledge where the key 
words for Drugs-Forum (Drugs-forum
5
, 2013; Drugs-forum
6
, 2013).  
Over the years the number of members have grown steadily in DF. An example 
is given below: There were only 55 members and 280 posts on 12.04.2003 
(Drugs-forum
7
, 2013). It has grown massively in about a decade to having over 
170,000 members with 1,030,000 posts and about 2.7 million readers every 
month (Drugs-forum
7a
, 2013). 
Members belong to several geographical locations (United States of America, 
United Kingdom, Australia, New Zealand, Canada, Finland, Netherlands, 
Norway, Spain, Germany, Bermuda, Afghanistan etc) (Drugs-forum
8
, 2013). 
They have a range of educational backgrounds and occupations such as chef, 
painter, home maker, university students, IT professionals, pharmacist, 
psychologists etc. It is useful to know there are many pharmacists and students 
who use these fora regularly (Drugs-forum
9
, 2013; Drugs-forum
10
, 2013).  
Few example profiles of members are given below:  
Profile  name:~lostgurl~, Female from New Zealand, education at University 
level (geography), total posts = 3,948 (Drugs-forum
11
, 2013). 
Profile name: beentheredonethatagain, Male from West Bank, contractor. 
technician, total posts = 2,553 (Drugs-forum
12
, 2013).  
Profile name (New member): Cid Lysergic, Male from Canada, Pharmacology 
student with A grades specialising in addictions (also diagnosed with drug 
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induced psychosis and multiple drug dependence), total posts = 66 (on 25.04.13) 
(Drugs-forum
13
, 2013). 
Profile name (Banned member): Nagognog2, Male, psychologist with 7,290 
posts (Drugs-forum
14
, 2013). 
Profile name (Platinum member): enquirewithin, male from Bermuda with 5,677 
posts (Drugs-forum
15
, 2013). 
These fora have strict rules and regulations. The user are not allowed to 
incriminate themselves, instead, they should use terms such as ‘AFOAF - A 
Friend Of A Friend’, ‘SWIM – Someone Who Isn’t Me’ or ‘my pet monkey 
tried this powder’ etc. Sale or discussions about vendors of NPS on these fora 
are prohibited. Breaking the rules would earn infraction points and end ban on 
members.  
Users write in detail about their experimentation with various NPS in various 
drug fora. For example, Erowid contains volumes of information on hundreds of 
NPS on topics such as preparation, first time use, adverse reactions, addiction 
potential etc. Greater emphasis is given to the subjective experience of a 
particular NPS. A discussion on any topic can be started by a member of a 
forum (eg, LSD and serotonin syndrome). Other members post their replies and 
this discussion could carry on for even years! (eg, ‘The Low-Dose LSD 
Appreciation Thread’ was started on 20.08.2006 and the last response was 
posted on 29.04.2013). (Erowid
1
, 2013; Bluelight
17
, 2013; Bluelight
18
, 2013).  
Each experience post is generally written up with the following information: 
name of the NPS, amount, mode of intake, body weight of the user, duration of 
action of NPS - serial time line starting from +T 00:00 to the peak and til the end 
of the effect/ hang over (eg, +T 13:00 hours), euphoria, unpleasant experiences, 
post trip notes, side effects, toxicity, any visits to the emergency departments, 
treatment provided etc. It is very common to find abusive and foul language 
used when describing any vicious effects of the NPS (Erowid
2
, 2013).  
Thus wealth of information is available on several web fora. It is a challenging 
task to go through all the information published in these sites. Information 
obtained from various fora provide insight into the way these online virtual 
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communities operate. Given the lack of evidence based literature on several 
NPS, the web fora supply useful, reliable information about unknown or 
unidentified NPS. Some of the fora include members who are well informed, 
trained and educated in pharmacology and related fields. However, the web fora 
are largely unregulated, user-led source of information. Hence there could be 
potentially misleading information for the new and uneducated users (Davey et 
al, 2012).  
The forum users discuss in detail about their experiences on overdoses for each 
substances. The online community warn the users about the safe dose range. 
However, the occurences of accidental overdoses due to the NPS is largely 
unpredictable due to many factors such as combination of NPS, 'mislabelling' of 
NPS, errors in measurement etc. (as the toxic dose of NPS vary hugely from one 
to another - in micrograms for some NPS eg, NBOMe series). It is vital to 
recognize and treat life threatening medical emergencies such as 
sympathomimetic toxicity and serotonin syndrome which could occur as a result 
of ingestion of NPS. The clinical signs, symptoms and its management are 
discussed below.  
Sympathomimetic toxicity:  
The use of a range of NPS (eg, mephedrone, naphyrone, TFMPP, BZP etc.) 
characterized by a stimulant activity can be associated with a sympathomimetic 
toxicity and this has been confirmed by published papers as well as the case 
report discussed above (Derungs et al, 2011; Wood et al, 2010; Wood et al, 
2008). Sympathomimetic toxicity must be recognosed early, because untreated 
patient could result in death. In the USA, following the ingestion of NPS 
(stimulants - methamphetamine type), 169 deaths occurred out of 66,540 cases 
(presenting with sympathomimetic effects) in 2011. These cases were reported 
to the American Association of Poison Control Centers (Bronstein et al, 2011).  
The onset of sympathomimetic symptoms usually occurs within 2 hours after 
ingestion. The signs and symptoms most commonly include: mydriasis, 
tachycardia, diaphoresis (sweating), bruxism (teeth grinding), delirium and even 
psychosis/paranoia. However, users can accidentally overdose on NPS. There 
can be several reasons for accidental overdose such as lack of sophisticated 
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balance especially measuring substances which are active in micrograms (25C-
NBOMe), redosing, presence of adulterants, mislabelling of NPS, combinations 
with other substances etc.  
It is very important to identify patients with toxicity early to prevent end organ 
damage and death. The life threatening complications occur in about 2 to 6 
hours after ingestion in most cases. Some of the toxic symptoms include 
hyperthermia (may be induced due to agitated behaviour, hot and humid dance 
clubs or seizures), extreme hypertension (severe headache, intracerebral 
haemorrhage, hypertensive encephalopathy as well as asymptomatic 
hypertension), cardiac arrhythmias (supraventricular tachycardia - atrial 
fibrillation / atrial flutter, ventricular tachycardia, torsades de pointes, ventricular 
fibrillation), myocardial ischaemia/ infarction, seizures, stroke etc (Kolecki et al, 
2013).  
The main treatment in the Emergency departments is given by a general 
supportive care for these patients, as no specific antidotes for most NPS 
poisoning exist. Most patients present with severe disturbances and hence 
provision of safe environment is the first step in the management. Extreme 
agitation could potentially precipitate hyperthermia, seizure and death. As a 
consequence, frequent use of benzodiazepines (eg, diazepam or lorazepam) in a 
titrated fashion may be the safest option to calm the patient (Kolecki et al, 
2013). Standard cooling measures should be used for hyperthermic patients. 
Hypertension not responding to sedatives should be treated with anti 
hypertensive medication. Seizures should be controlled by the use of IV 
benzodiazepines. CT scan is indicated for patients presenting with severe 
headache and focal neurological deficit to rule out cerebral pathology. Severe 
life threatening complications could occur (hyperthermia, seizure, acute 
respiratory distress syndrome (ARDS), renal failure, rhabdomyolysis, cerebral 
accidents) (Kolecki et al, 2013).   
Thus, benzodiazepines remain the treatment of intital choice for tachycardia, 
agitation, seizure, hypertension and hyperthermia in patients with toxicity of 
NPS (Kolecki et al, 2013).   
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Serotonin syndrome:  
It is well known known that the classical hallucinogens (eg, D- series of 
substances such as DOB) mainly act on 5HT2a serotonin receptors to produce 
its ‘psychedelic’ effects and the prescence of a methy group on the alpha carbon 
of substituted phenethylamines increases the effects by 210 fold due to its 
agonistic effects  (Nichols DE, 1994 and Acuna-Castillo C, 2002).   
The pharmacological characteristics of several unidentified NPS are not known 
yet. However, as a general finding on this research, the NPS (excluding the 
synthetic cannabinoids) are most likely to act via serotoninergic (5HT1a/1b/1d; 
5HT2a/2b/2c), noradrenergic or dopaminergic pathways. Some of them such as 
naphyrone act as triple reuptake inhibitor (acting on serotonin/dopamine and 
norepinephrine transporter) (Meltzer et al, 2006 and Simmler et al, 2012). These 
NPS possibly possess significant activity to inhibit MAOs in small doses leading 
to increased levels of monoamines such as dopamine or serotonin. Hence the 
chances of developing a dangerous clinical situation such as ‘Serotonin 
Syndrome’ is exceptionally high if combined with any other Serotonergic agents 
(eg, combination of NPS, combining with medications such as SSRI 
antidepressants, concimittant use of opioids etc).   
The Emergency Departments have become clueless in managing their acute 
toxicity, as the scientific literature is scant and most of the healthcare 
professionals are possibly unaware of these emerging phenomena of ‘novel 
psychoactive substances’. The mortality rate of serotonin syndrome is reported 
between 2% and 12%. In the USA, The Toxic Exposure Surveillance System 
reported 93 deaths due to serotonin syndrome in 2002 (Watson et al, 2002 and 
Frank, 2008).  
A serotonergic syndrome should be suspected in patients presenting to 
Emergency departments with a history of NPS ingestion and clinical signs of 
clonus, hyperthermia, hypertension and hypertonia. The core management of 
such emergency is basically symptomatic. First, further use of the offending 
NPS should be discontinued and the identity of all the NPS taken should be 
established, if possible and the sample must be sent to laboratory for GC-MS 
analysis. (Boyer and Shannon, 2005). Adequate hydration should be maintained 
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with diuresis above 50-100mls/ hr to avoid the risk of myoglobinuria (Jaunay et 
al, 2001). Benzodiazepines can be used to treat neurological symptoms such as 
agitation, hyper excitability, hyperreflexia and psychiatric manifestations. Since 
benzodiazepines act through GABA receptors and do not interfere with 
serotonergic/ dopaminergic pathways, prescription of diazepam or lorazepam for 
short term use is largely beneficial.  
Though agents such as propranolol, cyproheptadine and chlorpromazine can be 
used for treatment, they lack sound evidence base. Complicated patients need 
resuscitation (mechanical ventilation, antiepileptic/antihypertensive etc.) 
(Birmes et al, 2003; Jaunay et al, 2001; Mason et al, 2000).  
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Limitations  
 
An array of challenges await for those involved in this field of scientific 
research. Identifying and characterising these compounds would be the first 
major step towards gathering evidence based literature. This research is one of 
those that contribute towards this and it gives an overview of a sample of 
psychoactive substances.  
New NPS flood the online shops everyday replacing the older ones. There are 
several hundreds of such compounds available for sale online around the world. 
Most of these NPS lack robust evidence based literature. It may be difficult to 
conduct large clinical trials involving human subjects. It might well raise the 
ethical dilemma of such intervention. Also, it would be a colossal task to 
accomplish such studies for each compound.  
Another point to emphasise here is the relative instability of the above described 
'pro drug' websites. The information contained in the webfora is not guaranteed 
to be stable over time. New websites appear regularly and also websites close 
down constantly (Davey et al, 2012). Thus monitoring of these website fora 
should be a regular exercise (Davey et al, 2012).  
The market has developed into very flexible system and well prepared to 
dispatch new compounds for sale, once the older ones become controlled in a 
particular country.  Hence, as new NPS appear day by day, the evidence based 
information also needs to be updated relentlessly.   
It is difficult to track down a specific website which may sell NPS that are 
illegal in a country. In most cases, the websites could be based in a different 
country (eg, China, Mexico). Hence it could potentially become impossible to 
prosecute the website organisation based in one country using the law from 
another country.   
Also, the genuinity of each product is questionable. There have been numerous 
investigations into the identity of the samples and have concluded that the 
majority of the products do not contain the specified ingredients or they might 
contain other psychoactive substances and/ or adulterants (Brandt et al., 2010; 
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Baron et al., 2011; Khreit et al., 2012). Hence the toxicity report pertaining to a 
particular compound becomes dubious and whether it reflects the characteristics 
of the compound or its due to the combination of compounds in the mixture.  
This research has been based on the vast qualitative data supplied by the online 
drug misuse communities. The users discuss in depth about their experience and 
toxicity for a range of psychoactive compounds for which hardly any scientific 
literature exist. However, the information gathered from the web fora arise from 
online source alone. Interviewing users, their carers and analytical confirmation 
of the compounds bought online by standardised investigations such as Gas 
Chromatography and Mass Spectrometry would add more value.    
Thus, a number of opportunities as well as challenges exist in this field of NPS 
and the virtual communities – identification of new substances, tracking 
websites, criminality, amendments to the existing legislations, international 
cooperation, management of overdoses etc. Thankfully, research projects such as 
this one along with the ReDNet project have started to uncover the depths of this 
recreational world which could potentially become a major public health 
concern in the future.        
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 Conclusions 
 
A range of novel psychoactive substances have been made recently available 
across the globe. The sale is easily achieved through the Internet. New 
legislations are made to control some recreational substances whilst newer 
substances appear. Furthermore, the distributors sell the backlog of products 
even after controlling of the substance has occured and hence are liable to 
potentiating criminal investigations. Hence it is suggested as well that the 
'genuinity' of each onlince susbtance is questionable. Evidence-based literature 
is scant for the vast majority of these substances.This research was carried out 
on thirty NPS which could represent vast numbers of NPS emerging online. The 
summaries/technical reports on these thirty NPS has given an overview of the 
NPS on the worldwide market and provides useful insight into the online users 
perspectives/ subjective experiences, health related risks and their management.  
The online communities share information about NPS to support and warn 
members from the potential adverse effects of these substances. Accidental 
overdoses are common occurences and some of the potential life-threatening 
clinical situations include sympathomimetic toxidrome and serotonin syndrome. 
Benzodiazepines appear to help with agitation and neuropsychiatric 
manifestations. Prompt recognition of overdoses, access to Emergency 
departments, comprehensive assessment including full history are of paramount 
importance to prevent potential medical/psychiatric complications and even 
death.  
Better levels of international cooperation and rapid share of available 
information may be needed to tackle the emerging problem of the novel 
psychoactive substances. Further research is required to have a broad perceptive 
about the NPS and effective ways of managing them.  
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Appendix C  
Ethical committee’s advice on the Psychonaut web scanning project:   
Wandsworth Research Ethics Committee 
St George's University of London 
South London REC office 1 
Room 1.14,  
1st Floor, Jenner Wing 
Tooting 
London 
SW17 0QT 
 
Telephone: 020 8725 1558  
Facsimile: 020 8725 1980 
 
15th May 2008 
 
Dr. Paolo Deluca, Ph.D. 
Senior Research Fellow in Addictive Behaviour 
Section of Alcohol Research 
National Addiction Centre, PO48 
Division of Psychological Medicine and Psychiatry  
Institute of Psychiatry  
King's College London 
4 Windsor Walk 
London  
SE5 8BB 
 
Dear Dr Deluca,   
 
Full title of project: Psychonaut web scanning, alert on new recreational drugs on 
the web; building up a European-wide digital web scan 
monitoring system 
REC reference: 0040. 08 
 
Thank you for seeking the Committee’s advice about the above project. It has been 
considered by the Sub-Committee.  
 
 
I enclose a copy of our leaflet, “Defining Research”, which explains how we differentiate 
research from other activities.  The Sub-Committee has advised that the project is a survey 
and therefore not considered to be research according to this guidance. Therefore it does 
not require ethical review by a NHS Research Ethics Committee.  
 
This letter should not be interpreted as giving a form of ethical approval to the project or any 
endorsement of the project, but it may be provided to a journal or other body as evidence 
that ethical approval is not required under NHS research governance arrangements. 
 
However, if you, your sponsor/funder or any NHS organisation feels that the project should 
be managed as research and/or that ethical review by a NHS REC is essential, please write 
setting out your reasons and we will be pleased to consider further. 
 
Where NHS organisations have clarified that a project is not to be managed as research, the 
Research Governance Framework states that it should not be presented as research within 
the NHS. 
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Yours sincerely 
 
Emma Clark 
Committee Co-ordinator 
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username (e-mail address) and password.  
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included on the Author Services My Publications page if this service is available for your journal. 
See Offprint Information for further details: http://authorservices.wiley.com/bauthor/offprint.asp. 
 
OnlineOpen - Open Access Option 
Your accepted article can be made open access using OnlineOpen. OnlineOpen will make your article 
freely available to non-subscribers on publication and the final version of your article will be archived in 
PubMed Central. With OnlineOpen the author, or a funding agency or institution, pays a fee to ensure that 
the article is made open access. The OnlineOpen fee is fixed at US$3000 for most journals. To make your 
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subscribers. 
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